Quarterlytics / Consumer Defensive / Tobacco / Universal Corporation

Universal Corporation

uvv · NYSE Consumer Defensive
Claim this profile
Ticker uvv
Exchange NYSE
Sector Consumer Defensive
Industry Tobacco
Employees 10800
← All annual reports
FY2020 Annual Report · Universal Corporation
Sign in to download
Loading PDF…
2020 UNIVERSAL CORPORATION

ANNUAL REPORT
BUILDING FOR THE FUTURE

ABOUT US
ABOUT US

For over 100 years, Universal Corporation has been finding innovative solutions to 

serve our customers and meet their agri-products needs. We built a global presence, 

solidified long-term relationships with customers and suppliers, adapted to changing 

agricultural  practices,  embraced  state  of  the  art  technology,  and  emerged  as  the 

recognized industry leader. 

Today, we conduct business in over 30 countries on five continents, employ more 

than 20,000 permanent and seasonal workers, and procure, finance, process, pack, 

store, and ship leaf tobacco and other agri-products. Tobacco has been our principal 

focus since our founding in 1918, and we are the leading global leaf tobacco supplier. 

Recognizing that leaf tobacco is a mature industry, we have also been positioning 

your company for the future by investing in non-tobacco businesses and are focusing 

on building out a broader plant-based agri-product services platform. 

Universal  Corporation  has  a  long  history  of  operating  with  integrity,  honesty,  and 

a  focus  on  quality.  We  are  a  vital  link  in  the  leaf  tobacco  supply  chain,  providing 

expertise  in  working  with  large  numbers  of  farmers,  efficiently  selling  various 

qualities  of  leaf  to  a  broad  global  customer  base,  adapting  to  meet  evolving 

customer needs, and delivering products that meet stringent quality and regulatory 

specifications. Going forward, we will build on our history by seeking opportunities 

in  both  tobacco  and  non-tobacco  to  leverage  both  our  assets  and  expertise.  We 

will continue our commitment to leadership in setting industry standards, operating 

with transparency, providing products that are responsibly-sourced, and investing in 

and strengthening the communities where we operate.

FINANCIAL HIGHLIGHTS

in thousands, except per share data

Fiscal Year Ended

Fiscal Year Ended

Fiscal Year Ended

March 31, 2020

March 31, 2019

March 31, 2018

OPERATIONS 

Sales and other operating revenues 

$     1,909,979

$   2,227,153

$   2,033,947 

Operating income 

Segment operating income  

Net income  

Net income attributable to Universal Corporation

PER COMMON SHARE 

Net income attributable to Universal Corporation*

126,367

138,121

78,003

71,680

161,169

 186,772

110,134

104,121

170,825

179,950

116,168

105,662

common shareholders—diluted 

$             2.86

$             4.11

$             4.14

Dividends declared 

Market price at year end

AT YEAR END 

Working capital

3.04

44.21

3.00

57.63

2.18

48.50

$     1,212,218

$  1,334,397

$   1,321,323

Total Universal Corporation shareholders’ equity

1,246,665

1,337,087

1,342,429

4
0
.
3

0
0
.
3

8
1
.
2

4
1
.
2

0
1
.
2

1
1
.
4

4
1
.
4

2
9
.
3

*
*
8
8
.
0

6
8
.
2

6

5

4

3

2

1

0

3.5

2.8

2.1

1.4

0.7

0.0

2
.
1
6
1

8
.
0
7
1

4
.
8
7
1

0
.
2
8
1

4
.
6
2
1

300

240

180

120

60

0

20

19

18

17

16

20

19

18

17

16

20

19

18

17

16

Net Income Per Diluted Share* 

Dividends Declared

Operating Income 

in dollars

in dollars

in millions of dollars

*      Attributable  to  Universal  Corporation  common  shareholders  after  deducting  amounts  attributable  to  noncon-

trolling interests in consolidated subsidiaries.

**  Includes a one-time reduction of earnings available to common shareholders of $74 million, or $2.99 per diluted 
share, from the conversion for cash of the remaining shares of the Company’s Series B 6.75% Convertible Perpetual 
Preferred Stock.

Universal Corporation
Annual Report

1

 
 
BOARD OF DIRECTORS
Universal Corporation

George C. Freeman, III 1 * 2
Chairman, President and  
Chief Executive Officer 
Universal Corporation

Thomas H. Johnson 1 4 * 5
Chief Executive Officer  
The Taffrail Group, LLC 

Eddie N. Moore, Jr. 1 2 3
Retired President and  
Chief Executive Officer 
Norfolk State University

Michael T. Lawton 1 3 * 4
Retired Executive  
Vice President and 
Chief Financial Officer  
Domino’s Pizza, Inc.

Robert C. Sledd 2 * 3 5
Managing Partner 
Pinnacle Ventures, LLC

Diana F. Cantor 2 4 5 *
Partner 
Alternative Investment 
Management, LLC

Lennart R. Freeman 1 3 4
Retired Executive  
Vice President 
Swedish Match AB

DIRECTORS 
Universal Leaf Tobacco Company, Inc.   / Universal Global Ventures, Inc. +

Thomas H. Tullidge, Jr. 2 3 5
Chief Strategy Officer,  
Legal and Finance 
Cary Street Partners 
Financial LLC

Jacqueline T. Williams 2 3 5
Former Director 
Ohio Department of 
Commerce

George C. Freeman, III
Chairman, President and  
Chief Executive Officer

Catherine H. Claiborne
Senior Vice President and  
Secretary 

Friedrich G. Bossert
Managing Director,  
Dark Air-Cured Region

J. Patrick O’Keefe +
Senior Vice President 
Universal Global Ventures, Inc.

Airton L. Hentschke
Executive Vice President and 
Chief Operating Officer

Candace C. Formacek
Senior Vice President and 
Treasurer

Cesar A. Bünecker
Managing Director,  
South America Region

Gary S. Taylor
Managing Director,  
Africa Region

Johan C. Kroner
Executive Vice President and 
Chief Financial Officer

Preston D. Wigner
Senior Vice President,  
General Counsel and 
Assistant Secretary

Theodore G. Broome
Executive Vice President and 
Sales Director 

Paul G. Beevor
Managing Director, 
Asia Region

Domenico Cardinali
Managing Director,  
Europe Region 

Jonathan R. Wertheimer
President,  
Socotab, L.L.C.

Clayton G. Frazier
Managing Director,  
North America Region

2

Universal Corporation
Annual Report

OFFICERS
Universal Corporation

George C. Freeman, III
Chairman, President, and  
Chief Executive Officer

Catherine H. Claiborne
Vice President and  
Assistant Secretary 

H. Michael Ligon
Vice President, 
Corporate Affairs 

Jennifer S. Rowe
Assistant Vice President,  
Capital Markets

Airton L. Hentschke
Senior Vice President and 
Chief Operating Officer

Steven S. Diel
Vice President,  
Business Development 

Harvard B. Smith
Vice President and  
Chief Compliance Officer

Johan C. Kroner
Senior Vice President and 
Chief Financial Officer

Candace C. Formacek
Vice President and  
Treasurer

Preston D. Wigner
Vice President, General 
Counsel and Secretary

Scott J. Bleicher
Vice President and  
Controller 

Joseph W. Hearington, Jr.
Vice President,  
Internal Auditing

Beth Ann Luther
Corporate Director, 
Taxes

CHAIRMEN EMERITUS

Henry H. Harrell
Allen B. King

1  Executive Committee
2  Finance and Pension Investment Committee
3  Audit Committee
4   Compensation Committee
5  Nominating and Corporate Governance Committee

*  Committee Chairman

Universal Corporation
Annual Report

3

TO OUR SHAREHOLDERS

Before reviewing Universal Corporation’s fiscal 2020 performance, 

I  want  to  start  by  addressing  the  COVID-19  pandemic.  While  the 

pandemic  has  had  some  impact  across  the  industry  and  on  our 

recent results, we believe the actions that we have taken and the 

commitment  displayed  by  our  employees  will  enable  Universal 

Corporation to successfully navigate these dynamic times. 

Like many other companies, we have worked diligently to address this 

crisis and have implemented a number of measures to safeguard the 

health and wellbeing of our people. Universal Corporation conducts 

business in more than 30 countries across five continents and, during 

this  time,  our  number  one  priority  is  the  health  and  safety  of  our 

20,000+ permanent and seasonal employees. I am incredibly proud 

of their hard work under challenging conditions while continuing to 

deliver for our customers, partners, and shareholders.

Although  lower  carryover  crop  sales  volumes  and  the  impact  of  the  COVID-19  pandemic  in  our  fourth 

fiscal  quarter  on  currency  comparisons  and  shipment  timing  affected  our  fiscal  year  2020  results,  the 

business performed and has continued to perform as anticipated. In fiscal year 2020, we reported:

•   Net  income  of  $71.7  million,  or  $2.86  per  diluted  share,  compared  with  fiscal  year  2019’s  net 

income  of  $104.1  million,  or  $4.11  per  diluted  share.  Excluding  restructuring  and  impairment 

costs and certain non-recurring items, net income and diluted earnings per share declined by 

$25.3 million and $0.96, respectively, for fiscal year 2020, compared to fiscal year 2019.

•   Operating  income  of  $126.4  million,  compared  to  operating  income  of  $161.2  million  for  the 

fiscal year ended March 31, 2019.

•   Segment operating income of $138.1 million, a decrease of $48.7 million, compared to segment 

operating income of $186.8 million for the fiscal year ended March 31, 2019.

4

Universal Corporation
Annual Report

 
 
 
•   Consolidated revenues of $1.9 billion, a decrease of $317.2 million, for the year ended March 31, 

2020, primarily due to lower sales volumes and prices. 

Throughout the year, we also continued to execute on the four key capital allocation priorities we previously 

laid out in 2018. These are:

•  Strengthening and investing for growth in our tobacco business;

•  Increasing our strong dividend;

•   Exploring growth opportunities in non-tobacco industries and markets that utilize our assets 

and capabilities; and

•  Returning excess capital through share repurchases.

Consistent  with  these  priorities,  we  made  disciplined  investments  in  our  core  tobacco  business.  We 

recognize the tobacco industry is changing as consumption continues its slow decline and new products 

enter the marketplace. As a result, our investments were focused on increasing natural wrapper production 

in strategic regions around the world  to meet ongoing and future demands and enhancing our value-

added services for our natural wrapper customers.

In addition to investing in our core tobacco business, in January we closed on the acquisition of FruitSmart 

Inc. – a foundational step in building out a broader plant-based agri-products services platform. Soon 

thereafter, we announced the appointment of Patrick O’Keefe as Senior Vice President of Universal Global 

Ventures,  Inc.,  a  wholly-owned  non-tobacco  subsidiary  of  Universal  Corporation  that  holds  FruitSmart. 

With nearly three decades of food and beverage skills and industry experience that directly apply to our 

ongoing  strategic  and  growth  initiatives,  Patrick  expands  and  deepens  our  talented  executive  team  in 

areas outside of tobacco. Importantly, we maintain an active investment pipeline and plan to continue 

pursuing  opportunities  outside  of  our  leaf  tobacco  business  that  utilize  our  core  competencies  and 

position us for long‐term success. 

Universal Corporation
Annual Report

5

 
 
 
 
 
Lastly,  at  the  end  of  May,  we  proudly  announced  our  50th  annual  dividend  increase,  representing  the 

continuation of our strong record of returning value to our shareholders. In addition, over the course of 

fiscal 2020, we repurchased approximately $33.5 million worth of Universal stock.

As I wrote in my letter last year, we understand there’s more to business than profit, and we believe that we 

have a fundamental responsibility to our stakeholders to set high standards of social and environmental 

performance to support a sustainable supply chain. We continuously strive to improve efficiencies in our 

operations and supply chain, while also implementing programs that support the communities where we 

operate. For example, this fiscal year, we contributed significant resources to Cyclone Idai relief in southern 

Africa,  which  swept  through  our  operating  regions  in  Mozambique,  Malawi,  and  Zimbabwe.  Universal, 

in  partnership  with  our  customers,  distributed  over  $200,000  in  medicines,  foodstuffs,  water  purifiers, 

building  materials,  tents,  blankets,  and  mosquito  nets  to  those  affected  and  displaced  by  the  floods. 

To minimize the post cyclone Idai effects, part of this contribution was allocated to the rehabilitation of 

schools damaged by the cyclone in tobacco growing Districts of Tsangano, Angonia and Macanga in Tete 

Province, Mozambique. Once again, we have featured some of our sustainability programs in this annual 

report and in our Sustainability Report which can be found on our website, and I encourage you to read 

more about them.

Eddie N. Moore, Jr., our Lead Independent Director, will be retiring from our Board at the conclusion of 

our 2020 Annual Meeting of Shareholders. Eddie has been a valued member of our Board for 20 years, 

and I would like to thank him for his many contributions. Your Company has greatly benefited from Eddie’s 

insights and expertise, and we have deeply valued his distinguished service.

In  conclusion,  this  has  been  a  challenging,  yet  rewarding,  year  for  your  Company.  Despite  these 

unprecedented  times,  we  executed  on  our  plans  and  implemented  actions  to  better  position  your 

Company for growth and success in the future. On behalf of the entire Board, I am honored to be part of 

the Universal Corporation team, and we are all honored to work for you, our shareholders. Thank you for 

your continued support.

George C. Freeman, III
Chairman, President, and Chief Executive Officer 

6

Universal Corporation
Annual Report

Universal Corporation
Annual Report

7

ACTIONS WE ARE TAKING TO 
STRENGTHEN YOUR COMPANY

Tobacco
We  recognize  that  our  primary  business,  leaf 

tobacco,  is  changing  as  consumption  contin-

ues its slow decline and new products enter the 

Building for the Future
Fiscal  year  2020  has  been  a  year  of  investment 

marketplace.  Universal  is  proactively  adapting 

to these changes, and we remain committed to 

for your company. In the current turbulent times, 

our role as the leading global leaf tobacco sup-

when the world is confronting new and unprec-

plier  for  our  customers.  We  continue  to  make 

edented challenges, we remain focused on po-

investments  in  our  tobacco  business  that  we 

sitioning  your  company  for  future  success.  Uni-

believe will strengthen your company now and 

versal is strategically investing in projects in our 

in the future.

tobacco  business  that  provide  opportunities  to 

gain market share, expand the services we pro-

Recognizing  the  strong  demand  for  natural  to-

vide  our  customers,  and  increase  operating  ef-

bacco wrappers, we have taken steps to increase 

ficiencies.  We  made  a  foundational  investment 

production in strategic regions around the world 

outside tobacco in a fruit and vegetable proces-

to  meet  our  customers’  ongoing  and  future 

sor  and  maintain  an  active  investment  pipeline 

demands.  This  includes  expanding  our  partici-

of other non-tobacco growth prospects. In addi-

pation  in  key  wrapper  growing  areas  as  well  as 

tion, we continue to enhance our robust sustain-

growing  highly  desired  wrapper  varieties  in  ar-

ability  programs,  particularly  in  areas  that  pro-

eas where they have not been previously grown. 

mote responsible environmental stewardship.

In  addition,  we  are  increasing  additional  value- 

added  services  such  as  specialized  buying  ser-

vices,  sorting,  and  fermenting  for  our  natural 

wrapper customers.

8

Universal Corporation
Annual Report

  
 
Non-Tobacco
As part of our previously-announced capital allo-

cation strategy to invest in non-tobacco growth 

opportunities,  Universal  completed  the  acqui-

sition  of  FruitSmart,  Inc.  (“FruitSmart”)  in  early 

January 2020. We believe that FruitSmart, as an 

established value-added fruit and vegetable in-

gredient  processor  with  a  business-to-business 

customer  base  in  an  agricultural  niche  market, 

is  a  good  fit  for  your  company.  The  acquisition 

also represents a foundational step in our devel-

opment of a broader value-added, plant-based 

agri-products  service  platform  and  an  invest-

ment  in  the  section  of  the  agricultural  value 

FruitSmart, Inc.

Established value-added fruit and 
vegetable ingredient processor

•    Established value-added fruit and 

vegetable ingredient processor with 
roots dating back to 1982.

•    Supplies a broad set of juices, 

concentrates, blends, purees, fibers, 
seed and seed powders.

chain  where  we  believe  we  possess  significant 

•    Processes apples, grapes, 

blueberries, raspberries, cherries, 
blackberries, pears, cranberries and 
strawberries as well as other fruits 
and vegetables.

•    Business to business company that 

supplies products to food, beverage 
and flavor companies throughout the 
United States and internationally.

•    Headquartered in the Yakima Valley 

of Washington state where it has two 
manufacturing facilities.

business expertise. We consider the agricultural 

value chain to consist of agricultural inputs, crop 

production, agricultural processing, manufactur-

ing and distribution and retail sales.

Agricultural Value Chain

Agricultural Inputs

Crop Production

Agricultural Processing

Manufacturing & Distribution

Retail Sales

Universal Corporation
Annual Report

9

holders  to  improve  efficiency  and  emissions  on 
the  farms  where  we  contract.  We  may  provide 
financing for improved curing barns and provide 
training to farmers on best practices. We believe 
in  reducing  the  environmental  footprint  of  our 
supply chain.

Universal’s 3 Primary
Environmental Impacts

Water
Usage

Waste
Management

Greenhouse Gas
Emissions

Sustainability
Universal has a fundamental responsibility to its 
stakeholders to achieve high standards of envi-
ronmental  performance  to  support  sustainable 
operations.  Understanding  our  global  environ-
mental  impacts  and  opportunities  is  critical  to 
maintaining  commitments  to  the  communities 
in which we operate. Universal recognizes three 
primary  environmental  impacts  throughout  our 
global footprint: water usage, waste generation, 
and greenhouse gas emissions.

Universal  monitors  and  manages  our  identified 
environmental  impacts  sustainably  and  respon-
sibly. We manage water usage to reduce waste 
and  reuse  or  recycle  when  operationally  feasi-
ble.  We  continuously  strive  to  improve  efficien-
cies and work towards using renewable fuels in 
our operations and supply chain. Finally, we also 
promote  forestation  and  the  use  of  sustainably 
sourced wood in our operations and our supply 
chain. These actions are part of our ongoing ef-
forts to be part of the solution to climate change 
and improve our environmental footprint.

Universal  believes  in  implementing  practices 
that create a sustainable operating environment. 
We  have  invested  in  management  systems  that 
allow us to calculate and track emissions based 
on  our  fuel  use  data.  Within  our  operations  we 
make  investments  that  reduce  our  greenhouse 
gas  emissions  footprint,  primarily  in  biofuels, 
LED lighting, and electric vehicles. For example, 
in  Italy  our  electric  vehicles  generate  83%  less 
CO2 emissions than typical diesel forklifts. Uni-
versal  has  also  committed  to  continuing  to  re-
duce our greenhouse gas emissions. In order to 
align our operations with the Paris Agreement in 
support of limiting global warming to well-below 
2°C  above  pre-industrial  levels,  we  have  com-
mitted to set a science-based target through the 
Science Based Targets initiative.

Universal  believes  that  our  farmers  should  also 
grow  and  cure  tobacco  sustainably.  We  have 
invested  in  forestry  and  work  with  other  stake-

10

Universal Corporation
Annual Report

Universal Corporation
Annual Report

11

COMPARISON  OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among Universal Corporation, the S&P Smallcap 600 Index,
and a Peer Group

PERFORMANCE GRAPH
Comparison of 5 Year Cumulative Total Return*

$300

$250

$200

$150

$100

$50

$0

3/15

3/16

3/17

3/18

3/19

3/20

Universal Corporation

S&P Smallcap 600

Peer Group

*$100 invested on 3/31/15 in stock or index, including reinvestment of dividends. Fiscal year ending March 31.

Copyright© 2020Standard & Poor’s, a division of S&P Global. All rights reserved.

The performance graph compares the cumulative total shareholder return on Universal Corporation com-

mon stock for the last five fiscal years with the cumulative total return for the same period of the Standard 

& Poor’s Smallcap 600 Stock Index and the peer group index. The peer group represents Pyxus Internation-

al, Inc. (formerly Alliance One International, Inc.). The graph assumes that $100 was invested in Universal 

Corporation common stock at the end of the Company’s 2015 fiscal year, and in each of the comparative 

indices, in each case with dividends reinvested.

CUMULATIVE TOTAL RETURN UNIVERSAL CORPORATION COMMON STOCK

2015

2016

2017

2018

2019

2020

At March 31

Universal Corporation

$    100.00

$  125.38

$  161.95

$  115.13

$  143.37

$  115.94

S&P Smallcap 600

Peer Group

100.00

100.00

96.80

159.64

120.60

116.82

135.89

236.82

138.01

217.18

102.28

28.27

12

Universal Corporation
Annual Report

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 10-K 

☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE FISCAL YEAR ENDED MARCH 31, 2020
OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM ______________TO_______________

Commission File Number:  001-00652 

UNIVERSAL CORPORATION 
(Exact name of registrant as specified in its charter)

Virginia
(State or Other Jurisdiction of
Incorporation or Organization)

54-0414210
(I.R.S. Employer
Identification Number)

9201 Forest Hill Avenue, Richmond, Virginia 23235

(Address of Principal Executive Offices)

(Zip Code)

 804-359-9311 
(Registrant's telephone number, including area code) 

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class
Common Stock, no par value

Trading Symbol(s) Name of each exchange on which registered

UVV

New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:    None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.   
Yes þ No o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 (d) of the Act.  
Yes o  No þ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.    Yes þ  No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such
files).   Yes þ  No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer,  a smaller reporting company, or
an emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth
company" in Rule 12b-2 of the Exchange Act. 

Large Accelerated Filer

☑ Accelerated filer

☐ Non-accelerated filer

☐

Smaller reporting company ☐ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ☐   No ☑ 

The aggregate market value of the registrant's voting and non-voting common equity held by non-affiliates, based upon the closing sales price on the
New York Stock Exchange of the registrant's common stock on September 30, 2019, the last business day of the registrant's most recently completed
second fiscal quarter, was approximately $1.3 billion.

As of May 25, 2020, the total number of shares of common stock outstanding was 24,431,137.

DOCUMENTS INCORPORATED BY REFERENCE

Part  III  incorporates  certain  information  by  reference  from  the  registrant's  2020  Proxy  Statement  for  the  2020 Annual  Meeting  of
Stockholders, which will be filed no later than 120 days after the close of the registrant's fiscal year ended March 31, 2020.

UNIVERSAL CORPORATION
FORM 10-K
TABLE OF CONTENTS

PART I

Business ....................................................................................................................................................

Risk Factors...............................................................................................................................................

Unresolved Staff Comments .....................................................................................................................

Properties ..................................................................................................................................................

Legal Proceedings .....................................................................................................................................

Mine Safety Disclosures ...........................................................................................................................

PART II

Market for Registrant's Common Equity, Related Stockholder Matters 
and Issuer Purchases of Equity Securities.................................................................................................

Selected Financial Data.............................................................................................................................

Management's Discussion and Analysis of Financial Condition and Results of Operations....................

Item No.

1.

1A.

1B.

2.

3.

4.

5.

6.

7.

7A.

Quantitative and Qualitative Disclosures About Market Risk ..................................................................

8.

9.

9A.

9B.

10.

11.

12.

13.

14.

15.

16.

Financial Statements and Supplementary Data.........................................................................................

Changes in and Disagreements With Accountants on Accounting and Financial Disclosure...................

Controls and Procedures ...........................................................................................................................

Other Information .....................................................................................................................................

PART III

Directors, Executive Officers, and Corporate Governance.......................................................................

Executive Compensation...........................................................................................................................

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

Certain Relationships and Related Transactions, and Director Independence..........................................

Principal Accounting Fees and Services ...................................................................................................

PART IV

Exhibits, Financial Statement Schedules ..................................................................................................

Form 10-K Summary ................................................................................................................................

Schedule II - Valuation and Qualifying Accounts.....................................................................................

Exhibit Index.............................................................................................................................................

Signatures..................................................................................................................................................

2

Page

3

9

14

15

16

17

18

19

21

38

39

100

100

100

101

102

102

102

102

103

103

104

105

107

Forward-Looking Statements

This Annual Report on Form 10-K, which we refer to herein as our Annual Report, contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”).  Among other things, these statements relate to Universal Corporation’s financial condition, results of operations
and future business plans, operations, opportunities, and prospects.  In addition, Universal Corporation and its representatives may
make written or oral forward-looking statements from time to time, including statements contained in other filings with the Securities
and Exchange Commission (the “SEC”) and in reports to shareholders.  These forward-looking statements are generally identified
by the use of words such as we “expect,” “believe,” “anticipate,” “could,” “should,” “may,” “plan,” “will,” “predict,” “estimate,”
and  similar  expressions  or  words  of  similar  import.    These  forward-looking  statements  are  based  upon  management’s  current
knowledge and assumptions about future events and involve risks and uncertainties that could cause actual results, performance, or
achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied
by such forward-looking statements.  Such risks and uncertainties include, but are not limited to:  impacts of the ongoing COVID-19
pandemic; anticipated levels of demand for and supply of our products and services; costs incurred in providing these products and
services;  timing  of  shipments  to  customers;  changes  in  market  structure;  government  regulation;  product  taxation;  industry
consolidation and evolution; changes in exchange rates and interest rates; impacts of regulation and litigation on our customers;
integration of new businesses and the impact of these new businesses on future results; and general economic, political, market, and
weather conditions.  For a description of factors that may cause actual results to differ materially from such forward-looking statements,
see Item 1A, “Risk Factors.”  We caution investors not to place undue reliance on any forward-looking statements as these statements
speak only as of the date when made, and we undertake no obligation to update any forward-looking statements made in this report.
In addition, the discussion of the impact of current trends on our business in “Management’s Discussion and Analysis of Financial
Condition and Results of Operations – Other Information Regarding Trends and Management’s Actions” in Item 7 should be read
carefully in connection with evaluating our business and the forward-looking statements contained in this Annual Report.

General

This Annual Report uses the terms “Universal,” “the Company,” “we,” “us,” and “our” to refer to Universal Corporation
and its subsidiaries when it is not necessary to distinguish among Universal Corporation and its various operating subsidiaries or
when any distinction is clear from the context in which it is used.

 See the “Results of Operations” section in “Management’s Discussion and Analysis of Financial Condition and Results of
Operations” in Item 7 for a discussion of adjusted operating income (loss), adjusted net income (loss) attributable to Universal
Corporation, adjusted diluted earnings (loss) per share, and segment operating income (loss), non-GAAP financial measures that we
refer to in this Annual Report on Form 10-K and consider useful in understanding our business results and trends.

PART I

Item 1.   Business 

A.

The Company 

Overview 

We are an agri-products supplier.  Tobacco has been our principal focus since our founding in 1918, and we are the leading
global leaf tobacco supplier.  We operate in over 30 countries on five continents and procure, finance, process, pack, store and ship
leaf tobacco and other agri-products.  The largest portion of our business involves procuring and processing flue-cured and burley
leaf tobacco for manufacturers of consumer tobacco products.  We do not manufacture any consumer products.  Rather, we support
consumer product manufacturers by selling them processed raw products and performing related services for them.  Our reportable
segments for our flue-cured and burley tobacco operations are North America and Other Regions.  We also have a third reportable
segment, Other Tobacco Operations, which comprises our dark tobacco business, our oriental tobacco joint venture, our fruit and
vegetable processing businesses, and certain tobacco- and agribusiness-related services.  We generated approximately $1.9 billion
in consolidated revenues and earned $126.4 million in total operating income and $138.1 million in total segment operating income
in fiscal year 2020.  Universal Corporation is a holding company that operates through numerous directly and indirectly owned
subsidiaries.    Universal  Corporation’s  primary  subsidiary  is  Universal  Leaf  Tobacco  Company,  Incorporated.    See  Exhibit  21,
“Subsidiaries of the Registrant,” for additional subsidiary information.   

3

Key Operating Principles

We believe that by following several key operating principles we can continue to produce good financial returns and enhance

shareholder value.  These key operating principles are: 

•

•

•

•

•

Strategic market position. We work closely with both our customers and our suppliers to ensure that we deliver a
product  that  meets  our  customers'  needs  while  cultivating  a  strong,  sustainable  supplier  base. We  balance  product
purchases against indicated customer demand and maintain global procurement and production operations to maximize
supply chain efficiencies.

Strong local management. Having strong local management in all of our key supply origins allows us to identify and
react to constantly shifting market conditions.  Empowered and experienced local management, coupled with global
coordination, affords us the flexibility and knowledge necessary to adapt quickly in order to continually deliver high
quality, competitively-priced products and services. 

Compliant products. Customers expect a sustainable supply of compliant, traceable, competitively-priced product,
and we believe that we lead in delivering these products. Among other initiatives, we invest in training farmers in good
agricultural practices that encompass crop quality, sustainability, environmental stewardship and agricultural labor
standards. 

Diversified sources.  Our business is reliant on a strong and resilient supply chain, which enables us to deliver a stable
supply of quality products to our customers.  We operate in over 30 countries on five continents and maintain a presence
in all major flue-cured, burley, oriental, and dark air-cured tobacco origin markets.  This global presence allows us to
meet our customers' diverse product requirements while minimizing the effects of adverse crop conditions and other
localized supply disruptions.

Financial strength.  Financial strength is critical and enables us to fund our global operations efficiently and to facilitate
investment when suitable opportunities arise. Management of liquidity, interest expense, and capital costs provides us
with a competitive advantage, affords us flexibility when responding to customer requirements and market changes,
and allows us to enhance shareholder value. 

Additional Information

Our website address is www.universalcorp.com. We post regulatory filings on this website as soon as reasonably practicable
after they are electronically filed with or furnished to the SEC.  These filings include annual reports on Form 10-K, quarterly reports
on Form 10-Q, current reports on Form 8-K, proxy statements, Section 16 reports on Forms 3, 4, and 5, and any amendments to
those reports filed with or furnished to the SEC.  Access to these filings on our website is available free of charge.  Copies are also
available, without charge, from Universal Corporation Investor Relations, 9201 Forest Hill Avenue, Richmond, VA 23235. Reports
filed with the SEC may be viewed at www.sec.gov.  We also post our press releases on our website.  Information on our website is
not deemed to be incorporated by reference into this Annual Report.

In  addition,  our  Corporate  Governance  Guidelines,  Code  of  Conduct,  and  charters  for  the  Audit  Committee,  the
Compensation Committee, the Executive Committee, the Finance and Pension Investment Committee, and the Nominating and
Corporate Governance Committee are available free of charge to shareholders and the public through the “Corporate Governance”
section of our website.  Printed copies of the foregoing are available to any shareholder upon written request to our Treasurer at the
address set forth on the cover of this Annual Report or may be requested through our website, www.universalcorp.com.

4

B.

Description of Business 

General 

Our  primary  business  is  procuring,  financing,  processing,  packing,  storing,  and  shipping  leaf  tobacco  for  sale  to
manufacturers of consumer tobacco products.  Procuring leaf tobacco involves contracting with, providing agronomy support to,
and financing farmers in many origins.  We do not manufacture cigarettes or other consumer tobacco products.  Rather, we support
consumer product manufacturers by selling them processed leaf tobacco and performing related services for them. Through various
operating subsidiaries and unconsolidated affiliates located in tobacco-growing origins around the world, we contract, purchase,
process, and sell flue-cured and burley tobaccos, as well as dark air-cured and oriental tobaccos.  Flue-cured, burley, and oriental
tobaccos are used principally in the manufacture of cigarettes as well as in shisha and next generation products, and dark air-cured
tobaccos are used mainly in the manufacture of cigars, natural wrapped cigars and cigarillos, smokeless, and pipe tobacco products.
We also provide value-added services to our customers, including blending, chemical and physical testing of tobacco, service cutting
for select manufacturers, manufacturing reconstituted leaf tobacco, and managing just-in-time inventory.  

Several important operating factors characterize our company and our primary business, leaf tobacco:

•
•
•
•
•
•

Experience dealing with large numbers of farmers,
Expertise in delivering a sustainable supply of compliant, traceable, competitively-priced leaf tobacco,
Capability to meet unique customer requirements for style, volume and quality,
Longstanding customer, farmer and community relationships,
Presence in all major leaf tobacco sourcing areas, and 
Financial strength and flexibility.

In addition to our leaf tobacco business, we are involved in other smaller-scale tobacco and agribusiness opportunities.   Our
wholly-owned subsidiary, AmeriNic, Inc., produces liquid nicotine for next generation tobacco products.  AmeriNic’s products are
manufactured under stringent United States Pharmacopeia ("USP") standards.  Global Laboratory Services, Inc., another wholly-
owned subsidiary, provides testing for crop protection agents and tobacco constituents in seed, leaf, and finished products, including
e-cigarette liquids and vapors.  Analytical services include chemical compound testing in finished tobacco products and mainstream
smoke.  We also have a business in North Carolina that produces high-quality dehydrated and juiced vegetable and fruit ingredients
and  another  business  that  recycles  waste  materials  from  tobacco  production.    Additionally,  we  are  involved  in  research  and
development growth trials with trusted partners for agriproducts production, such as our current vanilla trial in Brazil. 

In  January  2020,  we  acquired  FruitSmart,  Inc.  (“FruitSmart”),  an  independent  specialty  fruit  and  vegetable  ingredient
processor serving global markets.  FruitSmart supplies a broad set of juices, concentrates, pomaces, purees, fruit fibers, seed and
seed powders, and other value-added products to food, beverage and flavor companies throughout the United States and internationally.
FruitSmart processes apples, grapes, blueberries, raspberries, cherries, blackberries, pears, cranberries and strawberries as well as
other fruits and vegetables.  This investment represents a foundational step in our development of a broader agri-products service
platform as well an investment in value-added agricultural processing, the section of the agricultural value chain where we possess
significant business expertise.  We consider the agricultural value chain to consist of agricultural inputs, crop production, agricultural
processing, manufacture and distribution, and retail sales.  We also maintain an active investment pipeline and continue to explore
growth opportunities in non-tobacco businesses and markets we believe will build on our foundational investment in FruitSmart and
deliver value to our shareholders.

With respect to our leaf tobacco business, we generate our revenues from product sales of processed, packed tobacco that
we source, from processing fees for tobacco owned by third parties, and from fees for other services.  Sales to our six largest customers,
with whom we have longstanding relationships, have accounted for more than two-thirds of our consolidated revenues for each of
the past three fiscal years.  Our sales consist primarily of flue-cured and burley tobaccos.  For the fiscal year ended March 31, 2020,
our flue-cured and burley operations accounted for 84% of our revenues and 86% of our segment operating income.

We conduct our business in varying degrees in a number of countries, including Bangladesh, Brazil, Canada, the Dominican
Republic, Ecuador, France, Germany, Guatemala, Hungary, India, Indonesia, Italy, Malawi, Mexico, Mozambique, the Netherlands,
Paraguay, the People’s Republic of China, the Philippines, Poland, Russia, Singapore, South Africa, Spain, Switzerland, Tanzania,
the United Arab Emirates, the United States, and Zimbabwe.  In addition, our oriental tobacco joint venture, Socotab, L.L.C. has
operations in Bulgaria, Greece, Macedonia, and Turkey.

Because unprocessed, or “green,” leaf tobacco is a perishable product, timely processing is an essential service to our
customers.  Our processing of leaf tobacco includes grading in the factories, blending, removal of non-tobacco material, separation
of leaf from the stems, drying, packing to precise moisture targets for proper aging, as well as temporary storage.  This generally
requires investments in factories and machinery in areas where the tobacco is grown.  Processed tobacco that has been properly
packed can be stored by customers for a number of years prior to use, but most processed tobacco is used within two to three years.

We are a major purchaser and processor in the chief exporting regions for flue-cured and burley tobacco throughout the
world.  Africa, Brazil, and the United States produce approximately two-thirds of the flue-cured and burley tobacco grown outside

5

of China.  We estimate that over the last five years we have handled, through leaf sales or processing, on average between 30% and
40% of the annual production of such tobaccos in both Africa and the United States and between 15% and 25% in Brazil.  These
percentages can change from year to year based on the size, price, and quality of the crops.  We participate in the procurement,
processing, storage, and sale of oriental tobacco through ownership of a 49% equity interest in Socotab, L.L.C., a leading supplier
of oriental tobaccos.  In addition, we maintain a presence, and in certain cases, a leading presence, in all other major tobacco growing
regions in the world.  We believe that our leading position in the leaf tobacco industry is based on our volumes handled, our operating
presence in all of the major sourcing areas, our ability to meet customer style, volume, and quality requirements, our expertise in
dealing with large numbers of farmers, our long-standing relationships with customers, our development of processing equipment
and technologies, and our financial position which enables us to make strategic investments in our business.  The efficiencies that
we offer our customers, due to our established network of operational expertise and infrastructure on the ground and our ability to
market most styles and grades of leaf to a diverse customer base, are also key to our success.

We also have a leading position in worldwide dark tobacco markets.  Our dark tobacco operations are located in most of
the major producing countries and in other smaller markets.  We operate in major dark tobacco producing countries, including the
United States, the Dominican Republic, Ecuador, Indonesia, Paraguay, the Philippines, and Brazil.  Dark tobaccos are typically used
in the manufacture of cigars, pipe tobacco, and smokeless tobacco products, and as components of certain “roll-your-own” cigarette
products.

Sales are made by our sales force and, to a much smaller degree, through the use of commissioned agents.  Most customers
are long-established tobacco product manufacturers.  Customer contract arrangements vary around the world and include negotiated
pricing as well as cost plus arrangements.  Discussions of a customer’s longer-term needs may begin as early as one to two years in
advance of a particular crop purchase.  These discussions are key to our future crop production planning.  Prior to planting each year,
we use early customer indications for type, style, processing, and volume requirements for the upcoming season’s crop to help us
determine  our  farmer  contracting  and  grower  input  needs  in  our  origins. We  work  with  our  farmers  and  customers  continually
throughout the crop season. As crops progress through the growing season, customers will inspect the crop, and a customer’s early
indications may be refined based upon emerging crop qualities and quantities and market pricing expectations.  Ultimately, purchase
agreements specifying quantity, quality, grade and price are executed, leading to inventory allocations of harvested green or processed
leaf that we have acquired.

In the majority of the countries where we operate, we contract directly with tobacco farmers or tobacco farmer cooperatives.
In most countries outside the United States, we advance seed or seedlings, fertilizer, and other agricultural inputs to farmers.  These
advances are repaid by farmers with the tobacco they produce.  We are dedicated to promoting a sustainable farmer base and provide
our farmers with agronomy support.  Our Good Agricultural Practices programs educate farmers in such matters as the reduction of
non-tobacco related materials, product traceability, environmental sustainability, agricultural labor standards, and social responsibility.

Our foreign operations are subject to international business risks, including unsettled political conditions, expropriation,
import and export restrictions, exchange controls, and currency fluctuations.  During the tobacco season in many of the countries
listed above, we advance funds, guarantee local loans, or do both, each in substantial amounts, for the eventual purchase of tobacco.
The majority of these seasonal advances and loan guarantees mature in one year or less upon the farmers’ delivery of contracted
tobaccos.  Most advances to farmers are denominated in local currency, which is a source of foreign currency exchange rate risk.
Most tobacco sales are denominated in U.S. dollars, which reduces our foreign currency exchange risk after the tobacco has been
purchased.  See Item 1A, “Risk Factors” for more information about our foreign currency exchange and other risks.

For a discussion of recent developments and trends in our business, along with factors that may affect our business, see
Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Item 1A, “Risk Factors.”

Seasonality 

Our operations are seasonal in nature.  Tobacco in Brazil is usually purchased from January through July, while buying in
Malawi, Mozambique, Zimbabwe, and other African countries typically begins around March and continues through November.
Farmers begin to sell U.S. flue-cured tobacco in late July, and the marketing season lasts for approximately four months.  

We normally operate each of our processing plants for seven to nine months of the year.  During this period for each region,
inventories of green tobacco, inventories of processed tobacco, and trade accounts receivable normally reach peak levels in succession.
We normally finance this expansion of current assets with cash, short-term borrowings from banks, and customer advances, and
these funding sources normally reach their peak usage in each region during its respective purchasing or processing period.  Our
balance sheet at our fiscal year end reflects seasonal expansions in working capital in South America and Central America.  Our
financial performance is also impacted by the seasonality of our business.  Due to global tobacco growing cycles, as well as customer
shipment preferences, we typically ship a larger portion of our volumes in the second half of our fiscal year.   Changes in customer
shipment schedules or changes in crop timing in a season can shift recognition of revenue in a given fiscal year or between fiscal
years.

6

Customers 

A material part of our business is dependent upon a few customers.  Our six largest customers are Altria Group Inc., British
American Tobacco plc, China Tobacco International, Inc., Imperial Brands plc, Japan Tobacco, Inc., and Philip Morris International,
Inc.   In the aggregate, these customers have accounted for more than two-thirds of our consolidated revenues for each of the past
three fiscal years.  For the fiscal year ended March 31, 2020, each of British American Tobacco plc, Imperial Brands plc, and Philip
Morris International, Inc., including their respective affiliates, accounted for 10% or more of our revenues.  The loss of, or substantial
reduction in business from, any of these customers could have a material adverse effect on our results.  We have longstanding
relationships with all of these customers.   

We had commitments from customers for approximately $532 million of the tobacco in our inventories at March 31, 2020.
Based upon historical experience, we expect that at least 90% of such orders will be delivered during fiscal year 2021.  Most of our
products require shipment via trucks and oceangoing vessels to reach customer destinations.  Delays in the delivery of orders can
result from such factors as truck and container availability, port access and capacity, vessel scheduling, and changing customer
requirements for shipment. 

As more fully described in Note 1 to the consolidated financial statements in Item 8 of this Annual Report, we recognize
revenue from the sale of tobacco when we complete our contractual performance obligation for the transfer of the tobacco, which
is generally when title and risk of loss is transferred to our customer.  Individual shipments may be large, and since the customer
typically specifies shipping dates, our financial results may vary significantly between reporting periods due to timing of sales.  In
some  markets,  including  Brazil,  Italy,  the  Philippines,  Poland,  and  the  United  States,  we  process  tobacco  that  is  owned  by  our
customers, and we recognize the revenue for that service when the processing is completed.

Competition 

Competition among leaf tobacco suppliers is based on the ability to meet customer specifications in the growing, buying,
processing, and financing of tobacco, and on the prices charged for products and services.  Competition varies depending on the
market or country involved.  The number of competitors varies from country to country, but there is competition in most areas to
buy  and  sell  the  available  tobacco.    Our  principal  competitor  is  Pyxus  International,  Inc.  (“Pyxus”)  (formerly  Alliance  One
International, Inc.).  Pyxus operates in many of the countries where we operate.  However, we are the only global leaf tobacco supplier
in Hungary, Italy, Mexico, Mozambique, the Philippines, and Poland.  We also have reconstituted tobacco sheet facilities and operations
that handle dark air-cured tobacco.  We consider ourselves and Pyxus to be the only global leaf suppliers based on our worldwide
scope of operations.  Most of our major customers are partially vertically integrated, and thus also compete with us for the purchase
of leaf tobacco in several of the major markets.

In most major markets, smaller competitors are very active.  These competitors typically have lower overhead requirements
and provide less support to customers and farmers.  Due to their lower cost structures, they can often offer a price on products that
is lower than our price.  However, we believe that we provide quality controls and farm programs that add value for our customers
in an increasingly regulated world and make our products highly desirable.  Our Good Agricultural Practices support an approach
to farming that is focused on sustainability, employing sound field production and labor management practices that meet our customers’
needs, promote farmer profitability, and reflect environmental sensitivity. We provide comprehensive training, technical support in
the field, and crop analytics through ongoing research and development.  We believe that our major customers increasingly require
these services and that our programs increase the quality and value of the products and services we offer.  We also believe that our
customers value the security of supply that we are able to provide due to our strong relationships with our farmer base and our global
footprint.

7

Reportable Segments

We evaluate the performance of our leaf tobacco business by geographic region, although the dark air-cured and oriental
tobacco businesses are each evaluated on the basis of their worldwide operations.  Performance of the oriental tobacco operations
is evaluated based on our equity in the pretax earnings of our affiliate.  Under this structure, we have the following primary operating
segments:  North America, South America, Africa, Europe, Asia, Dark Air-Cured, Oriental, and Special Services.  North America,
South America, Africa, Europe, and Asia are primarily involved in flue-cured and burley leaf tobacco operations for supply to cigarette
manufacturers.  Our Dark Air-Cured group supplies dark air-cured tobacco principally to manufacturers of cigars, pipe tobacco, and
smokeless tobacco products, and our Oriental business supplies oriental tobacco to cigarette manufacturers. Our fruit and vegetable
ingredients and liquid nicotine businesses are included in the Special Services group.  Our Special Services group also provides
laboratory services, including physical and chemical product testing, electronic nicotine delivery system and e-liquid testing, and
smoke testing for customers. 

The five regional operating segments serving our cigarette manufacturer customers share similar characteristics in the nature
of their products and services, production processes, class of customer, product distribution methods, and regulatory environment.
Based on the applicable accounting guidance, four of the regions – South America, Africa, Europe, and Asia – are aggregated into
a single reporting segment, Other Regions, because they have similar economic characteristics.  North America is reported as an
individual operating segment, because its economic characteristics differ from the other regions, generally because its operations
require lower working capital investments for crop financing and inventory.  The Dark Air-Cured, Oriental, and Special Services
segments, which have differing characteristics in some of the categories mentioned above, are reported together as Other Tobacco
Operations, because each is below the measurement threshold for separate reporting. 

C.

Employees 

We employed approximately 24,000 employees throughout the world during the fiscal year ended March 31, 2020.  We

estimated this figure because the majority of our personnel are seasonal employees. 

D.

Research and Development 

We did not expend material amounts for research and development during the fiscal years ended March 31, 2020, 2019, or

2018. 

E.

F.

Intellectual Property 

We hold no material patents, licenses, franchises, or concessions. 

Government Regulation, Environmental Matters, and Other Matters 

Our business is subject to general governmental regulation in the United States and in foreign jurisdictions where we conduct
business. Such regulation includes, but is not limited to, matters relating to environmental protection.  To date, governmental provisions
regulating the discharge of material into the environment have not had a material effect upon our capital expenditures, earnings, or
competitive position.  See Item 1A, “Risk Factors” for a discussion of government regulations and other factors that may affect our
business. 

8

Item 1A.   Risk Factors

The risks and uncertainties described below are those that we currently believe could materially adversely affect us. Other
risks and uncertainties that we do not presently consider to be material or of which we are not presently aware may become important
factors that affect us in the future. If any of the risks discussed below actually occur, our business, financial condition, operating
results or cash flows could be materially adversely affected. Accordingly, you should carefully consider the following risk factors,
as well as other information contained in or incorporated by reference in this Annual Report.

The ongoing coronavirus (COVID-19) pandemic could adversely affect our business, financial condition, results of operations and
demand for our products and services.

Since January 2020, the COVID-19 outbreak, characterized as a pandemic by the World Health Organization on March 11,
2020,  has  caused,  and  is  expected  to  continue  to  cause  a  widespread  health  crisis  and  significantly  disrupt  the  U.S.  and  global
economies, markets and supply chains. The potential and overall impact of the ongoing COVID-19 pandemic on our business,
financial condition, results of operations and the demand for our products and services in the future is uncertain and impossible to
predict at this time; however, COVID-19, and other adverse public health developments in countries and states where we operate,
could have a material and adverse effect on our business, financial condition, results of operations and the demand for our products
and services. These effects could include a negative impact on the availability of our employees, temporary closures of our facilities
or the facilities of our business partners, customers, suppliers, third party service providers or other vendors, and the interruption of
domestic and global supply chains, distribution channels, liquidity and capital markets. In addition, we have taken and will continue
to take precautionary measures, including through consultation with governmental authorities and union representatives, intended
to help minimize the risk of the ongoing COVID-19 pandemic to our employees, including implementing work-from-home protocols,
instituting mandatory stay-at-home policies for those who are ill or significantly exposed to COVID-19, acquiring personal protective
equipment (PPE), increasing sanitation and special sanitation of work areas, mandating social distancing (particularly among our
employees engaged in manual processes), altering work arrangements to maintain social distancing and limiting visitors and non-
employees at our facilities, each of which could negatively affect our business. Our business continuity plans and other safeguards,
however, may not be effective to mitigate the results of the ongoing COVID-19 pandemic. The extent to which the ongoing COVID-19
pandemic will impact our business, financial condition, results of operations and demand for our products and services will depend
on future developments, which are highly uncertain and cannot be predicted. Such developments may include the ongoing geographic
spread of COVID-19, the severity of the pandemic, the duration of the COVID-19 outbreak and the type and duration of actions that
may be taken by various governmental authorities in response to the COVID-19 pandemic and the impact on the U.S. and the global
economies, markets and supply chains. 

The impact of the ongoing COVID-19 pandemic and any worsening of the global business and economic environment
as a result may also exacerbate the following risk factors discussed below in this Form 10-K, any of which could have a
material effect on us. This situation is changing rapidly and additional impacts may arise that we are not aware of currently.

Operating Factors

In areas where we purchase leaf tobacco directly from farmers, we bear the risk that the tobacco we receive will not meet quality
and quantity requirements.

When we contract directly with tobacco farmers or tobacco farmer cooperatives, which is the method we use to purchase
tobacco in most countries, we bear the risk that the tobacco delivered may not meet customer quality and quantity requirements.  If
the tobacco does not meet such market requirements, we may not be able to fill all of our customers’ orders, and such failure would
have an adverse effect on profitability and results of operations. In a contract market our obligation is to purchase the entire tobacco
plant, which encompasses many leaf styles, therefore, we also have a risk that not all of that production will be readily marketable
at prices that support acceptable margins.  In addition, in many foreign countries where we purchase tobacco directly from farmers,
we provide them with financing.  Unless we receive marketable tobacco that meets the quality and quantity specifications of our
customers, we bear the risk that we will not be able to fully recover our crop advances or recover them in a reasonable period of
time.  

The leaf tobacco industry is competitive, and we are heavily reliant on a few large customers.

We are one of two major independent global competitors in the leaf tobacco industry, both of whom are reliant upon a few
large customers.  The loss of one of those large customers or a significant decrease in their demand for our products or services could
significantly decrease our sales of products or services, which would have a material adverse effect on our results of operations.  The
competition among leaf tobacco suppliers and dealers is based on the ability to meet customer requirements in the buying, processing,
and financing of tobacco, and on the price charged for products and services.  We believe that we consistently meet our customers’
requirements and charge competitive prices.  Since we rely upon a few significant customers, the consolidation or failure of any of
these large customers, or a significant increase in their vertical integration, could contribute to a significant decrease in our sales of
products and services.

We compete for both the purchase and sale of leaf with smaller leaf tobacco suppliers in some of the markets where we
conduct business.  Some of these smaller leaf tobacco suppliers operate in more than one country.  Since they typically provide little

9

or no support to farmers, these leaf tobacco suppliers typically have lower overhead requirements than we do.  Due to their lower
cost structures, they often can offer prices on products and services that are lower than our prices.  Our customers also directly source
leaf tobacco from farmers to meet some of their raw material needs.  Direct sourcing provides our customers with some qualities
and quantities of leaf tobacco that they prefer not to use in their existing blends and that may be offered for sale.  This competition
for both the sale and purchase of leaf, both with smaller leaf tobacco suppliers and direct sourcing, could reduce the volume of the
leaf we handle and could negatively impact our financial results.

Our financial results can be significantly affected by changes in the balance of supply and demand for leaf tobacco.

As a leaf tobacco supplier, our financial results can be significantly affected by changes in the overall balance of worldwide
supply and demand for leaf tobacco.  The demand for leaf tobacco, which is based upon customers’ expectations of their future
requirements,  can  change  from  time  to  time  depending  upon  factors  affecting  the  demand  for  their  products.    Our  customers’
expectations and their demand for leaf tobacco are influenced by a number of factors, including: 

•

•

•

•

•

trends in the global consumption of cigarettes,

trends in consumption of cigars and other tobacco products, 

trends in consumption of alternative tobacco products, such as electronic nicotine delivery systems and non-combustible
products,

levels of competition among our customers, and

regulatory and governmental factors.

The  world  supply  of  leaf  tobacco  at  any  given  time  is  a  function  of  current  tobacco  production,  inventories  held  by
manufacturers, and the stocks of leaf tobacco held by leaf tobacco suppliers.  Production of tobacco in a given year may be significantly
affected by such factors as:

•

•

•

•

•

•

demographic shifts that change the number of farmers or the amount of land available to grow tobacco,

decisions by farmers to grow crops other than leaf tobacco,

volume of annual tobacco plantings and yields realized by farmers,

availability of crop inputs, 

weather and natural disasters, including any adverse weather conditions that may result from climate change, and

crop infestation and disease.

Any significant change in these factors could cause a material imbalance in the supply of and demand for tobacco, which

would affect our results of operations.  

Our financial results will vary according to tobacco growing conditions, customer requirements, and other factors.  These factors
may also limit the ability to accurately forecast our future performance and increase the risk of an investment in our common stock
or other securities.

Our financial results, particularly our year-over-year quarterly comparisons, may be significantly affected by variations in
tobacco growing seasons and fluctuations in crop sizes.  The timing of the cultivation and delivery of tobacco is dependent upon a
number  of  factors,  including  weather  and  other  natural  events,  and  our  processing  schedules  and  results  of  operations  can  be
significantly altered by these factors.  In addition, the potential impact of climate change is uncertain and may vary by geographic
region.  The possible effects, as described in various public accounts, could include changes in rainfall patterns, water shortages,
changing storm patterns and intensities, and changing temperature levels that could adversely impact our costs and business operations
and the supply and demand for leaf tobacco.  Our operations also rely on dependable and efficient transportation services.  A disruption
in transportation services, as a result of climate change or otherwise, may also significantly impact our results of operations.

Further, the timing of customer orders and shipments may vary and may require us to keep tobacco in inventory and may
also result in variations in quarterly and annual financial results.  We base sales recognition on meeting our performance obligation
under our contract with the customer, which generally occurs with the passage of ownership of the tobacco.  Since individual shipments
may represent significant amounts of revenue, our quarterly and annual financial results may vary significantly depending on the
timing of needs and shipping instructions of our customers and the availability of transportation services.  These fluctuations result
in varying volumes and sales in given periods, which also reduce the comparability of financial results.

Major shifts in customer requirements for tobacco supply may significantly affect our operating results.

If our customers significantly alter their requirements for tobacco volumes from certain regions, we may have to change
our production facilities and alter our fixed asset base in certain origins.  Permanent or long-term reduction in demand for tobacco
from origins where we have operations may trigger restructuring and impairment charges.  We may also need to make significant
capital investments in other regions to develop the needed infrastructure to meet customer supply requirements.

10

Weather and other conditions can affect the marketability of our products.

Tobacco crops are subject to vagaries of weather and the environment that can, in some cases, change the quality or size of
the crops.  If a weather event is particularly severe, such as a major drought or hurricane, the affected crop could be destroyed or
damaged to an extent that it would be less desirable to manufacturers, which would result in a reduction in revenues.  If such an
event is also widespread, it could affect our ability to acquire the quantity of tobacco required by our customers.  In addition, other
factors can affect the marketability of tobacco, including, among other things, the presence of excess residues of crop protection
agents or non-tobacco related materials.  A significant event impacting the condition or quality of a large amount of any of the crops
that we buy could make it difficult for us to sell these products or to fill customers’ orders.

Our food ingredient business is subject to industry-specific risks which could adversely affect our operating results.

Our food ingredients business is subject to risks posed by food spoilage or food contamination; shifting consumer preferences;
federal, state, and local food processing regulations; product tampering; and product liability claims.  If one or more of these risks
were to materialize, our revenues and operating results could be adversely affected, and our Company’s reputation might be damaged.

We may be adversely impacted if our information technology systems fail to perform adequately, including with respect to cybersecurity
issues.

The  efficient  operation  of  our  business  depends  on  our  information  technology  systems.  We  rely  on  our  information
technology systems to effectively manage our business data, communications, supply chain, order entry and fulfillment, and other
business processes. The failure of our information technology systems (including those provided to us by third parties) to perform
as we anticipate could disrupt our business and affect our results of operations.

In addition, our information technology systems may be vulnerable to damage or interruption from circumstances beyond
our control, including fire, natural disasters, systems failures, security breaches or intrusions (including theft of confidential data),
and viruses. If we are unable to prevent physical and electronic break-ins, cyber-attacks and other information security breaches, we
may  suffer  financial  and  reputational  damage,  be  subject  to  litigation,  or  incur  remediation  costs  or  penalties  because  of  the
unauthorized disclosure of confidential information belonging to us or to our partners, customers, suppliers, or employees. 

11

Regulatory and Governmental Factors

Government efforts to regulate the production and consumption of tobacco products could have a significant impact on the businesses
of our customers, which would, in turn, affect our results of operations.

Less  than  5%  of  cigarettes  manufactured  worldwide  are  consumed  in  the  United  States.    Nationally,  the  U.S.  federal
government  and  certain  state  and  local  governments  have  taken  or  proposed  actions  that  may  have  the  effect  of  reducing  U.S.
consumption of tobacco products and indirectly reducing demand for our products and services.  These activities have included:

•

•

•

•

restrictions on the use of tobacco products in public places and places of employment,

legislation authorizing the U.S. Food and Drug Administration (“FDA”) to regulate the manufacturing and marketing
of all tobacco products,

increases in the federal, state, and local excise taxes on cigarettes and other "deemed" tobacco products, and

the policy of the U.S. government to link certain federal grants to the enforcement of state laws restricting the sale of
tobacco products.

Numerous other legislative and regulatory anti-smoking measures have been proposed at the federal, state, and local levels.

Globally, a number of foreign governments and non-government organizations continue to take or propose steps to restrict
or prohibit tobacco product advertising and promotion, to increase taxes on tobacco products, to indirectly limit the use of certain
types of tobacco, and to discourage tobacco product consumption.  A number of such measures, including plain packaging, are
included in the Framework Convention on Tobacco Control (“FCTC”), which was negotiated and promoted globally under the
auspices of the World Health Organization (“WHO”).  We cannot predict the extent or speed at which the efforts of governments or
non-governmental agencies to reduce tobacco consumption might affect the business of our primary customers.  However, a significant
decrease in worldwide tobacco consumption brought about by existing or future governmental laws and regulations would reduce
demand for tobacco products and services and could have a material adverse effect on our results of operations.

Government actions can have a significant effect on the sourcing of tobacco.  If some of the current efforts are successful, we could
have  difficulty  obtaining  sufficient  tobacco  to  meet  our  customers’  requirements,  which  could  have  an  adverse  effect  on  our
performance and results of operations.

Acting upon the advice of a working group established in 2008, the WHO, through the FCTC, issued policy options and
recommendations to promote crop diversification initiatives and alternatives to growing leaf tobacco in countries whose economies
depend upon tobacco production.  If certain countries were to follow these policy options and recommendations and seek to eliminate
or significantly reduce leaf tobacco production, we could encounter difficulty in sourcing leaf tobacco to fill customer requirements,
which could have an adverse effect on our results of operations.

 Certain recommendations by the WHO, through the FCTC, may cause shifts in customer usage of certain styles of tobacco.
As seen in countries like Canada and Brazil and in the European Union, efforts have been taken to eliminate ingredients from the
manufacturing  process  for  tobacco  products.    Recently,  the  FCTC  and  the  FDA  have  discussed  formulating  a  nicotine  strategy
(limitations on the level of nicotine allowed in tobacco and tobacco smoke).  Such decisions could cause a change in requirements
for certain styles of tobacco in particular countries.  Shifts in customer demand from one type of tobacco to another could create
sourcing challenges as requirements move from one origin to another.  

Trade proposals have included provisions that could effectively allow governments to regulate tobacco products differently

than other products.  These “carve outs” could negatively impact the industry and reduce requirements for leaf tobacco.

In addition, continued government and public emphasis on environmental issues, including climate change, conservation,
and natural resource management, could result in new or more stringent forms of regulatory oversight of industry activities, which
may lead to increased levels of expenditures for environmental controls, land use restrictions, and other conditions that could have
a material adverse effect on our business, financial condition, and results of operations.  For example, certain aspects of our business
generate carbon emissions, and regulatory restrictions on greenhouse gas emissions have been proposed in many countries.  Such
regulations may include limitations on such emissions, taxes or emission allowance fees on such emissions, various restrictions on
industrial operations, and other measures that could affect land-use decisions, the cost of agricultural production, and the cost and
means of processing and transporting our products.  These actions could adversely affect our business, financial condition, and results
of operations.

12

Because we conduct a significant portion of our operations internationally, political and economic uncertainties in certain countries
could have an adverse effect on our performance and results of operations.

Our  international  operations  are  subject  to  uncertainties  and  risks  relating  to  the  political  stability  of  certain  foreign
governments, principally in developing countries and emerging markets, and also to the effects of changes in the trade policies and
economic regulations of foreign governments.  These uncertainties and risks, which include undeveloped or antiquated commercial
law, the expropriation, indigenization, or nationalization of assets, and the authority to revoke or refuse to renew business licenses
and work permits, may adversely impact our ability to effectively manage our operations in those countries.  We have substantial
capital investments in South America and Africa, and the performance of our operations in those regions can materially affect our
earnings.  If the political situation in any of the countries where we conduct business were to deteriorate significantly, our ability to
recover assets located there could be impaired.  To the extent that we do not replace any lost volumes of tobacco with tobacco from
other sources, or we incur increased costs related to such replacement, our financial condition or results of operations, or both, would
suffer.

In addition, the current administration has called for substantial changes to U.S. foreign trade policy, including the possibility
of imposing greater restrictions on international trade and significant tariffs on goods imported into the United States.  Furthermore,
the U.S. is taking a more robust approach to country-wide labor compliance in foreign jurisdictions which could include some of
our strategic origins. An escalation of protectionist trade measures by the United States or other countries, such as taxes, tariffs,
increased customs duties or other measures, could have a materially adverse effect on our business, financial condition and results
of operations.  Due to broad uncertainty regarding the timing, content and extent of any regulatory changes in the United States or
abroad, we cannot predict the impact, if any, that these changes could have to our business, financial condition and results of operations.

Changes in tax laws in the countries where we do business may adversely affect our results of operations.

Through our subsidiaries, we are subject to the tax laws of many jurisdictions.  Changes in tax laws or the interpretation of
tax laws can affect our earnings, as can the resolution of various pending and contested tax issues. In most jurisdictions, we regularly
have audits and examinations by the designated tax authorities, and additional tax assessments are common.  We believe that we
comply with applicable tax laws in the jurisdictions where we operate, and we vigorously contest all significant tax assessments
where we believe we are in compliance with the tax laws.  

Financial Factors

Failure of our customers or suppliers to repay extensions of credit could materially impact our results of operations.

We extend credit to both suppliers and customers.  A significant bad debt provision related to amounts due could adversely
affect our results of operations.  In addition, crop advances to farmers are generally secured by the farmers’ agreement to deliver
green tobacco.  In the event of crop failure, delivery failure, or permanent reductions in crop sizes, full recovery of advances may
never be realized, or otherwise could be delayed until future crops are delivered.  See Notes 1 and 17 to the consolidated financial
statements in Item 8 for more information on these extensions of credit. 

Fluctuations in foreign currency exchange rates may affect our results of operations.

We account for most of our tobacco operations using the U.S. dollar as the functional currency.  The international tobacco
trade generally is conducted in U.S. dollars, and we finance most of our tobacco operations in U.S. dollars.  Although this generally
limits foreign exchange risk to the economic risk that is related to leaf purchase and production costs, overhead, and income taxes
in the source country, significant currency movements could materially impact our results of operations.  Changes in exchange rates
can make a particular crop more or less expensive in U.S. dollar terms.  If a particular crop is viewed as expensive in U.S. dollar
terms, it may be less attractive in the world market.  This could negatively affect the profitability of that crop and our results of
operations.  In tobacco markets that are primarily domestic, the local currency is the functional currency.  In addition, the local
currency is the functional currency in other markets, such as Western Europe, where export sales have been denominated primarily
in local currencies. In these markets, reported earnings are affected by the translation of the local currency into the U.S. dollar.  See
Item 7A, “Qualitative and Quantitative Disclosure About Market Risk” for additional discussion related to foreign currency exchange
risk.

Our purchases of tobacco are generally made in local currency, and we also provide farmer advances that are denominated
in the local currency.  We account for currency remeasurement gains or losses on those advances as period costs, and they are usually
accompanied by offsetting increases or decreases in the purchase cost of tobacco, which is priced in the local currency.  The effect
of differences in the cost of tobacco is generally not realized in our earnings until the tobacco is sold, which often occurs in a quarter
or fiscal year subsequent to the recognition of the related remeasurement gains or losses.  The difference in timing could affect our
profitability in a given quarter or fiscal year.   

We have used currency hedging strategies to reduce our foreign currency exchange rate risks in some markets.  In addition,
where we source tobacco in countries with illiquid or nonexistent forward foreign exchange markets, we often manage our foreign
exchange risk by matching funding for inventory purchases with the currency of sale and by minimizing our net investment in these

13

countries.  To the extent that we have net monetary assets or liabilities in local currency, and those balances are not hedged, we may
have currency remeasurement gains or losses that will affect our results of operations.    

Changes in interest rates may affect our results of operations.

We generally use both fixed and floating interest rate debt to finance our operations.  Changes in market interest rates expose
us to changes in cash flows for floating rate instruments and to changes in fair value for fixed rate instruments.   We normally maintain
a proportion of our debt in both variable and fixed interest rates to manage this exposure, and from time to time we may enter hedge
agreements to swap the interest rates.  In addition, our customers may pay market rates of interest for inventory purchased on order,
which could mitigate a portion of the floating interest rate exposure on short-term borrowings.  To the extent we are unable to match
these interest rates, a decrease in interest rates could increase our net financing costs.  We also periodically have large cash balances
and may receive deposits from customers, both of which we use to fund seasonal purchases of tobacco, reducing our financing needs.
Decreases in short-term interest rates could reduce the income we derive from those investments.  Changes in interest rates also
affect expense related to our defined benefit pension plan, as described below. 

Low investment performance by our defined benefit pension plan assets and changes in pension plan valuation assumptions may
increase our pension expense and may require us to fund a larger portion of our pension obligations, thus diverting funds from other
potential uses. 

We sponsor domestic defined benefit pension plans that cover certain eligible employees.  Our results of operations may
be positively or negatively affected by the amount of expense we record for these plans.  U.S. generally accepted accounting principles
(“GAAP”) require that we calculate expense for the plans using actuarial valuations.  These valuations reflect assumptions about
financial market and other economic conditions that may change based on changes in key economic indicators.  The most significant
year-end assumptions we used to estimate pension expense for fiscal year 2020 were the discount rate, the expected long-term rate
of return on plan assets, and the mortality rates.  In addition, we are required to make an annual measurement of plan assets and
liabilities, which may result in a significant change to shareholders’ equity through a reduction or increase to the “Pension and other
postretirement benefit plans” component of Accumulated Other Comprehensive Loss.  At the end of fiscal year 2020, the projected
benefit obligation of our qualified U.S. pension plan was $244 million and plan assets were $231 million.  For a discussion regarding
how our financial statements can be affected by pension plan valuation assumptions, see “Critical Accounting Estimates – Pension
and Other Postretirement Benefit Plans” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations”
in Item 7 and in Note 13 to the consolidated financial statements in Item 8.  Although GAAP expense and pension funding contributions
are not directly related, key economic factors that affect GAAP expense can also affect the amount of cash we are required to contribute
to our pension plans under requirements of the Employee Retirement Income Security Act (“ERISA”).  Failure to achieve expected
returns on plan assets could also result in an increase to the amount of cash we would be required to contribute to our pension plans.
In order to maintain or improve the funded status of our plans, we may also choose to contribute more cash to our plans than required
by ERISA regulations.

Item 1B.   Unresolved Staff Comments

None 

14

Item 2.   Properties

We own the following significant properties (greater than 500,000 square feet):

Location

Flue-Cured and Burley Leaf Tobacco Operations:

North America:

United States

Principal Use

Building Area
(Square Feet)

Nash County, North Carolina .......................................................................... Factory and storages

1,323,000

Other Regions:

Brazil

Santa Cruz ....................................................................................................... Factory and storages

2,386,000

Malawi

Lilongwe.......................................................................................................... Factory and storages

942,000

Mozambique

Tete .................................................................................................................. Factory and storages

770,000

Philippines

Agoo, La Union ............................................................................................... Factory and storages

770,000

Tanzania

Morogoro......................................................................................................... Factory and storages

895,000

Zimbabwe
Harare (1) .......................................................................................................... Factory and storages

1,445,000

Other Tobacco Operations:

United States

Lancaster, Pennsylvania .................................................................................. Factory and storages

793,000

(1)

Owned by an unconsolidated subsidiary.

We lease headquarters office space of about 50,000 square feet at 9201 Forest Hill Avenue in Richmond, Virginia, which

we believe is adequate for our current needs.  

Our business involves, among other things, storing and processing green tobacco and storing processed tobacco.  We operate
processing facilities in major tobacco growing areas.  In addition, we require tobacco storage facilities that are in close proximity to
the processing facilities.  We own most of the tobacco storage facilities, but we lease additional space as needs arise.  We believe
that the properties currently utilized in our tobacco operations are maintained in good operating condition and are suitable and
adequate for our purposes at our current volumes.  

In addition to our significant properties listed above, we own other processing facilities in the following countries: Germany,
Guatemala, Italy, the Netherlands, Poland, and the United States. In addition, we have an ownership interest in a processing plant in
Mexico and have access to processing facilities in other areas, such as India, the People’s Republic of China, and South Africa.
Socotab L.L.C., an oriental tobacco joint venture in which we own a noncontrolling interest, owns tobacco processing plants in
Bulgaria, Macedonia, and Turkey.  

Except for the Lancaster, Pennsylvania facility, the facilities described above are engaged primarily in processing tobaccos
used by manufacturers in the production of cigarettes.  The Lancaster facility, as well as facilities in Brazil, the Dominican Republic,
Indonesia, and Paraguay, process tobaccos used in making cigar, pipe, and smokeless products, as well as components of certain
“roll-your-own” products.

As discussed in Note 4 to the consolidated financial statements in Item 8, due to changes that have affected the Company's
operations in Tanzania, an impairment charge was recorded during the third quarter of fiscal year 2019 to reduce the carrying values
of the factory and storages in Morogoro, Tanzania to their estimated fair values.

15

Item 3.   Legal Proceedings 

Tanzania Fair Competition Commission Proceeding

In June 2012, our Tanzanian subsidiary, Tanzania Leaf Tobacco Company Ltd. (“TLTC”), entered into a two crop-year
supply agreement for unprocessed “green” tobacco with a newly-formed Tanzanian subsidiary of one of our major customers.  The
agreement involved green tobacco purchases from four of the approximately 400 grower cooperatives in Tanzania, which allowed
the customer and its Tanzanian subsidiary on a small test basis to evaluate whether it would be a viable alternative for the customer
to establish its own vertically integrated supply operations in that market.  Prior to that time, the customer’s subsidiary did not exist,
and it only purchased processed Tanzanian tobacco from tobacco dealers in specified amounts and only for certain grades and stalk
positions.  In contrast, the agreement with TLTC required the customer’s subsidiary to purchase green tobacco on a “run of crop”
basis.  “Run of crop” requires the purchase of all green tobacco produced on the tobacco plant, regardless of grade or stalk position.
The agreement, therefore, enabled the customer’s subsidiary on a small test basis to evaluate the quality of green tobacco purchased
on a “run of crop” basis and to assess how such tobacco would be suited to the customer's tobacco requirements.  The customer
unilaterally elected to establish its own vertically integrated supply operations in Tanzania after the expiration of the agreement, and
its subsidiary began purchasing green tobacco directly from Tanzanian grower cooperatives during the second crop year thereafter.

Despite the pro-competitive object and effect of the agreement between TLTC and the customer’s subsidiary, in October
2016, the Tanzania Fair Competition Commission (“FCC”) notified TLTC and the customer’s subsidiary that it reviewed the agreement
and provisionally concluded that it infringed Tanzania antitrust law by having the object and effect of preventing competition in the
purchase of unprocessed green tobacco in the area in which the four grower cooperatives were located.  The FCC also provisionally
concluded that our U.S. subsidiary, Universal Leaf Tobacco Company, Inc. (“ULT”), and additional subsidiaries of the customer,
were jointly and severally liable for the actions of TLTC and the customer’s Tanzanian subsidiary, respectively.  TLTC and ULT
submitted a written response contesting the FCC’s allegations, and on February 27, 2018, the FCC issued its decision to TLTC and
ULT which confirmed its initial conclusion that the agreement infringed Tanzanian antitrust law.  In its decision, the FCC concluded
incorrectly that the parties to the agreement unfairly benefited in the amount of $105 thousand.  The FCC arbitrarily assessed a fine
jointly against TLTC and ULT of approximately $197 million and a fine jointly against the customer’s Tanzanian subsidiary and
another subsidiary of the customer exceeding $1 billion.

TLTC and ULT worked closely with expert legal advisors and economists on this matter.  Based on these engagements and
consultations, the Company firmly believed the FCC’s allegations were frivolous and clearly without merit or support from the facts,
law or economic analysis.  The Company further believed the FCC’s proceedings were rife with irregularities and did not comply
with applicable legal and regulatory procedures with respect to this matter, including failing to establish jurisdiction over ULT or to
offer a legal justification for including ULT in the proceeding.  To the contrary, the Company believed the facts, law and economic
analysis clearly supported the legality and pro-competitive nature of the agreement and supported a proper conclusion that there was
no infringement of Tanzania antitrust law, and the agreement had no negative impact on the Tanzania tobacco market.  The Company
further believed the FCC’s proposed fine is ludicrous, unwarranted and contrary to Tanzania law.  TLTC and ULT immediately
appealed the FCC findings to the Tanzania Fair Competition Tribunal, which immediately stayed the execution of any FCC fines. 

On January 22, 2019, the FCC delivered provisional findings regarding two new allegations of antitrust violations.  In those
two new provisional findings, the FCC manufactured claims against ULT and ULT's subsidiaries in Tanzania, in addition to other
parties in Tanzania.  ULT and its Tanzania subsidiaries had already begun working closely with expert legal advisors on these matters
to prepare and submit to the FCC proper and comprehensive responses.  The Company also believed the most recent FCC provisional
findings and allegations were frivolous and clearly without merit and lack facts, law or economic analysis to support them. In one
of the two new matters, based on the Company's review of the provisional findings and consultation with counsel, the Company
believed the FCC was seeking an equally large, ludicrous, unwarranted, and unlawful fine as the one sought in the original matter.
The FCC's motivations for initiating these additional, spurious allegations against the Company's subsidiaries were unclear.  

The FCC contacted TLTC during the pendency of the three matters to initiate settlement discussions in order to resolve and
dismiss all outstanding matters.  After protracted negotiations with the FCC regarding mutually-agreeable and reasonable procedural
aspects of settlement, on March 27, 2020, ULT, its Tanzania subsidiaries and the FCC executed a binding no-fault settlement of the
three matters (the “Settlement Agreement”).  The terms of the Settlement Agreement included mutual confidentiality obligations and
mutual releases which discharged all actions, claims, rights and demands of the FCC, ULT and its Tanzania subsidiaries in all these
matters, as well as a settlement amount to be paid to the FCC.  Although the confidentiality obligations in the Settlement Agreement
do not permit the Company publicly to disclose the settlement amount, such amount was not material to the fourth fiscal quarter or
the fiscal year ended March 31, 2020. We are pleased to avoid the cost of further litigating these frivolous matters, and we believe
no further related costs will be incurred.

16

Other Contingent Liabilities

In addition, some of our subsidiaries are involved in other litigation or legal matters incidental to their business activities.
While the outcome of these matters cannot be predicted with certainty, we are vigorously defending the matters and do not currently
expect that any of them will have a material adverse effect on our business or financial position.  However, should one or more of
these matters be resolved in a manner adverse to our current expectation, the effect on our results of operations for a particular fiscal
reporting period could be material. 

Item 4.   Mine Safety Disclosures 

Not applicable.

17

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 

Common Equity 

Our common stock is traded on the New York Stock Exchange (“NYSE”) under the symbol “UVV.” The following table
sets forth the high and low sales prices per share of the common stock on the NYSE Composite Tape, based upon published financial
sources, and the dividends declared on each share of common stock for the quarter indicated.

Fiscal Year Ended March 31, 2020

  Cash dividends declared .....................................................................................

$

0.76

$

0.76

$

0.76

$

0.76

First Quarter

Second Quarter

Third Quarter

Fourth Quarter

  Market price range:

  High..................................................................................................................

  Low ..................................................................................................................

60.94

51.02

62.70

49.39

57.06

50.27

58.14

38.58

Fiscal Year Ended March 31, 2019

  Cash dividends declared .....................................................................................

$

0.75

$

0.75

$

0.75

$

0.75

  Market price range:

  High..................................................................................................................

  Low ..................................................................................................................

68.25

46.40

71.60

55.66

76.98

53.03

60.67

52.60

Our current dividend policy anticipates the payment of quarterly dividends in the future.  However, the declaration and
payment of dividends to holders of common stock is at the discretion of the Board of Directors and will be dependent upon our future
earnings, financial condition, and capital requirements. Under certain of our credit facilities, we must meet financial covenants relating
to minimum tangible net worth and maximum levels of debt.  If we were not in compliance with them, these financial covenants
could restrict our ability to pay dividends.  We were in compliance with all such covenants at March 31, 2020.  At May 25, 2020,
there were 992 holders of record of our common stock.  See Notes 9 and 14 to the consolidated financial statements in Item 8 for
more information on debt covenants and equity securities.

Purchases of Equity Securities

As  indicated  in  the  following  table,  we  repurchased  shares  of  our  common  stock  during  the  three-month  period  ended

March 31, 2020.  

Common Stock

Period (1)

Total Number
of Shares
Repurchased

Average
Price Paid
Per Share (2)

Total Number of
Shares
Repurchased as
Part of Publicly
Announced Plans
(3)

or Programs 

Dollar Value of
Shares that May Yet
Be Purchased Under
the Plans or
Programs (3)

January 1-31, 2020.......................................................................................

23,134

$

February 1-28, 2020.....................................................................................

March 1-31, 2020.........................................................................................

100,374

155,018

Total .............................................................................................................

278,526

$

53.14

50.84

45.15

47.87

23,134

$

68,232,199

100,374

155,018

63,129,363

56,129,802

278,526

$

56,129,802

(1)

(2)

(3)

Repurchases are based on the date the shares were traded.  This presentation differs from the consolidated statement of cash flows, where the cost of share
repurchases is based on the date the transactions were settled.

Amounts listed for average price paid per share include broker commissions paid in the transactions.

A stock repurchase plan, which was authorized by our Board of Directors, became effective and was publicly announced on November 7, 2017 and further
extended on May 29, 2019. This stock repurchase plan authorized the purchase of up to $100 million in common and/or preferred stock in open market or
privately negotiated transactions, subject to market conditions and other factors. This stock repurchase program will expire on the earlier of November 15, 2020,
or when we have exhausted the funds authorized for the program.

18

Item 6.   Selected Financial Data

Fiscal Year Ended March 31,

2020

2019

2018

2017

2016

(in thousands, except share and per share data, ratios, and
number of shareholders)

Summary of Operations

Sales and other operating revenues...................................................................... $ 1,909,979

$ 2,227,153

$ 2,033,947

$ 2,071,218

$ 2,120,373

Operating income................................................................................................. $
(1) ............................................................................. $

Segment operating income 

126,367

138,121

Net income ........................................................................................................... $
(2) ......................................... $

Net income attributable to Universal Corporation 

78,003

71,680

Earnings available to Universal Corporation common shareholders................... $

71,680

Return on beginning common shareholders’ equity ............................................

5.4%

Earnings per share attributable to 

Universal Corporation common shareholders:

Basic............................................................................................................... $

Diluted............................................................................................................ $

2.87

2.86

$

$

$

$

$

$

$

161,169

186,772

110,134

104,121

104,121

7.8%

4.14

4.11

$

$

$

$

$

$

$

170,825

179,950

116,168

105,662

105,662

8.2%

4.18

4.14

$

$

$

$

$

$

$

178,401

188,534

112,506

106,304

20,890

1.7%

0.89

0.88

$

$

$

$

$

$

$

182,018

186,439

118,148

109,016

94,268

8.2%

4.16

3.92

Financial Position at Year End

Current ratio .........................................................................................................

5.53

6.26

5.94

5.83

6.65

Total assets ........................................................................................................... $ 2,120,921

$ 2,133,184

$ 2,168,632

$ 2,123,405

$ 2,231,177

Long-term debt..................................................................................................... $

368,764

$

368,503

$

369,086

$

368,733

$

368,380

Working capital .................................................................................................... $ 1,212,218

$ 1,334,397

$ 1,321,323

$ 1,293,403

$ 1,392,276

Total Universal Corporation shareholders’ equity ............................................... $ 1,246,665

$ 1,337,087

$ 1,342,429

$ 1,286,489

$ 1,414,222

General

Number of common shareholders........................................................................

1,000

1,028

1,131

1,182

1,225

Weighted average common shares outstanding:

Basic..................................................................................................................

24,982,259

25,129,192

25,274,975

23,433,860

22,683,290

Diluted...............................................................................................................

25,106,351

25,330,437

25,508,144

23,770,088

27,825,491

Dividends per share of convertible perpetual preferred stock (annual)

(3) .......... $

— $

— $

— $

50.63

Dividends per share of common stock (annual) .................................................. $

3.04

Book value per common share............................................................................. $

51.05

$

$

3.00

53.50

$

$

2.18

53.85

$

$

2.14

50.90

$

$

$

67.50

2.10

52.94

(1)  

(2)  

(3)  

We evaluate the performance of our segments based on segment operating income, which is operating income after allocated overhead expenses (excluding
significant non-recurring charges or credits), plus equity in the pretax earnings of unconsolidated affiliates. Segment operating income is a non-GAAP measure.
See Note 17 to the consolidated financial statements in Item 8 of this Annual Report for information on reportable operating segments.

We hold less than a 100% financial interest in certain consolidated subsidiaries, and a portion of net income is attributable to the noncontrolling interests in those
subsidiaries.

In December 2016 and January 2017, all outstanding shares of the Company's Series B 6.75% Convertible Perpetual Preferred Stock were converted for common
stock or for cash, and none were outstanding during fiscal years 2018 to 2020.  

Significant items included in the operating results in the above table are as follows:

•

Fiscal Year 2020 –  $7.5 million of restructuring and impairment costs, primarily related to our tobacco operations in
North Carolina and Africa. The restructuring and impairment costs included employee termination benefits, as well as
impairment charges related to certain property, plant, equipment, and noncurrent assets.The restructuring and impairment
costs reduced net income by $6.3 million, or $0.25 per diluted share. We incurred $4.7 million of non-tax deductible
transaction costs associated with the acquisition of FruitSmart that reduced diluted earnings per share by $0.19. We
recognized a $2.7 million expense in cost of goods sold relating to the expensing of a fair value adjustment to inventory
associated with the initial acquisition accounting for FruitSmart, that reduced net income by $2.1 million, or $0.08 per
diluted share. Additionally, income tax expense included $2.8 million for the settlement of an income tax matter related

19

•

•

•

•

to a foreign subsidiary that reduced diluted earnings per share by $0.11.  On a combined basis, the net effect of these
items decreased net income by $15.9 million, or $0.63 per diluted share.

Fiscal Year 2019 – $20.3 million of restructuring and impairment costs, primarily related to our operations in Tanzania.
The restructuring and impairment costs included employee termination benefits, as well as impairment charges related
to certain property, plant, equipment, and goodwill.  The restructuring and impairment costs reduced net income by
$16.5 million, or $0.64 per diluted share.  In addition, we benefited from a $7.8 million reduction in income tax expense
for the reversal of amounts previously recorded for dividend withholding taxes on distributed and undistributed retained
earnings of a foreign subsidiary following the resolution of uncertainties with the local country taxing authorities with
respect to the inclusion of the tax under a tax holiday applicable to the subsidiary.  The reduction of income tax expense
increased diluted earnings per share by $0.30.  On a combined basis, the net effect of these items decreased net income
by $8.7 million, or $0.34 per diluted share.

Fiscal Year 2018 – a $4.5 million reduction of income tax expense from the enactment of the Tax Cuts and Jobs Act in
December 2017.  The reduction in income tax expense increased diluted earnings per share by $0.18. 

Fiscal Year 2017 – $4.4 million of restructuring and impairment costs, primarily related to our decision to close our
tobacco processing facility in Hungary.  We are now processing tobaccos sourced from Hungary in our facilities in Italy.
The restructuring and impairment costs reduced net income by $2.8 million, or $0.10 per diluted share.  In addition, all
218,490 outstanding shares of our Series B 6.75% Convertible Perpetual Preferred Stock were converted during the
third and fourth quarters.  Of the total shares converted, 107,418 shares were converted for cash, resulting in a reduction
of retained earnings of approximately $74.4 million for the excess of the conversion cost over the carrying value of the
shares.  The reduction in retained earnings resulted in a corresponding one-time reduction of earnings available to
common shareholders for purposes of determining the amounts reported for basic and diluted earnings per share for the
year.  The reduction in earnings available to common shareholders decreased diluted earnings per share by $2.99. 

Fiscal Year 2016 – a $3.4 million pretax gain arising from the acquisition of a joint venture partner's 50% ownership
interest in a tobacco processing entity in Guatemala.  The transaction increased our ownership interest in the entity to
100%, requiring us to consolidate the financial statements of the entity and to remeasure our original 50% ownership
interest to fair value, resulting in the gain. In addition, we recorded restructuring and impairment costs of  $2.4 million
related to a decision to significantly scale back our operations in Zambia.  The net effect of the gain and the restructuring
and impairment costs increased pretax income by $1.0 million and net income by $0.7 million, or $0.02 per diluted
share.

20

Item 7.   Management’s Discussion and Analysis of Financial Condition and Results of Operations 

The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of,
and should be read in conjunction with, Part I, Item 1, “Business” and Item 8, “Financial Statements and Supplementary Data.”
For information on risks and uncertainties related to our business that may make past performance not indicative of future results,
or cause actual results to differ materially from any forward-looking statements, see “General,” and Part I, Item 1A, “Risk Factors.”

OVERVIEW

We source, process, and supply agri-products.  Tobacco has been our principal focus since our founding in 1918, and we
are the leading global leaf tobacco supplier.  We derive most of our revenues from sales of processed tobacco to manufacturers of
tobacco products throughout the world and from fees and commissions for specific services.  We hold a strategic position in the
world leaf markets where we work closely with both our customers and farmers to ensure that we deliver a compliant product that
meets our customers' needs while promoting a strong supplier base.  We adapt to meet changes in customer requirements as well as
broader changes in the leaf markets, while continuing to provide the stability of supply and high level of service that distinguishes
us in the marketplace.  We believe that we have successfully met the needs of both our customers and suppliers while adapting to
changes in leaf markets.  Recognizing that leaf tobacco is a mature industry, we have also been positioning our company for the
future by investing in non-tobacco businesses and are focusing on building out a broader plant-based agri-product services platform.
Over the last three fiscal years, we have generated over $250 million in net cash flow from operations, invested over $185 million
in our businesses, and returned over $250 million to our shareholders through a combination of dividends and share repurchases.

In fiscal year 2018, net income remained steady at about $106 million, despite modestly lower lamina volumes.  We also
continued to grow our market share and expand the services we provide our customers, including gaining new multi-year processing
commitments in Brazil.  In addition, we rewarded our shareholders by increasing our dividend rate and returning almost $55 million
through dividends and repurchasing about $22 million, or 2%, of our outstanding common stock.  Fiscal year 2018 was not without
its challenges as fewer carryover crop sales and shipment delays in North America, African burley crop sizes that were down more
than 40% over the prior year, and a $10 million reduction in income from the timing of receipt of distributions of unconsolidated
subsidiaries compared to fiscal year 2017, negatively impacted our results.  However, we did benefit from a return to normal crop
volumes in Brazil, and the resultant gains from higher volumes and lower factory unit costs there.

Fiscal year 2019 was another strong year for Universal.  We increased our tobacco volumes handled, earned additional
business with our customers by expanding the services we provide, and have continued to improve our market share. During fiscal
year 2019, we benefited from the recovery of African burley production, strong carryover volumes in the first half of the year, and
robust demand for wrapper tobacco.  Our revenues were up about 10% on those higher volumes, compared to fiscal year 2018.  Our
gross margin percentage remained flat, even though our product mix was less favorable as we handled a higher percentage of by-
products in fiscal year 2019.  In addition, results in our North America segment were negatively impacted by weather damage to
tobacco crops in the United States, which reduced yields and third party processing volumes. 

Near the end of fiscal year 2020, uncertain market conditions, mainly driven by the ongoing COVID-19 pandemic, led to
extreme weakening of the Indonesian rupiah, Brazilian real, and Mexican peso relative to the U.S. dollar, all of which experienced
double-digit depreciation during the month of March 2020. These currency weaknesses were the primary drivers for unfavorable
currency comparisons, mainly attributable to remeasurement, of $13 million for the year ended March 31, 2020.  Towards the end
of fiscal year 2020, we also saw some shipment delays in certain regions due to the COVID-19 pandemic and slower customer orders,
which increased our uncommitted inventory levels. In addition, our results for fiscal year 2020 were negatively impacted by lower
carryover volumes compared to fiscal year 2019, mainly in North America and Africa.  Our gross margins for fiscal year 2020,
however, remained relatively flat compared to fiscal year 2019.

As we move into fiscal year 2021, we are forecasting that global flue-cured and burley tobacco production will decline by
about 7% and 10%, respectively, which we believe will keep flue-cured tobacco in a slight oversupply position and burley will remain
in a balanced supply position.  We are closely monitoring the impacts of COVID-19 in all of our operations around the world.
Business activity during the first fiscal quarter is usually lower than in other quarters, as crop purchases are continuing in Brazil and
just beginning in Africa.  To date we have not seen a material impact to our supply chain or seasonal planting or harvesting requirements,
however, we have experienced increased volatility in foreign currency exchange rates, which we believe is related to the uncertainties
from COVID-19.  In some regions, our processing facilities temporarily experienced partial or total closures.  Nearly all operations
have resumed, and we have instituted measures to protect our employees including reduced staffing and social distancing.  We have
experienced slower processing due to social distancing requirements, which may delay shipments of packed orders.  We have also
taken steps at this time to conserve our liquidity position, including limiting most discretionary spending and non-essential capital
spending.  

We are continuing to position our company for success.  As part of our capital allocation strategy, we made disciplined
investments in both tobacco and non-tobacco businesses in fiscal year 2020 that we believe will be able to deliver shareholder value.
Recognizing the strong demand for natural tobacco wrappers, we have taken steps to increase production in strategic regions to meet
our customers’ ongoing and future demands. Our acquisition of FruitSmart Inc. in January 2020 represents a foundational step in
building out a broader plant-based agri-products services platform for which we maintain an active investment pipeline.  At the same

21

time, we are focused on prudently managing our financial position and believe that we are well positioned to fund upcoming working
capital needs, including any potential requirements due to the COVID-19 pandemic, and to take advantage of investment opportunities
in our tobacco business.  We are also extremely proud that we are able to deliver value to shareholders through dividend increases
as illustrated by our milestone 50th annual dividend increase on May 27, 2020

COVID-19 Pandemic Impact

On March 11, 2020, the World Health Organization declared COVID-19 a pandemic. Foreign governmental organizations
and  governmental  organizations  in  the  United  States  have  taken  various  actions  to  combat  the  spread  of  COVID-19,  including
imposing stay-at-home orders and closing “non-essential” businesses and their operations.  We are closely monitoring developments
related to the ongoing coronavirus (COVID-19) pandemic and have taken and continue to take steps intended to mitigate the potential
risks to us. It is paramount that our employees who operate our businesses are safe and informed.  We have assessed and updated
our existing business continuity plans for our business in the context of this pandemic.  For example, we have taken precautions with
regard to employee and facility hygiene, imposed travel limitations on our employees, directed certain employee groups to work
remotely whenever possible, and we continue to assess protocols designed to protect our employees, customers and the public. 

We are also working with our suppliers to understand the potential impacts to our supply chain; however, at this time, we
have not experienced a material impact to our supply chain.  During the quarter ended March 31, 2020, we experienced increased
volatility in foreign currency exchange rates, which we believe is in part related to the uncertainties from COVID-19, as well as
actions taken by governments and central banks in response to COVID-19. Certain foreign currencies depreciated significantly
against the U.S. dollar in March 2020, including the Indonesian rupiah, Brazilian real, and Mexican peso.  We expect continued
volatility in foreign currency exchange rates during fiscal year 2021, though we cannot reasonably estimate the duration or extent
of that volatility.

We continue to monitor the impacts of COVID-19, which include slower processing of our products due to controlled
staffing in our facilities that could lead to later timing of shipments to our customers.  We currently have sufficient liquidity to meet
our current obligations and business operations remain fundamentally unchanged other than shipping delays, which could impact
quarterly comparisons. This is, however, a rapidly evolving situation, and we cannot predict the extent or duration of the ongoing
COVID-19 pandemic, the effects of it on the global, national or local economy, including the impacts on our ability to access capital,
or its effects on our business, financial position, results of operations, and cash flows. We will continue to monitor developments
affecting our employees, customers and operations and take additional steps to address the spread of COVID-19 and its impacts, as
necessary.

RESULTS OF OPERATIONS

Amounts described as net income (loss) and earnings (loss) per diluted share in the following discussion are attributable to Universal
Corporation and exclude earnings related to non-controlling interests in subsidiaries. Adjusted operating income (loss), adjusted net
income (loss) attributable to Universal Corporation, adjusted diluted earnings (loss) per share, and the total for segment operating
income (loss) referred to in this discussion are non-GAAP financial measures. These measures are not financial measures calculated
in accordance with GAAP and should not be considered as substitutes for operating income (loss), net income (loss) attributable to
Universal  Corporation,  diluted  earnings  (loss)  per  share,  cash  from  operating  activities  or  any  other  operating  or  financial
performance measure calculated in accordance with GAAP, and may not be comparable to similarly-titled measures reported by
other companies. A reconciliation of adjusted operating income (loss) to consolidated operating (income), adjusted net income (loss)
attributable to Universal Corporation to consolidated net income (loss) attributable to Universal Corporation and adjusted diluted
earnings (loss) per share to diluted earnings (loss) per share are provided in Other Items below.  In addition, we have provided a
reconciliation  of  the  total  for  segment  operating  income  (loss)  to  consolidated  operating  income  (loss)  in  Note  17.  "Operating
Segments"  to  the  consolidated  financial  statements  in  Item  8.  Management  evaluates  the  consolidated  Company  and  segment
performance excluding certain significant charges or credits. We believe these non-GAAP financial measures, which exclude items
that  we  believe  are  not  indicative  of  our  core  operating  results,  provide  investors  with  important  information  that  is  useful  in
understanding our business results and trends. 

Fiscal Year Ended March 31, 2020, Compared to the Fiscal Year Ended March 31, 2019

Net income for the fiscal year ended March 31, 2020, was $71.7 million, or $2.86 per diluted share, compared with $104.1
million, or $4.11 per diluted share, for the prior fiscal year.  Excluding restructuring and impairment costs and certain non-recurring
items, detailed in Other Items below, net income and diluted earnings per share declined by $25.3 million and $0.96, respectively,
for fiscal year 2020, compared to fiscal year 2019.  Operating income of $126.4 million for the fiscal year ended March 31, 2020,
decreased by $34.8 million, compared to operating income of $161.2 million for the fiscal year ended March 31, 2019.  

Segment operating income was $138.1 million for the fiscal year ended March 31, 2020, a decrease of $48.7 million, compared
to the fiscal year 2019.  Results reflected earnings declines in the North America and Other Regions segments, partially offset by
earnings improvements in the Other Tobacco Operations segment for fiscal year 2020, compared to fiscal year 2019.   Consolidated
revenues decreased by $317.2 million to $1.9 billion for the year ended March 31, 2020, compared to the year ended March 31, 2019,
on lower sales volumes and prices.

22

Flue-cured and Burley Leaf Tobacco Operations

Other Regions

Operating income for the Other Regions segment decreased by $40.8 million to $110.8 million for the fiscal year ended
March 31, 2020, compared with fiscal year 2019, on lower sales and processing volumes.  In fiscal year 2020, volumes decreased in
Africa on smaller burley tobacco crops and lower carryover crop sales, and results for Brazil were down on lower volumes and a less
favorable product mix, compared to fiscal year 2019.  Results for Europe also reflected lower processing and sales volumes for fiscal
year 2020, while Asia saw higher sales and trading volumes.  Selling, general, and administrative costs for the segment were lower
for fiscal year 2020, largely on lower customer claim costs, gains on fixed asset sales, and lower incentive compensations costs,
partially offset by unfavorable foreign currency comparisons and lower net recoveries on advances to suppliers, compared with fiscal
year 2019.  Revenues for the Other Regions segment of $1.4 billion for the year ended March 31, 2020, were down $197.3 million,
compared to fiscal year 2019, on lower sales prices and volumes.

North America

Operating income for the North America segment of $8.4 million for the fiscal year ended March 31, 2020, was down by
$14.7 million, compared to the fiscal year ended March 31, 2019, primarily on significantly lower carryover crop sales volumes.  In
the first half of fiscal year 2019, carryover crop sales volumes were higher on shipments that had been delayed in fiscal year 2018
due to reduced transportation availability in the United States. In addition, in the fiscal year ended March 31, 2020, carryover crop
sales  volumes  were  down  on  reduced  sales  of  U.S.  burley  tobaccos  and  current  crop  sales  volumes  were  down  in  Mexico  and
Guatemala, compared to fiscal year 2019.  Selling, general, and administrative costs for the North America segment were up for the
fiscal year ended March 31, 2020, largely on unfavorable currency comparisons in Mexico.  Revenues for this segment decreased by
$146.4 million to $236.3 million for the fiscal year ended March 31, 2020, compared to the prior fiscal year, on lower sales volumes.

Other Tobacco Operations

The Other Tobacco Operations segment operating income of $19.0 million increased by $6.8 million for fiscal year 2020,
compared with the fiscal year 2019. In fiscal year 2020, results for our dark tobacco operations reflected higher wrapper sales volumes
and unfavorable foreign currency remeasurement comparisons due to the significant weakening of the Indonesian rupiah in the fourth
fiscal quarter, compared to fiscal year 2019.  Results for our oriental joint venture were down for fiscal year 2020, compared to fiscal
year 2019, primarily from lower sales volumes and margins partially offset by lower operating expenses as well as favorable currency
remeasurement and exchange variances.  Selling, general, and administrative costs for the segment were higher in the fiscal year
ended March 31, 2020, compared with fiscal year 2019, mostly from unfavorable currency variances in Indonesia.  Revenues for the
segment increased by $26.5 million to $301.3 million for the fiscal year ended March 31, 2020, largely on higher wrapper sales
volumes and revenues from our newly acquired fruit and vegetable business.

Other Items

Cost of goods sold in the fiscal year ended March 31, 2020, decreased by 15% to $1.6 billion, compared with the prior fiscal
year, consistent with a similar percentage decrease in revenues.  Selling, general, and administrative costs for fiscal year 2020 decreased
by $2.2 million to $222.9 million, as lower compensation costs, value-added tax charges, and customer claims costs as well as gains
on sales of fixed assets were largely offset by unfavorable currency variances of approximately $13 million, primarily in Indonesia,
Brazil, and Mexico. 

23

The following tables set forth restructuring and impairment costs and certain non-recurring items included in reported results
to reconcile adjusted operating income to consolidated operating income and adjusted net income to net income available to Universal
Corporation:

Adjusted Operating Income:

(in thousands)

As Reported: Consolidated operating income
Restructuring and impairment costs(1)

FruitSmart acquisition transaction costs(2)
FruitSmart acquisition purchase accounting adjustment(3)

Adjusted operating income

Adjusted Net Income and Diluted Earnings Per Share

(in thousands except for per share amounts)

(all amounts reported net of income taxes)

As Reported: Net income available Universal Corporation
Restructuring and impairment costs(1)
FruitSmart acquisition transaction costs(2)
FruitSmart acquisition purchase accounting adjustment(3)
Income tax settlement for foreign subsidiary(4)
Income tax benefit from dividend withholding tax liability reversal(5)

As adjusted: Net income available to Universal Corporation

Adjusted diluted earnings per share

Fiscal Year Ended March 31,

2020

2019

$

$

126,367

$

7,543

4,668

2,700

161,169

20,304

—

—

141,278

$

181,473

Fiscal Year Ended March 31,

2020

2019

$

71,680

$

6,283

4,668

2,133

2,766

—

$

$

87,530

3.49

$

$

104,121

16,469

—

—

—

(7,765)

112,825

4.45

(1) 

(2) 

(3) 

(4) 

(5) 

Restructuring and impairment costs are included in Consolidated operating income in the consolidated statements of income and comprehensive, but excluded
for purposes of Adjusted operating income, Adjusted net income available to Universal Corporation, and Adjusted diluted earnings per share. See Note 4 to the
consolidated financial statements in Item 8 of this Annual Report for more information.

The Company incurred selling, general, and administrative expenses for due diligence and other transaction costs associated with the acquisition of FruitSmart
(effective January 1, 2020). These costs are not deductible for U.S. income tax purposes. See Note 2 to the consolidated financial statements in Item 8 of this
Annual Report for more information.

The Company recognized an increase in cost of goods sold in the 4th quarter of fiscal year 2020, relating to the expensing of a fair value adjustment to inventory
associated with the initial acquisition accounting for FruitSmart, Inc. See Note 2 to the consolidated financial statements in Item 8 of this Annual Report for
more information.

During fiscal year 2020, the Company recognized an income tax settlement charge related to operations at a foreign subsidiary. See Note 6 to the consolidated
financial statements in Item 8 of this Annual Report for more information.

During fiscal year 2019, the Company reversed amounts previously recorded for dividend withholding taxes on distributed and undistributed retained earnings
of a foreign subsidiary.  The reversal followed the resolution of uncertainties with the local country taxing authorities with respect to the inclusion of the tax
under a tax holiday applicable to the subsidiary and was attributable to retained earnings amounts previously distributed or expected to be distributed prior to
the expiration of the tax holiday. See Note 6 to the consolidated financial statements in Item 8 of this Annual Report for more information.

The Company’s consolidated effective tax rate for the fiscal year ended March 31, 2020, was approximately 31%. Income
tax expense for the fiscal year ended March 31, 2020, included $2.8 million of additional expense ($0.11 per diluted share) for the
resolution of a transfer pricing matter at a foreign subsidiary.  Without the effect of this item, the consolidated effective tax rate for
fiscal year 2020, would have been 29%. 

For the fiscal year ended March 31, 2019, the Company’s consolidated effective income tax rate on pretax earnings was
27%. Income tax expense for fiscal year 2019 included a $7.8 million ($0.30 per diluted share) benefit from reversing a portion of a
liability previously recorded for dividend withholding taxes on the cumulative retained earnings of a foreign subsidiary. Without the
dividend withholding tax reversal, the consolidated effective income tax rate for fiscal year 2019 would have been 33%. 

The effective tax rates include the benefit of various tax planning opportunities, the effects of exchange rate changes on
local earnings and taxes of foreign subsidiaries, as well as the net effect of items accounted for on a discrete basis in the respective
reporting periods.

24

Fiscal Year Ended March 31, 2019, Compared to the Fiscal Year Ended March 31, 2018

Net income for the fiscal year ended March 31, 2019, was $104.1 million, or $4.11 per diluted share, compared with $105.7
million, or $4.14 per diluted share, for the fiscal year ended March 31, 2018.  Those results included certain non-recurring items,
detailed in Other Items below, which decreased diluted earnings per share by $0.34 and increased diluted earnings per share by $0.18
for the fiscal years ended March 31, 2019 and March 31, 2018, respectively.  Excluding those non-recurring items, net income and
earnings per share increased by $11.7 million and $0.49, respectively, for fiscal year 2019 compared to fiscal year 2018.  Operating
income of $161.2 million for the fiscal year ended March 31, 2019, which included restructuring and impairment charges of $20.3
million detailed in Other Items below, decreased by $9.7 million, compared to operating income of $170.8 million for the fiscal year
ended March 31, 2018. Segment operating income was $186.8 million for the fiscal year ended March 31, 2019, an increase of $6.8
million, compared to segment operating income of $180.0 million for the fiscal year ended March 31, 2018.  Results reflected earnings
improvements in the Other Regions and Other Tobacco Operations segments and flat results for the North America segment for fiscal
year 2019.  Consolidated revenues increased by $193.2 million to $2.2 billion for the fiscal year 2019, compared to fiscal year 2018,
primarily due to higher sales and processing volumes.

Flue-cured and Burley Leaf Tobacco Operations

Other Regions

Operating income for the Other Regions segment increased by $4.8 million to $151.5 million for the fiscal year ended March
31, 2019, compared with fiscal year 2018, on stronger sales and processing volumes partially offset by higher selling, general and
administrative costs.  In fiscal year 2019, volumes increased in Africa, mainly from higher burley production volumes and carryover
crop sales. In South America, volumes also increased, but the product mix was less favorable.  Results for Asia reflected lower sales
and trading volumes for fiscal year 2019, while Europe saw improvements in processing volumes.  Selling, general, and administrative
costs were higher for fiscal year 2019 compared to fiscal year 2018, primarily from negative foreign currency remeasurement and
exchange variances, higher compensation and incentive accruals, and higher customer claim costs, partially offset by higher net
recoveries on advances to suppliers.  Revenues for the Other Regions segment of $1.6 billion for fiscal year 2019, were up $87.6
million compared to fiscal year 2018, on higher volumes and processing revenues, offset in part by lower sales prices and a less
favorable product mix.

North America

Operating income for the North America segment of $23.1 million for year ended March 31, 2019, was flat, compared to
fiscal year 2018.  Results for fiscal year 2019 reflected higher carryover crop sales volumes on shipments delayed from the fourth
quarter of fiscal year 2018 due to reduced transportation availability in the United States, offset by lower U.S. current crop sales and
processing volumes largely due to weather-affected crops.  Results for fiscal year 2019 also included higher shipment volumes from
Guatemala and Mexico, compared to fiscal year 2018.  Selling, general, and administrative costs for the North America segment for
the fiscal year ended March 31, 2019, were modestly lower and declined as a percentage of sales, compared to fiscal year 2018.
Revenues for this segment increased by $73.9 million to $382.6 million for the fiscal year ended March 31, 2019, compared to the
fiscal year ended March 31, 2018, on the higher sales volumes, partly offset by lower processing revenues. 

Other Tobacco Operations

The Other Tobacco Operations segment operating income increased by $2.1 million to $12.2 million for the fiscal year ended
March 31, 2019, compared with fiscal year 2018.  Results for the dark tobacco operations reflected higher sales of wrapper tobacco
and stronger processing and other revenues for fiscal year 2019, compared to fiscal year 2018.  Those improvements were partly
offset by declines in the oriental joint venture.  Lower sales volumes in the fiscal year 2019 and the absence of gain on the sale of
idle  assets  in  fiscal  year  2018  for  the  oriental  joint  venture  were  offset  in  part  by  favorable  currency  remeasurement  variances,
compared to fiscal year 2018.  Selling, general, and administrative costs for the segment were up for the fiscal year ended March 31,
2019, compared with fiscal year 2018, as higher value-added tax charges and higher compensation and incentive accruals were only
partly offset by favorable currency remeasurement comparisons.  Revenues for the segment increased by $31.7 million to $274.8
million for the fiscal year ended March 31, 2019, compared to fiscal year 2018, largely as a result of the higher wrapper tobacco sales
volumes and increased processing and other revenues, partly offset by lower oriental tobacco volumes shipped into the United States.

25

Other Items

Cost of goods sold increased by 10% to $1.8 billion for the fiscal year ended March 31, 2019, compared with fiscal year
2018, and consistent with similar percentage changes in revenues.  Selling, general, and administrative costs for fiscal year 2019,
increased by $24.0 million to $225.1 million, mainly driven by higher compensation and incentive accruals, higher customer claims
and allowance costs, negative foreign currency remeasurement and exchange variances, and higher value-added tax charges, partly
offset by higher net recoveries on advances to suppliers, compared with fiscal year 2018.  Selling, general, and administrative costs
were flat as a percentage of sales for the fiscal year ended March 31, 2019, compared to the fiscal year ended March 31, 2018.

For the fiscal year ended March 31, 2019, the Company’s consolidated effective income tax rate on pretax earnings was
27%.  Income tax expense for fiscal year 2019 included a $7.8 million ($0.30 per diluted share) benefit from reversing a portion of
a liability previously recorded for dividend withholding taxes on the cumulative retained earnings of a foreign subsidiary.  Without
the dividend withholding tax reversal, the consolidated effective income tax rate for fiscal year 2019 would have been 33%.  The
effective tax rate included the benefit of various tax planning opportunities, as well as the effects of exchange rate changes on local
earnings and taxes of foreign subsidiaries.  For the fiscal year ended March 31, 2018, the Company’s consolidated effective income
tax rate was 30%.  Income tax expense for fiscal year 2018 included a one-time adjustment amounting to a reduction of $4.5 million
($0.18 per diluted share) for the fiscal year ended March 31, 2018, from the enactment of major changes to U.S. corporate income
tax law in December 2017.  Excluding those items, the effective tax rate for fiscal year 2018, would have been 33%.

Results for the fiscal year ended March 31, 2019, included restructuring and impairment charges of $20.3 million ($0.64
per diluted share), primarily recorded to reflect the cost of workforce reductions and impairment in the carrying value of property,
plant,  and  equipment  assets  as  a  result  of  changes  in  the  Company’s  business  in Tanzania.    For  more  details,  see  Note  4  to  the
consolidated financial statements in Item 8 of this Annual Report.

Accounting Pronouncements

See "Accounting Pronouncements" in Note 1 to the consolidated financial statements in Item 8 of this Annual Report for a
discussion of recent accounting pronouncements issued by the Financial Accounting Standards Board ("FASB") that will become
effective and be adopted by the Company in future reporting periods.

26

Overview 

LIQUIDITY AND CAPITAL RESOURCES

Our working capital requirements in fiscal year 2020 were lower than those in fiscal year 2019 mainly due to lower green
tobacco prices and volumes. In fiscal year 2020, we also generated $10.9 million in cash flows from our operating activities, and
our liquidity was sufficient to meet our needs.  We continued our conservative financial policies and returned funds to shareholders.

Our liquidity and capital resource requirements are predominately short-term in nature and primarily relate to working
capital for crop purchases.  Working capital needs are seasonal within each geographic region. The geographic dispersion and the
timing of working capital needs permit us to predict our general level of cash requirements, although crop size, prices paid to farmers,
shipment  and  delivery  timing,  and  currency  fluctuations  affect  requirements  each  year.    Peak  working  capital  requirements  are
generally reached during the first and second fiscal quarters.  Each tobacco production region follows a cycle of buying, processing,
and shipping tobacco, and in many regions we also provide agricultural materials to tobacco farmers during the growing season.
The timing of the elements of each cycle is influenced by such factors as local weather conditions and individual customer shipping
requirements, which may change the level or the duration of tobacco crop financing.  Despite a predominance of short-term needs,
we maintain a portion of our total debt as long-term to reduce liquidity risk.  We also periodically may have large cash balances that
we utilize to meet our working capital requirements.

We believe that our financial resources are adequate to support our capital needs for at least the next twelve months.  Our
seasonal borrowing requirements primarily relate to purchasing crops in South America and Africa and can increase from March to
September by more than $300 million.  The funding required can vary significantly depending upon such factors as crop sizes, the
price of leaf, the relative strength of the U.S. dollar, and the timing of shipments and customer payments.  We deal with this uncertainty
by maintaining substantial credit lines and cash balances.  In addition to our operating requirements for working capital, we expect
to spend around $45 to $55 million during fiscal year 2021 for capital expenditures to maintain our facilities and invest in opportunities
to grow and improve our businesses.  We also expect to provide about $10 million in funding to our pension plans.  We have no long-
term debt maturing until fiscal year 2024.  

At this time, COVID‐19 has not had a material impact on our operations other than indirectly from unsettled currency
markets, and we currently anticipate our current cash balances, cash flows from operations, and our available sources of liquidity
will be sufficient to meet our cash requirements.  However, given the uncertainty of future impacts from the ongoing COVID-19
pandemic including slower processing and possible delays in timing of some shipments, we have taken several steps at this time to
conserve our liquidity position including temporarily limiting most discretionary spending and non-essential capital spending.

Cash Flow

Our operations generated about $10.9 million in operating cash flows in fiscal year 2020.   That amount was about $153.6
million lower than the $164.5 million we generated in fiscal year 2019, largely due to lower current and carryover crop sales volumes
in fiscal year 2020 and later timing of sales and shipments compared to the prior year’s fourth fiscal quarter. During the fiscal year
ended March 31, 2020, we spent $35.2 million on capital projects and $80.2 million on the acquisition of a new business, and we
returned $108.8 million to shareholders in the form of dividends and share repurchases.  At March 31, 2020, cash balances totaled
$107.4 million.

Working Capital

Working capital at March 31, 2020, was about $1.2 billion, down about $122.2 million from last fiscal year's level.  Cash
and cash equivalents were down $190.1 million at the end of fiscal year 2020, compared to balance at the end of fiscal year 2019,
in part due to our acquisition of FruitSmart and increased share repurchases.  Tobacco inventories of $707.3 million at March 31,
2020, were up $77.7 million compared to inventory levels at the end of the prior fiscal year, mostly on larger inventories of wrapper
and North American tobacco.  Other inventories are also up $29.7 million at March 31, 2020, from prior year levels largely on our
acquisition of the new business in January 2020.  We usually finance inventory with a mix of cash, notes payable, and customer
deposits, depending on our borrowing capabilities, interest rates, and exchange rates, as well as those of our customers.  We generally
do not purchase material quantities of tobacco on a speculative basis. However, when we contract directly with tobacco farmers, we
are obligated to buy all stalk positions, which may contain less marketable leaf styles. Our uncommitted tobacco inventories increased
by approximately $47.0 million to $175.0 million, or about 25% of tobacco inventory, at March 31, 2020, which was above our
target range.  Uncommitted inventories at March 31, 2019, were $128.0 million, which represented 20% of tobacco inventory.  The
level of these uncommitted inventories is influenced by timing of farmer deliveries of new crops, as well as the receipt of customer
orders.  At the end of fiscal year 2020, market disruptions due to the COVID-19 pandemic delayed some receipts of customer orders,
particularly in Brazil.  We estimate that as of April 30, 2020, our uncommitted inventories had already begun to decline as customer
orders were received.

27

Capital Allocation

Our capital allocation strategy focuses on four strategic priorities:

•

•

•

•

Strengthening and investing for growth in our leaf tobacco business;

Increasing our strong dividend;

Exploring growth opportunities in non-tobacco industries and markets that utilize our assets and capabilities; and

Returning excess capital through share repurchases.

Our mission is to remain the leading global leaf tobacco supplier.  We will continue to make disciplined investments within
our leaf business and taking advantage of growth opportunities in tobacco as well as in non-tobacco industries and markets that
utilize our assets and capabilities.  Through these actions, we believe that will be able to deliver enhanced shareholder value through
earnings growth and the generation of free cash flow despite operating in a mature industry.

In January 2020, we acquired FruitSmart for approximately $80 million, with potential earnout payments totaling $25
million based on Fruit Smart achieving certain financial targets in calendar years 2020 and 2021.  We financed the acquisition using
borrowings under our committed revolving credit facility and cash on hand.  The investment in FruitSmart represents a foundational
step in the development of a broader agri-products services platform.  As we look ahead, we will continually evaluate opportunities
to return capital to shareholders.  At the same time, we remain committed to maintaining our investment grade credit rating and
extending our 50-year history of dividend increases.

Share Activity

Our Board of Directors approved our current share repurchase program in November 2017, and in May 2019, extended its
expiration to November 15, 2020.  The program authorizes the purchase of up to $100 million of our common stock.  Under the
current authorization, we may purchase shares from time to time on the open market or in privately negotiated transactions at prices
not exceeding prevailing market rates. Repurchases of shares under the repurchase program may vary based on management discretion,
as well as changes in cash flow generation and availability. During fiscal year 2020, we purchased 656,820 shares of common stock
at an aggregate cost of $33.5 million (average price per share of $50.94). At March 31, 2020, our available authorization under our
current share repurchase program was approximately $56 million, and approximately 24.4 million common shares were outstanding.

Capital Spending

Our capital expenditures are generally limited to those that add value, replace or maintain equipment, increase efficiency,
or position us for future growth.  In deciding where to invest capital resources, we look for opportunities where we believe we can
earn an adequate return, leverage our assets and expertise, and enhance our farmer base.  During fiscal years 2020 and 2019, we
invested $35.2 million and $38.8 million, respectively, in our property, plant, and equipment. Depreciation expense was approximately
$38.4 million and $37.1 million, respectively, in fiscal years 2020 and 2019.  Generally, our capital spending on maintenance projects
is at a level below depreciation expense in order to maintain strong cash flow.  In addition, from time to time, we undertake projects
that require capital expenditures when we identify opportunities to improve efficiencies, add value for our customers, and position
ourselves for future growth.  We currently plan to spend approximately $45 to $55 million in fiscal year 2021 on capital projects for
maintenance of our facilities and other investments to grow and improve our businesses.  Typically, our capital expenditures for
maintenance projects are less than $30 million per fiscal year. 

Outstanding Debt and Other Financing Arrangements

We consider the sum of notes payable and overdrafts, long-term debt (including any current portion), and customer advances
and deposits, less cash, cash equivalents, and short-term investments on our balance sheet to be our net debt.  We also consider our
net debt plus shareholders' equity to be our net capitalization.  Net debt increased by $203.0 million to $349.6 million during the
fiscal year ended March 31, 2020.  The increase primarily reflects lower cash balances.  Net debt as a percentage of net capitalization
was approximately 22% at March 31, 2020, up from 10% at March 31, 2019.

As of March 31, 2020, we had $430 million available under a committed revolving credit facility that will mature in December
2023, and we, together with our consolidated affiliates, had approximately $316 million in uncommitted lines of credit, of which
approximately $238 million were unused and available to support seasonal working capital needs.  The financial covenants under
our committed revolving credit facility require us to maintain certain levels of tangible net worth and observe restrictions on debt
levels.  As of March 31, 2020, we were in compliance with all covenants of our debt agreements.  We also have an active, undenominated
universal shelf registration filed with the SEC in November 2017 that provides for future issuance of additional debt or equity
securities.  We have no long-term debt maturing until fiscal year 2024.

28

Derivatives

From time to time, we use interest rate swap agreements to manage our exposure to changes in interest rates.  Currently,
we have interest rate swap agreements that convert the variable benchmark LIBOR rates on our two outstanding term loans entered
to fixed rates. With the swap agreements in place, the effective interest rates on the $150 million five-year term loan and the $220
million seven-year term loan were 3.94% and 4.26%, respectively, as of March 31, 2020. These agreements were entered into to
eliminate the variability of cash flows in the interest payments on our variable rate five- and seven-year term loans and are accounted
for as cash flow hedges.  Under the swap agreements, we receive variable rate interest and pay fixed rate interest.  At March 31,
2020, the fair value of our open interest rate hedge swaps was a net liability of approximately $37 million.  

We also enter forward contracts from time to time to hedge certain foreign currency exposures, primarily related to forecast
purchases of tobacco and related processing costs in Brazil and Africa, as well as our net monetary asset exposure in local currency
there.  We generally account for our hedges of forecast tobacco purchases as cash flow hedges.  At March 31, 2020, the fair value
of those open contracts was a net liability of approximately $11 million.  We also had other forward contracts outstanding that were
not designated as hedges, and the fair value of those contracts was a net liability of approximately $4 million at March 31, 2020.
For additional information, see Note 11 to the consolidated financial statements in Item 8.

Pension Funding

The funds supporting our ERISA-regulated U.S. defined benefit pension plan during fiscal year 2020 which remained at
approximately $231 million.  The accumulated benefit obligation (“ABO”) and the projected benefit obligation (“PBO”) were both
approximately $239 million and $244 million, respectively as of March 31, 2020. The ABO and PBO are calculated on the basis of
certain assumptions that are outlined in Note 13 to the consolidated financial statements in Item 8. We expect to make contributions
of about $10 million to our pension plans during the next year.  It is our policy to regularly monitor the performance of the funds
and to review the adequacy of our funding and plan contributions.

Off-Balance Sheet Arrangements

We do not have any off balance sheet arrangements that have or are reasonably likely to have a current or future effect on
our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or
capital resources.

Contractual Obligations

Our contractual obligations as of March 31, 2020, were as follows:

(in thousands of dollars)

Total

2021

2022-2023

2024-2025

After 2025

Notes payable and long-term debt 

(1) ........................................................................

$

507,336

$

96,573

$

30,556

$

173,176

$

207,031

Operating lease obligations ........................................................................................

43,962

13,830

14,411

8,924

6,797

Inventory purchase obligations:

Tobacco ....................................................................................................................

465,814

377,744

88,070

Agricultural materials...............................................................................................

Other purchase obligations .........................................................................................

42,810

9,194

37,554

6,871

5,256

1,684

—

—

639

—

—

—

Total..........................................................................................................................

$ 1,069,116

$

532,572

$

139,977

$

182,739

$

213,828

(1)

Includes interest payments.  Interest payments on $78.0 million of variable rate debt were estimated based on rates as of March 31, 2020.  We have entered into
interest rate swaps that effectively convert the interest payments on the $370.0 million outstanding balance of our two bank term loans from variable to fixed.
The fixed rate has been used to determine the contractual interest payments for all periods.

In addition to principal and interest payments on notes payable and long-term debt, our contractual obligations include
operating lease payments, inventory purchase commitments, and capital expenditure commitments.  Operating lease obligations
represent minimum payments due under leases for various production, storage, distribution, and other facilities, as well as vehicles
and equipment.  Tobacco inventory purchase obligations primarily represent contracts to purchase tobacco from farmers.  The amounts
shown above are estimates since actual quantities purchased will depend on crop yield, and prices will depend on the quality of the
tobacco delivered.  We have partially funded our tobacco purchases in some origins with short-term advances to farmers and other
suppliers, which totaled approximately $134 million, net of allowances, at March 31, 2020.  In addition, we have guaranteed bank
loans to farmers in Brazil that relate to a portion of our tobacco purchase obligations there.  At March 31, 2020, we were contingently
liable under those guarantees for outstanding balances of approximately $3 million (including accrued interest), and we had recorded
a liability of approximately $0.1 million for the fair value of those guarantees.  As tobacco is purchased and the related bank loans
are repaid, our contingent liability is reduced.  

29

CRITICAL  ACCOUNTING ESTIMATES AND ASSUMPTIONS

In preparing the financial statements in accordance with GAAP, we are required to make estimates and assumptions that
have an impact on the assets, liabilities, revenue, and expense amounts reported.  These estimates can also affect our supplemental
information disclosures, including information about contingencies, risks, and financial condition.  We believe, given current facts
and circumstances, that our estimates and assumptions are reasonable, adhere to GAAP, and are consistently applied.  However,
changes in the assumptions used could result in a material adjustment to the financial statements.  Our critical accounting estimates
and assumptions are in the following areas: 

Inventories  

Inventories of tobacco are valued at the lower of cost or net realizable value with cost determined under the specific cost
method.  Raw materials are clearly identified at the time of purchase.  We track the costs associated with raw materials in the final
product lots, and maintain this identification through the time of sale.  We also capitalize direct and indirect costs related to processing
raw materials.  This method of cost accounting is referred to as the specific cost or specific identification method.  We write down
inventory for changes in net realizable value based upon assumptions related to future demand and market conditions if the indicated
value is below cost. Future demand assumptions can be impacted by changes in customer sales, changes in customers’ inventory
positions and policies, competitors’ pricing policies and inventory positions, and varying crop sizes and qualities.  Market conditions
that differ significantly from those assumed by management could result in additional write-downs.  We experience inventory write-
downs routinely.  Inventory write-downs in fiscal years 2020, 2019, and 2018 were $10.3 million, $4.0 million, and $7.7 million,
respectively. 

Advances to Suppliers and Guarantees of Bank Loans to Suppliers

In many sourcing origins, we provide tobacco growers with agronomy services and seasonal crop advances of, or for, seed,
fertilizer, and other supplies.  These advances are short term in nature and are customarily repaid upon delivery of tobacco to us.  In
several origins, we have also made long-term advances to tobacco farmers to finance curing barns and other farm infrastructure.  In
Brazil, we also guarantee bank loans made to farmers for seasonal crop financing.  In some years, due to low crop yields and other
factors, individual farmers may not deliver sufficient volumes of tobacco to repay maturing advances.  In those cases, we may extend
repayment of the advances into the following crop year or satisfy the guarantee by acquiring the loan from the bank.  In either
situation, we will incur losses whenever we are unable to recover the full amount of the loans and advances.  At each reporting period,
we must make estimates and assumptions in determining the valuation allowance for advances to farmers and the liability to accrue
for our obligations under bank loan guarantees.  At March 31, 2020, the gross balance of advances to suppliers totaled approximately
$153 million, and the related valuation allowance totaled approximately $16 million.  The fair value of the loan guarantees for farmers
in Brazil was a liability of less than $1.0 million at March 31, 2020.

Recoverable Value-Added Tax Credits

In  many  foreign  countries,  we  pay  significant  amounts  of  value-added  tax  (“VAT”)  on  purchases  of  unprocessed  and
processed tobacco, crop inputs, packing materials, and various other goods and services.  In some countries, VAT is a national tax,
and in other countries it is assessed at the state level.  Items subject to VAT vary from jurisdiction to jurisdiction, as do the rates at
which the tax is assessed.  When we sell tobacco to customers in the country of origin, we generally collect VAT on those sales.  We
are normally permitted to offset our VAT payments against those collections and remit only the incremental VAT collections to the
tax authorities.  When tobacco is sold for export, VAT is normally not assessed.  In countries where our tobacco sales are predominately
for export markets, we often do not generate enough VAT collections on downstream sales to fully offset our VAT payments.  In
those situations, we can accumulate unused VAT credits.  Some jurisdictions have procedures that allow companies to apply for
refunds of unused VAT credits from the tax authorities, but the refund process often takes an extended period of time and it is not
uncommon for refund applications to be challenged or rejected in part on technical grounds.  Other jurisdictions may permit companies
to sell or transfer unused VAT credits to third parties in private transactions, although approval for such transactions must normally
be obtained from the tax authorities, limits on the amounts that can be transferred may be imposed, and the proceeds realized may
be heavily discounted from the face value of the credits.  Due to these factors, in some countries we can accumulate significant
balances of VAT credits over time.  We review these balances on a regular basis, and we record valuation allowances on the credits
to reflect amounts that we do not expect to recover, as well as discounts anticipated on credits we expect to sell or transfer.  In
determining the appropriate valuation allowance to record in a given jurisdiction, we must make various estimates and assumptions
about factors affecting the ultimate recovery of the VAT credits.  At March 31, 2020, the gross balance of recoverable tax credits
(primarily VAT) totaled approximately $52 million, and the related valuation allowance totaled approximately $19 million.

30

Goodwill

We review the carrying value of goodwill for potential impairment on an annual basis and at any time that events or business
conditions indicate that it may be impaired.  As permitted under Accounting Standards Codification Topic 350 (“ASC 350”), at March
31, 2020 and 2019, we elected to base our initial assessment of potential impairment on qualitative factors.  Those factors did not
indicate any impairment of our recorded goodwill in fiscal year 2020.  However, during fiscal year 2019, based on business changes
that have affected our operations in Tanzania, we recorded a charge of approximately $0.9 million for the full impairment of goodwill
attributable  to  that  reporting  unit.    In  fiscal  years  prior  to  basing  our  initial  assessment  on  qualitative  factors,  we  followed  the
quantitative approach in ASC 350 in assessing the fair value of our goodwill, which involved the use of discounted cash flow models
(Level 3 of the fair value hierarchy under GAAP).  Under our current qualitative assessment, we would also use those discounted
cash flow models to measure any expected impairment indicated by the assessment. The calculations in these models are not based
on observable market data from independent sources and therefore require significant management judgment with respect to operating
earnings growth rates and the selection of an appropriate discount rate.  Significant adverse changes in our operations or our estimates
of future cash flows for a reporting unit with recorded goodwill, such as those caused by unforeseen events or changes in market
conditions, could result in an impairment charge.  A majority of our consolidated goodwill balance relates to our reporting unit in
Brazil and recent acquisition of FruitSmart, Inc.. 

Fair Value Measurements

We hold various financial assets and financial liabilities that are required to be measured and reported at fair value in our
financial statements, including money market funds, trading securities associated with deferred compensation plans, interest rate
swaps, forward foreign currency exchange contracts, and guarantees of bank loans to tobacco growers.  We follow the relevant
accounting guidance in determining the fair values of these financial assets and liabilities.  Money market funds are valued based
on net asset value (“NAV”), which is used as a practical expedient to measure the fair value of those funds (not classified within the
fair value hierarchy).  Quoted market prices (Level 1 of the fair value hierarchy) are used in most cases to determine the fair values
of trading securities.   Interest rate swaps and forward foreign currency exchange contracts are valued based on dealer quotes using
discounted cash flow models matched to the contractual terms of each instrument (Level 2 of the fair value hierarchy).  The fair
value of the guarantees of bank loans to tobacco growers, which was approximately $0.1 million at March 31, 2020, is derived using
an internally-developed discounted cash flow model.  The model requires various inputs, including historical loss percentages for
comparable loans and a risk-adjusted interest rate.  Because significant management judgment is required in determining and applying
these inputs to the valuation model, our process for determining the fair value of these guarantees is classified as Level 3 of the fair
value hierarchy.  At March 31, 2020, a 1% increase in the expected loss percentage for all guaranteed farmer loans would not have
had a material effect on the fair value of the guarantee obligation.  In addition, a 1% change in the risk-adjusted interest rate would
not have had a material effect on the fair value of the guarantee obligation.  We incorporate credit risk in determining the fair values
of our financial assets and financial liabilities, but that risk did not materially affect the fair values of any of those assets or liabilities
at March 31, 2020.  We estimate the fair value of acquisition-related contingent consideration obligations by applying an income
approach model that utilizes probability-weighted discounted cash flows. Each period we evaluate the fair value of the acquisition-
related contingent consideration obligations.  Significant judgment is applied to this model and therefore acquisition-related contingent
consideration obligation is classified within Level 3 of the fair value hierarchy.

Income Taxes  

Our  consolidated  effective  income  tax  rate  is  based  on  our  expected  taxable  income,  tax  laws  and  statutory  tax  rates,
prevailing foreign currency exchange rates, and tax planning opportunities in the various jurisdictions in which we operate.  Significant
judgment is required in determining the effective tax rate and evaluating our tax position.  We are subject to the tax laws of many
jurisdictions, and could be subject to a tax audit in each of these jurisdictions, which could result in adjustments to tax expense in
future periods.  In the event that there is a significant, unusual, or one-time item recognized in our results, the tax attributed to that
discrete item would be recorded at the same time as the item.

Our consolidated income tax expense and effective tax rate are heavily dependent on the tax rates of the individual countries
in which we operate, the mix of our pretax earnings from those countries, and the prevailing rates of exchange of their local currencies
with the U.S. dollar. The mix of pretax earnings and local currency exchange rates in particular can change significantly between
annual and quarterly reporting periods based on crop sizes, market conditions, and economic factors.  Our effective tax rate can be
volatile from year-to-year and from quarter-to-quarter as result of these factors.

We have no undistributed earnings of consolidated foreign subsidiaries that are classified as permanently or indefinitely
reinvested.  We assume that all undistributed earnings of our foreign subsidiaries will be repatriated back to their parent entities in
the U.S. where the funds are best placed to meet our cash flow requirements.  In addition, we strive to mitigate economic, political,
and currency risk by following a disciplined annual approach to the distribution of excess capital back to the U.S.  Based on these
assumptions, in our income tax expense for each reporting period we fully provide for all applicable foreign country withholding
taxes that are expected to be due on these distributions.

31

Our accounting for uncertain tax positions requires that we review all significant tax positions taken, or expected to be
taken, in income tax returns for all jurisdictions in which we operate.  In this review, we must assume that all tax positions will
ultimately  be  audited,  and  either  accepted  or  rejected  based  on  the  applicable  tax  regulations  by  the  tax  authorities  for  those
jurisdictions.  We must recognize in our financial statements only the tax benefits associated with tax positions that are “more likely
than  not”  to  be  accepted  upon  audit,  at  the  greatest  amount  that  is  considered  “more  likely  than  not”  to  be  accepted.    These
determinations require significant management judgment, and changes in any given quarterly or annual reporting period could affect
our consolidated income tax rate.  

Tax regulations require items to be included in taxable income in the tax return at different times, and in some cases in
different amounts, than the items are reflected in the financial statements.  As a result, our effective tax rate reflected in the financial
statements is different than that reported in our tax returns. Some of these differences are permanent, such as expenses that are not
tax deductible, while others are related to timing issues, such as differences in depreciation methods. Timing differences create
deferred tax assets and liabilities.  Deferred tax liabilities generally represent tax expense recognized in our financial statements for
which payment has been deferred or income taxes related to expenses that have not yet been recognized in the financial statements,
but have been deducted in our tax return.  Deferred tax assets generally represent items that can be used as a tax deduction or credit
in future tax returns for which we have already recorded the tax benefit in our financial statements. We record valuation allowances
for deferred tax assets when the amount of estimated future taxable income is not likely to support the use of the deduction or credit.
Determining the amount of such valuation allowances requires significant management judgment, including estimates of future
taxable income in multiple tax jurisdictions where we operate.   Based on our periodic earnings forecasts, we project the upcoming
year’s taxable income to help us evaluate our ability to realize deferred tax assets.    

For additional disclosures on income taxes, see Notes 1 and 6 to the consolidated financial statements in Item 8.

Pension and Other Postretirement Benefit Plans 

The measurement of our pension and other postretirement benefit obligations and costs at the end of each fiscal year requires
that we make various assumptions that are used by our outside actuaries in estimating the present value of projected future benefit
payments to all plan participants.  Those assumptions take into consideration the likelihood of potential future events such as salary
increases and demographic experience.  The assumptions we use may have an effect on the amount and timing of future contributions
to our plans. The plan trustee conducts an independent valuation of the fair value of pension plan assets.  The significant assumptions
used in the calculation of our pension and other postretirement benefit obligations are: 

•

•

•

•

•

Discount rate – The discount rate is based on investment yields on a hypothetical portfolio of actual long-term corporate
bonds rated AA that align with the cash flows for our benefit obligations.

Salary scale – The salary scale assumption is based on our long-term actual experience for salary increases, the near-
term outlook, and expected inflation. 

Expected long-term return on plan assets – The expected long-term return on plan assets reflects asset allocations and
investment strategy adopted by the Finance and Pension Investment Committee of the Board of Directors. 

Retirement and mortality rates – Retirement rates are based on actual plan experience along with our near-term outlook.
Early retirement assumptions are based on our actual experience.  Mortality rates are based on standard industry group
annuity mortality tables which are updated to reflect projected improvements in life expectancy. 

Healthcare cost trend rates – For postretirement medical plan obligations and costs, we make assumptions on future
inflationary increases in medical costs. These assumptions are based on our actual experience, along with third-party
forecasts of long-term medical cost trends. 

From one fiscal year to the next, the rates we use for each of the above assumptions may change based on market developments
and other factors.  The discount rate reflects prevailing market interest rates at the end of the fiscal year when the benefit obligations
are actuarially measured and will increase or decrease based on market patterns.  The expected long-term return on plan assets may
change based on changes in investment strategy for plan assets or changes in indicated longer-term yields on specific classes of plan
assets.  In addition to the changes in actuarial assumptions from year to year, actual plan experience affecting our net benefit obligations,
such as actual returns on plan assets and actual mortality experience, will differ from the assumptions used to measure the obligations.
The effects of these changes and differences increase or decrease the obligation we record for our pension and other postretirement
benefit plans, and they also create gains and losses that are accumulated and amortized over future periods, thus affecting the expense
we recognize for these plans over those periods.   Changes in the discount rate from year to year generally have the largest impact
on our projected benefit obligation and annual expense, and the effects may be significant, particularly over successive years where
the discount rate moves in the same direction.

32

As of March 31, 2020, the effect of the indicated increase or decrease in the selected pension and other postretirement

benefit valuation assumptions is shown below. The effect assumes no change in benefit levels.

(in thousands of dollars)

Changes in Assumptions for Pension Benefits

Discount Rate:

Effect on
2020 Projected
Benefit
Obligation
Increase
(Decrease) 

Effect on
2021 Annual
Expense
Increase
(Decrease) 

1% increase .....................................................................................................................................................................

$

(31,562) $

1% decrease ....................................................................................................................................................................

38,852

Expected Long-Term Return on Plan Assets:

1% increase .....................................................................................................................................................................

1% decrease ....................................................................................................................................................................

Changes in Assumptions for Other Postretirement Benefits

Discount Rate:

1% increase .....................................................................................................................................................................

1% decrease ....................................................................................................................................................................

Healthcare Cost Trend Rate:

1% increase .....................................................................................................................................................................

1% decrease ....................................................................................................................................................................

—

—

(2,541)

3,014

238

(219)

(2,845)

3,158

(2,524)

2,524

(257)

295

78

(72)

A 1% increase or decrease in the salary scale assumption would not have a material effect on the projected benefit obligation
or on annual expense for the Company's pension benefits.  See Note 13 to the consolidated financial statements in Item 8 for additional
information on pension and other postretirement benefit plans.

Other Estimates and Assumptions 

Other management estimates and assumptions are routinely required in preparing our financial statements, including the
determination of valuation allowances on accounts receivable and the fair value of long-lived assets.  Changes in market and economic
conditions, local tax laws, and other related factors are considered each reporting period, and adjustments to the accounts are made
based on management’s best judgment.

33

OTHER INFORMATION REGARDING TRENDS
AND MANAGEMENT’S ACTIONS

Our financial performance depends on our ability to obtain an appropriate price for our products and services, to secure the
product volumes and quality desired by our customers, and to maintain efficient, competitive operations.  As the leading global leaf
tobacco supplier, we continually monitor issues and opportunities that may impact the supply of and demand for leaf tobacco, the
volumes of leaf tobacco that we handle, and the services we provide.

We believe that a key factor to perform successfully in the tobacco industry is our ability to provide customers with the
quality of leaf and the level of service they desire on a global basis at competitive prices, while maintaining stability of supply. We
add significant value to the leaf tobacco supply chain, providing expertise in dealing with large numbers of farmers, efficiently selling
various qualities of leaf produced in each crop to a broad global customer base, and delivering products and services produced in a
sustainable manner that meet stringent quality and regulatory specifications. We also help stabilize the tobacco markets and influence
crop development at the farm level.  As part of our commitment to our customers, we adapt our business model to meet their evolving
needs and monitor new product developments in the tobacco industry to identify areas where we can provide additional value to
them.

Non-Tobacco Investments

As we have stated in our capital allocation strategy, we will continue to make disciplined investments within our leaf business
to take advantage of growth opportunities in tobacco as well as in non-tobacco industries and markets that utilize our assets and
capabilities.  Through these actions, we believe that we will be able to deliver enhanced shareholder value through earnings growth
and the generation of free cash flow despite operating in a mature industry.  

In our non-tobacco investments, we are focusing on building out a broader plant-based agri-product services platform.  We
made our first acquisition in this space with our purchase in January 2020 of FruitSmart, an independent specialty fruit and vegetable
ingredient processor serving global markets, and we maintain an active investment pipeline.  Our acquisition of FruitSmart represents
a foundational step in our development of a broader agri-products service platform as well an investment in value-added agricultural
processing, the section of the agricultural value chain where we possess significant business expertise.  We consider the agricultural
value chain to consist of agricultural inputs, crop production, agricultural processing, manufacture and distribution, and retail sales.
We also recently hired a senior executive to be responsible for our agri-product services platform and play a key strategic role in our
efforts to build out this platform.  Our current target for our agri-product services platform is for it to eventually represent 10% to
20% of our earnings.

Current Tobacco Industry Trends

Mature Leaf Tobacco Markets

Leaf tobacco is sourced directly by product manufacturers, by global leaf suppliers such as ourselves, and by other smaller,
mostly regional or local, leaf suppliers.  We estimate that, of the flue-cured and burley tobacco grown outside of China in countries
that are key export markets for tobacco, on average a little over a third is purchased directly by major manufacturers.  Global leaf
suppliers also usually purchase a little over a third of the tobacco, and the remainder is sourced by the smaller regional or local
suppliers.  Some of the tobacco purchased directly by manufacturers is processed by the global leaf suppliers.   Although we operate
in a mature industry, where demand for the end products has been declining at a compound annual rate of about 2% over the last
five years, our mission is to remain the leading global leaf tobacco supplier.  In recent years, we have been and believe that we will
continue to be able to grow parts of our business, and maintain performance despite declines in demand for leaf tobacco from product
manufacturers.  We have done this by continuing to increase our delivery of services, driving supply chain efficiencies, enhancing
the range of services we provide to certain customers, including direct buying, agronomic support, and specialized processing services,
and improving our market share.  We intend to continue to work to expand our business while at the same time maintaining an
appropriate return for the services we provide and believe that there are several longer term trends in the industry that could provide
additional opportunities for us both to offer additional services to our customers and to increase our market share.

We continually explore options to capitalize on the strengths of our core competencies and seek growth opportunities related
to leaf tobacco and our operations around the world.  For example, we have expanded our leaf purchasing, processing, and grower
support services in multiple origins in response to customer demand. We have increased our product offerings to meet demand for
shisha (water pipe) style leaf tobacco for customers in the Middle East and North Africa (MENA) region and natural wrappers in
the United States and Europe.  As we look at non-tobacco investments and explore new growth opportunities within tobacco, Universal
is dedicated to remaining the leading global leaf tobacco supplier and building on our strong history.

34

Focus on Cost Management

Manufacturers naturally seek to mitigate raw materials cost increases, and they are placing increased emphasis on cost
containment as they address declining demand.  While this is not a new trend, it continues to offer opportunities to us as we bring
supply chain efficiencies to the leaf markets.  We believe that global leaf suppliers add efficiencies to the markets through economies
of scale, as well as through the vital role played in finding buyers for all styles and qualities of leaf tobacco, which achieves overall
cost reductions. To understand our business, it is important to note that tobacco is not a commodity product. Flavor and smoking
characteristics of tobacco vary based on the type of tobacco, the region where the tobacco is grown, and the position of the leaf on
the stalk of the plant.  Many different styles and grades of tobacco may be produced in a single tobacco crop.  A particular manufacturer
may only want and have use for certain leaves of a plant.  The leaf tobacco supplier plays a vital role in the industry by finding buyers
for all of the leaf grades and styles of tobacco produced in a farmer’s crop. This role helps to improve leaf utilization.

In addition to bringing supply chain efficiencies to the leaf tobacco markets, we bring operational efficiencies to the industry,
which in turn help reduce costs.  These efficiencies include economical utilization of processing capacity, an established and scalable
global network of agronomists and technicians helping to maintain a stable, productive, and sustainable farmer base, as well as
agronomic and production improvements to optimize leaf yields and qualities.  In addition, we are able to offer manufacturers a
complete range of services from the field to the delivery of the packed product that benefit from our efficiencies.  These services
include such things as buying station optimization, processing to specific customer specifications or needs, storage of green or packed
leaf tobacco, and logistical services.  In recent years, there has been an increase in the level of direct purchasing, processing, and
other supply chain services that we provide our customers, notably in the United States, Mexico, Brazil, Poland, Guatemala, the
Dominican Republic, and the Philippines.  We believe this increase acknowledges the efficiencies and services that we bring to the
entire supply chain.

We have also seen some reductions in sourcing from lower-volume tobacco growing origins by both global leaf suppliers
and major manufacturers.  Flue-cured tobacco is produced in over 70 countries around the world, and burley tobacco is grown in
over 45 countries.  However, over 80% of both the flue-cured tobacco grown outside of China and the worldwide burley tobacco
production is sourced from the top ten growing areas for each type of tobacco.  We believe that these moves to reduce sourcing areas
and concentrate on major tobacco export markets are another way for the industry to increase efficiency and to reduce costs.  We
have contributed to cost reduction and elimination of excess capacity in the supply chain through the closure or realignment of
programs in Argentina, Canada, Germany, Italy, Hungary, Malawi, Nicaragua, Switzerland, Tanzania, and Zambia. We maintain a
strong presence in all of the major tobacco sourcing areas and believe that any growth in these areas would favor global leaf suppliers
such as ourselves.  In the future, we expect that increased regulations requiring stringent monitoring and testing of leaf chemistry
and compliant sourcing documentation will place greater emphasis on major sourcing areas.

Importance of Compliant Leaf

As we have said for a number of years, the production of compliant leaf for the tobacco industry continues to grow in
importance.  To be considered compliant, leaf tobacco must be grown in a traceable, sustainable manner utilizing Good Agricultural
Practices (“GAP”).  We have long invested significant resources in the programs and infrastructure needed to work with growers to
produce compliant leaf and continue to enhance our ability to monitor and demonstrate this compliance for customers.  Our Good
Agricultural Practices focus on implementing international principles of sustainability by encouraging and training our farmers to
employ sound field production and labor management practices that promote farmer profitability and minimal environmental impact.
To assist farmers, Universal provides comprehensive training, technical support in the field, and crop analytics through ongoing
research  and  development.    Our  commitment  to  compliance  is  reinforced  through  MobilLeaf™,  our  proprietary  mobile  device
platform that captures and shares data in real-time, embedding sustainability throughout our supply chain and providing monitoring
of GAP efforts, compliance with labor standards, and opportunities to enhance efficiencies.  We believe that compliant leaf will
continue to grow in importance to our customers and, as a result, will favor global suppliers who are able to deliver this product.

Growth of Alternative Tobacco Products

Most of the major tobacco product manufacturers have been developing next generation and modified risk products.  These
include electronic nicotine delivery systems (“ENDS”), oral tobacco and nicotine products, and heated tobacco products.  ENDS
use liquid nicotine, which is predominately derived from leaf tobacco, and heated tobacco products use leaf tobacco.  Oral tobacco
and nicotine products may use liquid nicotine or leaf tobacco.  At this time it is unclear how these new products will affect demand
for leaf tobacco. However, as our customers have been developing these products, we have been working with them to make sure
we are able to meet their needs for both their traditional and new products. This is consistent with our commitment to efficiently and
effectively  adapt  our  business  model  to  meet  our  customers’  evolving  needs.    Specifically,  we  have  expertise  in  tobacco  seed
development,  crop  production  methods,  crop  sourcing,  processing,  and  manufacturing  of  reconstituted  sheet  tobacco,  which  is
beneficial to our customers as they continue to develop alternative tobacco products.  We also are able to provide high quality liquid
nicotine through our subsidiary, AmeriNic.  We continue to monitor industry developments regarding next generation products,
including consumer acceptance and regulation, and will adapt accordingly.

35

Leaf Tobacco Supply

Production

Flue-cured tobacco crops grown outside of China were up slightly in fiscal year 2020 by less than 2% to 1.9 billion kilos
compared to fiscal year 2019.  Global burley tobacco production decreased by about 7% to about 552 million kilos in fiscal year
2020, largely due to smaller crops in Africa.  Flue-cured tobacco crops grown outside of China are projected to decrease by about
7% to 1.8 billion kilos in fiscal year 2021.  Burley volumes are also forecast to decrease further to about 499 million kilos in fiscal
year 2021.  We estimate that as of March 31, 2020, industry uncommitted flue-cured and burley inventories, excluding China, totaled
about 122 million kilos, an increase of about 13% from March 31, 2019 levels.  At this time, we believe that flue-cured tobacco is
in a slight oversupply position and burley tobacco is in line with anticipated demand.

We also forecast that oriental tobacco production will increase by about 8%, and dark air-cured production will increase by
about 2% in fiscal year 2021.  Over the long term, we believe that global tobacco production will continue to decline slightly in line
with slightly declining total demand. South America, Asia, Africa, and North America will remain key sourcing regions for flue-
cured and burley tobaccos.

China

China is a significant cigarette market.  However, most of the cigarettes consumed in China and the leaf tobacco used in
those  cigarettes  are  produced  domestically.    Therefore,  we  normally  view  the  Chinese  market  independently  when  evaluating
worldwide leaf tobacco supply and demand.  In the past few years, China’s domestic leaf production has exceeded their domestic
needs for the local cigarette market, and there has been a build-up of domestic leaf inventory there.  China is continuing to demonstrate
efforts to re-align their domestic leaf production and inventories to balance their needs, and these efforts could influence global
supply/demand in the short term.

Pricing

Factors that affect green tobacco prices include global supply and demand, market conditions, production costs, foreign
exchange rates, and competition from other crops.  We work with farmers to maintain tobacco production and to secure product at
price levels that are attractive to both the farmers and our customers.  Our objective is to secure compliant tobacco that is produced
in a cost-effective manner under a sustainable business model with the desired quality for our customers.  In some areas, tobacco
competes with agricultural commodity products for farmer production.  In the past, leaf shortages in specific markets or on a worldwide
basis have also led to green tobacco price increases.

Leaf Tobacco Demand 

Industry data shows that over the past five years, total world consumption of cigarettes fell at a compound annual rate of
about 2%. We believe that growth in world consumption of cigarettes peaked several years ago and is declining.  As a result, we
expect that near term global demand for leaf tobacco will continue to slowly decline in line with declining global cigarette consumption.

Our sales consist primarily of flue-cured and burley tobaccos. Those types of tobacco, along with oriental tobaccos, are
used in American-blend cigarettes which are primarily smoked in Western Europe and the United States.  English-blend cigarettes
which use flue-cured tobacco are mainly smoked in the United Kingdom and Asia and other emerging markets.  Industry data shows
that consumption of American-blend cigarettes has declined at a compound annual rate of about 2% for the five years ended in 2019.
If demand for American-blend cigarettes declines at a higher rate than reductions in demand for English-blend cigarettes, there may
be less demand for burley and oriental tobaccos and more demand for flue-cured tobacco.  However, demand is affected by many
factors, including regulation, product taxation, illicit trade, alternative tobacco products, and Chinese imports. To the extent that
domestic leaf production and inventory durations in China do not meet requirements for Chinese cigarette blends, that tobacco could
be sourced from other origins where we have major market positions.  On a year-to-year basis, we are also susceptible to fluctuations
in leaf supply due to crop sizes and leaf demand as manufacturers adjust inventories or respond to changes in cigarette markets. We
currently believe that the supply of flue-cured tobaccos slightly exceeds anticipated demand, and the supply of burley tobaccos is in
line with anticipated demand.  However, inventories held by our customers may affect their near-term demand for leaf tobacco.  We
also sell oriental tobaccos, which are used in American-blend cigarettes, and dark tobaccos, which are used in cigars and other
smokeless products.  While we expect demand for oriental tobaccos and dark tobaccos used in cigar filler to be generally in line with
supply, we are continuing to see strong demand for wrapper tobacco.

Regulation and Product Taxation

Decreased social acceptance of smoking and increased pressure from anti-smoking groups have had an ongoing adverse
effect on the percentage of the population using tobacco products, particularly in the United States and Western Europe.  Many
governments have additionally taken or proposed steps to restrict or prohibit tobacco product advertising and promotion, to increase
taxes on such products, to prohibit smoking in public areas, and to discourage tobacco product consumption.  A number of such
measures are included in the Framework Convention on Tobacco Control (“FCTC”), which was negotiated under the auspices of
the World Health Organization (“WHO”) and offers guidelines for, among other issues, discouraging or controlling tobacco use.
Such guidelines are reviewed and developed biennially at a Conference of Parties (“COP”), with COP-9 scheduled to be held in

36

November 2021.  The 180 countries that are signatories to the FCTC may choose how to fulfill their obligations in implementing
the articles in a manner that is most suitable with their approach to tobacco control.  For example, China imposed a ban on smoking
in public places, while in the United Kingdom and Australia, laws have been passed mandating plain packaging, the removal of
branding on cigarette packages. We cannot predict the extent to which government efforts to reduce tobacco consumption might
affect the business of our primary customers.  However, a significant decrease in worldwide tobacco consumption, as well as shifts
to modified risk tobacco products facilitated by existing or future governmental laws and regulations, could reduce demand for leaf
tobacco and services and have a material adverse effect on our business.

Recommendations by the WHO, through the FCTC, may cause shifts in customer usage of certain types and styles of
tobacco.  As seen in the United States, Canada, Brazil, and the European Union, efforts have been taken to eliminate flavorings from
tobacco products.  Additionally, discussions continue about the possibility of mandating the reduction of nicotine content in certain
tobacco products to less than addictive levels.  Such decisions could cause a change in requirements for certain leaf tobaccos in
particular countries.  Shifts in customer demand from one type of leaf tobacco to another could create sourcing issues as requirements
move from one origin to another.  Furthermore, instruction at the farm level may be required to produce the changing styles of leaf
tobacco needed by tobacco product manufacturers.  Given our strong global footprint, well-developed programs, and networks at
the farm level worldwide, we remain particularly well positioned to meet any changes to manufacturer requirements.

In 2009, the U.S. Congress passed the Family Smoking Prevention and Tobacco Control Act (“the Act”). This legislation
authorizes the Food and Drug Administration (“FDA”) to regulate the manufacturing and marketing of all tobacco products.  The
FDA has banned flavored cigarettes, restricted youth access to tobacco products, banned advertising claims regarding certain tobacco
products, promulgated new smokeless tobacco warnings, and issued new cigarette health warnings.  In addition, the FDA established
the Center for Tobacco Products (“CTP”).  Over the past decade, the CTP has focused on establishing the scientific foundation and
regulatory framework for regulating tobacco products in the United States.  On May 10, 2016, the FDA released “deeming” regulations
that extend FDA oversight to all tobacco products, including electronic nicotine delivery systems, cigars, hookah tobacco, pipe
tobacco, dissolvables, and “novel and future products.”  The regulations require that tobacco product manufacturers register tobacco
products that were on the market on February 15, 2007, and to seek FDA authorization to sell any products modified or introduced
after such date.  All such submissions require manufacturers to list ingredients in their products.  Per an order issued by the U.S.
District Court for the District of Maryland in July 2019, the deadline for all pre-market tobacco application submissions moved to
May 12, 2020. However, due to the global COVID-19 pandemic, the Court will likely extend this deadline. 

On July 28, 2017, then FDA Commissioner Scott Gottlieb announced a new regulatory approach for the regulation of
combustible and non-combustible products focusing on nicotine reduction and the continuum of risk.  The agency issued an Advanced
Notice of Proposed Rule Making (“ANPRM”) with the intention of developing a nicotine product standard for cigarettes that reduces
the level of nicotine to below-addictive levels. Additional ANPRMs were issued: 1) to explore the science behind exempting premium
cigars from premarket authorization requirements and 2) to address menthol in cigarettes, flavors in vapor and other ENDS products,
and the future ENDS and vapor product standards.  Furthermore, as part of the comprehensive plan, the FDA approved the first
“heat-not-burn” premarket tobacco application to permit the product’s sale in the United States.

In December 2019, Dr. Stephen Hahn was sworn in as FDA Commissioner. Prompted by an uptick in youth use of ENDS
products as reported by the National Youth Tobacco Study, FDA finalized its guidance related to its compliance policy regarding
certain  flavored  ENDS  products.  This  guidance,  among  other  things,  prioritized  FDA’s  enforcement  of  the  premarket  review
requirements against any “flavored, cartridge-based ENDS product (other than a tobacco- or menthol-flavored ENDS product)”
previously marketed under the terms of FDA’s enforcement discretion policy without an otherwise-required marketing order. The
final guidance did not consider further enforcement of flavored cigars despite discussions in the draft guidance.

Regulations impacting our customer base that change the requirements for leaf tobacco or restrict their ability to sell their
products will inherently impact our business.  As discussed, we have established programs that begin at the farm level to assist our
customers with raw material information to support leaf traceability and customer testing requirements, including the detection of
nicotine levels.  Additionally, given our global presence, we also have the ability to source different types and styles of tobacco for
our customers should their needs change due to regulation.  

A number of governments, particularly federal and local governments in the United States and the European Union, impose
excise or similar taxes on tobacco products.  Further legislation proposing new or increased taxes on tobacco products is likely to
continue.  In some cases, proposed legislation seeks to significantly increase existing taxes on tobacco products, or impose new taxes
on products that have not  been subject to tax (e.g. ENDS products and liquid nicotine).  Increases in product taxation may reduce
the  affordability  of,  and  demand  for,  tobacco  products,  which  will  affect  requirements  for  leaf  tobacco  by  tobacco  product
manufacturers.

Illicit Trade

Illicit trade is another factor which influences demand for leaf tobacco.  Industry estimates of the illegal, unregulated illicit
market for cigarettes are approximately 10% to 12% of global stick consumption, representing $40 to $50 billion in lost tax revenue
globally. The United States, European Union, and the WHO have initiated substantial steps in combating illicit trade. We continue
to support both governmental and industry efforts to eradicate illicit trade.

37

Item 7A.   Quantitative and Qualitative Disclosures about Market Risk 

Interest Rate Risk

We generally use both fixed and floating interest rate debt to finance our operations.  Changes in market interest rates expose
us to changes in cash flows for floating rate instruments and to changes in fair value for fixed-rate instruments.   We normally maintain
a proportion of our debt in both variable and fixed interest rates to manage this exposure, and from time to time we may enter hedge
agreements to swap the interest rates.  In addition, our customers may pay market rates of interest for inventory purchased on order,
which could mitigate a portion of the floating interest rate exposure.  We also periodically have large cash balances and may receive
deposits from customers, both of which we use to fund seasonal purchases of tobacco, reducing our financing needs. Excluding our
bank term loans, which have been converted to fixed-rate borrowings with interest rate swaps, debt carried at variable interest rates
was approximately $78 million at March 31, 2020.  Although a hypothetical 1% change in short-term interest rates would result in
a change in annual interest expense of approximately $0.8 million, that amount would be at least partially mitigated by changes in
charges to customers. 

In addition, changes in interest rates affect the calculation of our pension plan liabilities.  As rates decrease, the liability for
the present value of amounts expected to be paid under the plans increases.  Rate changes also affect expense.  As of the March 31,
2020 measurement date, a 1% decrease in the discount rate would have increased the projected benefit obligation (“PBO”) for
pensions by $39 million and increased annual pension expense by $3 million.  Conversely, a 1% increase in the discount rate would
have reduced the PBO by $32 million and reduced annual pension expense by $3 million.

Currency Risk

The international leaf tobacco trade generally is conducted in U.S. dollars, thereby limiting foreign exchange risk to that
which is related to leaf purchase and production costs, overhead, and income taxes in the source country.  We also provide farmer
advances that are directly related to leaf purchases and are denominated in the local currency.  Any currency gains or losses on those
advances are usually offset by increases or decreases in the cost of tobacco, which is priced in the local currency.  However, the
effect of the offset may not occur until a subsequent quarter or fiscal year.  Most of our tobacco operations are accounted for using
the U.S. dollar as the functional currency.  Because there are no forward foreign exchange markets in many of our major countries
of tobacco origin, we often manage our foreign exchange risk by matching funding for inventory purchases with the currency of
sale, which is usually the U.S. dollar, and by minimizing our net local currency monetary position in individual countries.  We are
vulnerable to currency remeasurement gains and losses to the extent that monetary assets and liabilities denominated in local currency
do not offset each other.  We recognized net remeasurement losses of $16.4 million in fiscal year 2020 and $1.8 million in fiscal year
2019, and net remeasurement gains of $0.2 million in fiscal year 2018.  We recognized net foreign currency transaction losses of
$2.9 million in fiscal year 2020, $4.3 million in fiscal year 2019, and $0.1 million in fiscal year 2018.  In addition to foreign exchange
gains and losses, we are exposed to changes in the cost of tobacco due to changes in the value of the local currency in relation to the
U.S. dollar.  We have entered forward currency exchange contracts to hedge against the effects of currency movements on purchases
of tobacco to reduce the volatility of costs.  In addition, we periodically enter into forward contracts to hedge balance sheet exposures.
See Note 11 to the consolidated financial statements in Item 8 for additional information about our hedging activities.

In certain tobacco markets that are primarily domestic, we use the local currency as the functional currency.  Examples of
these markets are Poland and the Philippines. In other markets, such as Western Europe, where export sales are primarily in local
currencies, we also use the local currency as the functional currency.  In each case, reported earnings are affected by the translation
of the local currency into the U.S. dollar.

Hedging Risk

Hedging interest rate exposure using swaps and hedging foreign currency exchange rate exposure using forward contracts
are specifically contemplated to manage risk in keeping with management's policies.  We may use derivative instruments, such as
swaps, forwards, options, or futures, which are based directly or indirectly upon interest rates and currencies to manage and reduce
the risks inherent in interest rate and currency fluctuations.  When we use foreign currency derivatives to mitigate our exposure to
exchange rate fluctuations, we may choose not to designate them as hedges for accounting purposes, which may result in the effects
of the derivatives being recognized in our earnings in periods different from the items that created the exposure.

We do not utilize derivatives for speculative purposes, and we do not enter into market risk-sensitive instruments for trading
purposes.  Derivatives are transaction-specific so that a specific debt instrument, forecast purchase, contract, or invoice determines
the amount, maturity, and other specifics of the hedge.  We routinely review counterparty risk as part of our derivative program.

38

Item 8.   Financial Statements and Supplementary Data 

UNIVERSAL CORPORATION 
CONSOLIDATED STATEMENTS OF INCOME 

(in thousands of dollars, except share and per share data)

2020

2019

2018

Sales and other operating revenues......................................................................................................... $

1,909,979

$

2,227,153

$

2,033,947

Fiscal Year Ended March 31,

Costs and expenses

Cost of goods sold................................................................................................................................

1,553,167

1,820,562

1,661,999

Selling, general and administrative expenses ......................................................................................

Restructuring and impairment costs.....................................................................................................

222,902

7,543

225,118

20,304

201,123

—

Operating income....................................................................................................................................

126,367

161,169

170,825

Equity in pretax earnings of unconsolidated affiliates.........................................................................

Other non-operating income (expense)................................................................................................

Interest income.....................................................................................................................................

4,211

986

1,581

Interest expense....................................................................................................................................

19,854

Income before income taxes ...................................................................................................................

Income taxes ........................................................................................................................................

Net income ..............................................................................................................................................

Less:  net income attributable to noncontrolling interests in subsidiaries ..............................................

113,291

35,288

78,003

(6,323)

5,299

832

1,532

17,510

151,322

41,188

110,134

(6,013)

9,125

662

1,686

15,621

166,677

50,509

116,168

(10,506)

Net income attributable to Universal Corporation.................................................................................. $

71,680

$

104,121

$

105,662

Earnings per share:

Basic..................................................................................................................................................... $

Diluted.................................................................................................................................................. $

2.87

2.86

$

$

4.14

4.11

$

$

4.18

4.14

Weighted average common shares outstanding:

Basic.....................................................................................................................................................

24,982,259

25,129,192

25,274,975

Diluted..................................................................................................................................................

25,106,351

25,330,437

25,508,144

See accompanying notes.

39

UNIVERSAL CORPORATION 
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME 

(in thousands of dollars)

Fiscal Year Ended March 31,

2020

2019

2018

Net income .............................................................................................................................................. $

78,003

$

110,134

$

116,168

Other comprehensive income (loss):

Foreign currency translation, net of income taxes ...............................................................................

Foreign currency hedge, net of income taxes ......................................................................................

Interest rate hedge, net of income taxes...............................................................................................

Pension and other postretirement benefit plans, net of income taxes ..................................................

Total other comprehensive income (loss), net of income taxes .....................................................

Total comprehensive income .........................................................................................................

Less: comprehensive income attributable to noncontrolling interests....................................................

(3,066)

(11,850)

(26,468)

(14,766)

(56,150)

21,853

(6,079)

(16,316)

(341)

(7,462)

(11,665)

(35,784)

74,350

(5,856)

14,162

223

4,498

2,613

21,496

137,664

(10,134)

Comprehensive income attributable to Universal Corporation .............................................................. $

15,774

$

68,494

$

127,530

See accompanying notes.

40

UNIVERSAL CORPORATION 
CONSOLIDATED BALANCE SHEETS 

(in thousands of dollars)

Current assets

ASSETS

March 31,

2020

2019

Cash and cash equivalents .................................................................................................................................................... $

107,430

$

Accounts receivable, net.......................................................................................................................................................

Advances to suppliers, net....................................................................................................................................................

Accounts receivable—unconsolidated affiliates ..................................................................................................................

340,711

133,778

11,483

297,556

368,110

106,850

30,951

Inventories—at lower of cost or net realizable value:

Tobacco..............................................................................................................................................................................

707,298

629,606

Other..................................................................................................................................................................................

Prepaid income taxes............................................................................................................................................................

Other current assets ..............................................................................................................................................................

99,275

12,144

67,498

69,611

14,264

71,197

Total current assets ............................................................................................................................................................

1,479,617

1,588,145

Property, plant and equipment

Land......................................................................................................................................................................................

Buildings ..............................................................................................................................................................................

Machinery and equipment ....................................................................................................................................................

21,376

256,488

634,395

912,259

22,952

261,976

608,191

893,119

Less accumulated depreciation..........................................................................................................................................

(597,106)

(590,625)

315,153

302,494

Other assets

Operating lease right-of-use assets.......................................................................................................................................

Goodwill and other intangibles, net .....................................................................................................................................

Investments in unconsolidated affiliates ..............................................................................................................................

Deferred income taxes..........................................................................................................................................................

Other noncurrent assets ........................................................................................................................................................

39,256

144,687

77,543

20,954

43,711

—

97,994

80,482

13,357

50,712

326,151

242,545

Total assets......................................................................................................................................................................... $

2,120,921

$

2,133,184

41

UNIVERSAL CORPORATION 
CONSOLIDATED BALANCE SHEETS—(Continued) 

(in thousands of dollars)

Current liabilities

LIABILITIES AND SHAREHOLDERS’ EQUITY

March 31,

2020

2019

Notes payable and overdrafts............................................................................................................................................... $

78,033

$

Accounts payable and accrued expenses .............................................................................................................................

140,202

Accounts payable—unconsolidated affiliates......................................................................................................................

Customer advances and deposits .........................................................................................................................................

Accrued compensation.........................................................................................................................................................

Income taxes payable...........................................................................................................................................................

Current portion of operating lease liabilities .......................................................................................................................

Current portion of long-term debt........................................................................................................................................

55

10,242

23,710

5,334

9,823

—

54,023

145,506

106

21,675

31,372

1,066

—

—

Total current liabilities ................................................................................................................................................

267,399

253,748

Long-term debt........................................................................................................................................................................

368,764

Pensions and other postretirement benefits.............................................................................................................................

Long-term operating lease liabilities ......................................................................................................................................

Other long-term liabilities.......................................................................................................................................................

Deferred income taxes ............................................................................................................................................................

70,680

25,893

69,427

29,474

368,503

59,257

—

43,214

28,584

Total liabilities ............................................................................................................................................................

831,637

753,306

Shareholders’ equity

Universal Corporation:

Preferred stock:

Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized, 
none issued or outstanding.............................................................................................................................................

—

—

Common stock, no par value, 100,000,000 shares authorized, 24,421,835 shares issued 
and outstanding (24,989,946 at March 31, 2019) .............................................................................................................

321,502

326,600

Retained earnings..............................................................................................................................................................

1,076,760

1,106,178

Accumulated other comprehensive loss............................................................................................................................

(151,597)

(95,691)

Total Universal Corporation shareholders' equity.......................................................................................................

1,246,665

1,337,087

Noncontrolling interests in subsidiaries..................................................................................................................................

42,619

42,791

Total shareholders' equity ...........................................................................................................................................

1,289,284

1,379,878

Total liabilities and shareholders' equity..................................................................................................................... $

2,120,921

$

2,133,184

See accompanying notes.

42

UNIVERSAL CORPORATION 
CONSOLIDATED STATEMENTS OF CASH FLOWS 

(in thousands of dollars)

Cash Flows From Operating Activities:

Fiscal Year Ended March 31,

2020

2019

2018

Net income .............................................................................................................................................. $
Adjustments to reconcile net income to net cash provided by operating activities:

78,003

$

110,134

$

116,168

Depreciation and amortization .............................................................................................................
Provision for losses (recoveries) on advances and guaranteed loans to suppliers ...............................
Inventory write-downs .........................................................................................................................
Stock-based compensation expense .....................................................................................................
Foreign currency remeasurement loss (gain), net ................................................................................
Deferred income taxes..........................................................................................................................
Equity in net income of unconsolidated affiliates, net of dividends ....................................................
Restructuring and impairment costs .....................................................................................................
Restructuring payments........................................................................................................................
Other, net ..............................................................................................................................................
Changes in operating assets and liabilities, net:

Accounts and notes receivable ..........................................................................................................
Inventories and other assets...............................................................................................................
Income taxes......................................................................................................................................
Accounts payable and other accrued liabilities .................................................................................
Customer advances and deposits .......................................................................................................

  Net cash provided by operating activities .......................................................................................

Cash Flows From Investing Activities:

Purchase of property, plant and equipment ..........................................................................................
Purchase of business, net of cash held by the business ........................................................................
Proceeds from sale of property, plant and equipment ..........................................................................
Other.....................................................................................................................................................

38,379

937

10,319

5,631

16,422

(8,697)

1,101

7,543

(2,787)

(8,772)

16,267

(94,538)

10,927

(48,534)

(11,304)

10,897

(35,227)

(80,180)

8,547

495

37,104

(2,339)

4,002

8,152

1,786

3,873

3,659

20,304

(4,014)

5,613

(8,373)

33,796

(8,981)

(54,912)

14,718

164,522

34,836

3,730

7,687

7,610

(184)

(11,132)

(1,521)

—

(315)

(7,866)

38,264

(116,728)

1,239

13,397

(3,940)

81,245

(38,760)

(34,037)

—

2,061

2,000

—

5,194

1,450

  Net cash used by investing activities...............................................................................................

(106,365)

(34,699)

(27,393)

Cash Flows From Financing Activities:

Issuance (repayment) of short-term debt, net .......................................................................................
Issuance of long-term debt ...................................................................................................................
Repayment of long-term debt...............................................................................................................
Dividends paid to noncontrolling interests in subsidiaries...................................................................
Repurchase of common stock...............................................................................................................

Dividends paid on common stock ........................................................................................................

Proceeds from termination of interest rate swap agreements...............................................................
Debt issuance costs and other...............................................................................................................

  Net cash used by financing activities ..............................................................................................

Effect of exchange rate changes on cash.................................................................................................

Net increase (decrease) in cash and cash equivalents .............................................................................

Cash and cash equivalents at beginning of year......................................................................................

24,114

—

—

(6,251)

(33,457)

(75,368)

—

(3,184)

(94,146)

(512)

(190,126)

297,556

12,036

41,147

(41,147)

(5,938)

(1,443)

(69,883)

5,428

(5,987)

(65,787)

(608)

63,428

234,128

Cash and Cash Equivalents at End of Year ........................................................................................ $

107,430

$

297,556

$

(18,159)

—

—

(7,350)

(21,610)

(54,699)

—

(2,828)

(104,646)

929

(49,865)

283,993

234,128

Supplemental information—cash paid for:

Interest .................................................................................................................................................. $

Income taxes, net of refunds................................................................................................................. $

19,376

30,984

$

$

16,462

44,856

$

$

15,621

58,339

See accompanying notes.

43

UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(in thousands of dollars)

Fiscal Year Ended March 31, 2020

Universal Corporation Shareholders

Common
Stock

Retained 
Earnings

Accumulated
Other
Comprehensive
Income
(Loss)

Non-
controlling
Interests

Total
Shareholders'
Equity

Balance at beginning of year..................................................................................

$ 326,600

$ 1,106,178

$

(95,691) $

42,791

$

1,379,878

 Changes in common stock

Repurchase of common stock .......................................................................

Accrual of stock-based compensation ..........................................................

Withholding of shares from stock-based compensation for grantee income
taxes..........................................................................................................

Dividend equivalents on restricted stock units (RSUs) ................................

(8,562)

5,631

(3,183)

1,016

Changes in retained earnings

Net income ....................................................................................................

Cash dividends declared on common stock ($3.04 per share)......................

Repurchase of common stock .......................................................................

Dividend equivalents on restricted stock units (RSUs) ................................

Other comprehensive income (loss)

Foreign currency translation, net of income taxes ........................................

Foreign currency hedge, net of income taxes ...............................................

Interest rate hedge, net of income taxes........................................................

Pension and other postretirement benefit plans, net of income taxes ...........

Other changes in noncontrolling interests

Dividends paid to noncontrolling shareholders ............................................

—

—

—

—

—

—

—

—

—

—

—

—

—

71,680

(75,187)

(24,895)

(1,016)

—

—

—

—

—

—

—

—

—

—

—

—

—

(2,822)

(11,850)

(26,468)

(14,766)

—

—

—

—

6,323

—

—

—

(244)

—

—

—

(8,562)

5,631

(3,183)

1,016

78,003

(75,187)

(24,895)

(1,016)

(3,066)

(11,850)

(26,468)

(14,766)

—

(6,251)

(6,251)

Balance at end of year............................................................................................

$ 321,502

$ 1,076,760

$

(151,597) $

42,619

$

1,289,284

44

UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)

(in thousands of dollars)

Fiscal Year Ended March 31, 2019

Universal Corporation Shareholders

Common
Stock

Retained 
Earnings

Accumulated
Other
Comprehensive
Income
(Loss)

Non-
controlling
Interests

Total
Shareholders'
Equity

Balance at beginning of year..................................................................................

$ 321,559

$ 1,080,934

$

(60,064) $

42,873

$

1,385,302

 Changes in common stock

Repurchase of common stock .......................................................................

Accrual of stock-based compensation ..........................................................

Withholding of shares from stock-based compensation for grantee income
taxes..........................................................................................................

Dividend equivalents on restricted stock units (RSUs) ................................

(397)

8,152

(3,697)

983

Changes in retained earnings

Net income ....................................................................................................

Cash dividends declared on common stock ($3.00 per share)......................

Repurchase of common stock .......................................................................

Dividend equivalents on restricted stock units (RSUs) ................................

Adoption of FASB Accounting Standards Update 2016-16 eliminating

deferred income taxes on unrecognized gains on intra-entity transfers
of assets other than inventory ...................................................................

Other comprehensive income (loss)

Foreign currency translation, net of income taxes ........................................

Foreign currency hedge, net of income taxes ...............................................

Interest rate hedge, net of income taxes........................................................

Pension and other postretirement benefit plans, net of income taxes ...........

Other changes in noncontrolling interests

Dividends paid to noncontrolling shareholders ............................................

—

—

—

—

—

—

—

—

—

—

—

—

—

—

104,121

(74,914)

(1,046)

(983)

(1,934)

—

—

—

—

—

—

—

—

—

—

—

—

—

—

(16,159)

(341)

(7,462)

(11,665)

—

—

—

—

6,013

—

—

—

—

(157)

—

—

—

(397)

8,152

(3,697)

983

110,134

(74,914)

(1,046)

(983)

(1,934)

(16,316)

(341)

(7,462)

(11,665)

—

(5,938)

(5,938)

Balance at end of year............................................................................................

$ 326,600

$ 1,106,178

$

(95,691) $

42,791

$

1,379,878

45

UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)

(in thousands of dollars)

Fiscal Year Ended March 31, 2018

Universal Corporation Shareholders

Common
Stock

Retained 
Earnings

Accumulated
Other
Comprehensive
Income
(Loss)

Non-
controlling
Interests

Total
Shareholders'
Equity

Balance at beginning of year..................................................................................

$ 321,207

$ 1,034,841

$

(69,559) $

40,089

$

1,326,578

 Changes in common stock

Repurchase of common stock .......................................................................

Accrual of stock-based compensation ..........................................................

Withholding of shares from stock-based compensation for grantee income
taxes..........................................................................................................

Dividend equivalents on restricted stock units (RSUs) ................................

(5,142)

7,610

(2,828)

712

Changes in retained earnings

Net income ....................................................................................................

Cash dividends declared on common stock ($2.18 per share)

Repurchase of common stock .......................................................................

Dividend equivalents on restricted stock units (RSUs) ................................

Other comprehensive income (loss)

Foreign currency translation, net of income taxes ........................................

Foreign currency hedge, net of income taxes ...............................................

Interest rate hedge, net of income taxes........................................................

Pension and other postretirement benefit plans, net of income taxes ...........

Other changes in accumulated other comprehensive income (loss)

Reclassification of disproportionate tax effects related to changes in U.S.
corporate income tax law to retained earnings (ASU 2018-02) (see
Notes 1 and 6)...........................................................................................

Other changes in noncontrolling interests

Dividends paid to noncontrolling shareholders ............................................

—

—

—

—

—

—

—

—

—

—

—

—

—

105,662

(54,762)

(16,468)

(712)

—

—

—

—

—

—

—

—

—

—

—

14,534

223

4,498

2,613

12,373

(12,373)

—

—

—

—

10,506

—

—

(5,142)

7,610

(2,828)

712

116,168

(54,762)

(16,468)

(712)

(372)

14,162

—

—

—

—

223

4,498

2,613

—

—

—

(7,350)

(7,350)

Balance at end of year............................................................................................

$ 321,559

$ 1,080,934

$

(60,064) $

42,873

$

1,385,302

46

UNIVERSAL CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY—(Continued)

Fiscal Year Ended March 31,

2020

2019

2018

Common Shares Outstanding:

    Balance at beginning of year.................................................................................................................

24,989,946

24,930,725

25,274,506

    Issuance of common stock ....................................................................................................................

88,709

    Repurchase of common stock ...............................................................................................................

(656,820)

89,998

(30,777)

59,843

(403,624)

    Balance at end of year...........................................................................................................................

24,421,835

24,989,946

24,930,725

See accompanying notes.

47

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(All dollar amounts are in thousands, except per share amounts or as otherwise noted.) 

NOTE 1.   NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is the
leading global leaf tobacco supplier.  The Company conducts its leaf tobacco business in over 30 countries, primarily in major
tobacco-producing regions of the world.  The Company also has operations in smaller-scale businesses adjacent to the leaf tobacco
business, as well as a fruit and vegetable ingredients business.

The extent to which the ongoing COVID-19 pandemic will impact the Company's financial condition, results of operations
and demand for the Company's products and services will depend on future developments, which are highly uncertain and cannot
be predicted. Such developments may include the ongoing geographic spread of COVID-19, the severity of the pandemic, the duration
of the COVID-19 outbreak and the type and duration of actions that may be taken by various governmental authorities in response
to the COVID-19 pandemic and the impact on the U.S. and the global economies, markets and supply chains. At March 31, 2020,
it is not possible to predict the overall impact of the ongoing COVID-19 pandemic on the Company's business, financial condition,
results of operations and demand for our products and services. 

Consolidation

The consolidated financial statements include the accounts of Universal Corporation and all domestic and foreign subsidiaries
in which the Company maintains a controlling financial interest.  Control is generally determined based on a voting interest of greater
than 50%, such that Universal controls all significant corporate activities of the subsidiary.  All significant intercompany accounts
and transactions are eliminated in consolidation.  

The equity method of accounting is used for investments in companies where Universal Corporation has a voting interest
of 20% to 50%.  These investments are accounted for under the equity method because Universal exercises significant influence
over those companies, but not control.  The Company received dividends totaling $3.9 million in fiscal year 2020, $7.5 million in
fiscal year 2019, and $5.5 million in fiscal year 2018, from companies accounted for under the equity method.  Investments where
Universal has a voting interest of less than 20% are not significant and do not have readily determinable fair values.  As such, the
Company  has  elected  the  alternate  method  of  measuring  these  investments  at  cost,  less  any  impairment.   The  Company's  49%
ownership interest in Socotab L.L.C. (“Socotab”), a leading supplier of oriental tobaccos with operations located principally in
Eastern Europe and Turkey, is the primary investment accounted for under the equity method.  The investment in Socotab is an
important part of the Company's overall product and service arrangements with its major customers.  The Company reviews the
carrying value of its investments in Socotab and its other unconsolidated affiliates on a regular basis and considers whether any
factors exist that might indicate an impairment in value that is other than temporary.  At March 31, 2020, the Company determined
that no such factors existed with respect to those investments. 

The  Company's  operations  in  Zimbabwe  are  deconsolidated  under  accounting  requirements  that  apply  under  certain
conditions to foreign subsidiaries that are subject to foreign exchange controls and other government restrictions.  The investment
in the Zimbabwe operations is accounted for at cost less impairment, and was zero at March 31, 2020 and 2019.  The Company has
a net foreign currency translation loss associated with the Zimbabwe operations of approximately $7.2 million, which remains a
component of accumulated other comprehensive loss.  As a regular part of its reporting, the Company reviews the conditions that
resulted in the deconsolidation of the Zimbabwe operations to confirm that such accounting treatment is still appropriate.  Dividends
from the Zimbabwe operations are recorded in income in the period received. 

The Company holds less than a 100% financial interest in certain consolidated subsidiaries.  The net income and shareholders’
equity attributable to the noncontrolling interests in these subsidiaries are reported on the face of the consolidated financial statements.
During fiscal year 2018, the Company purchased the noncontrolling interest of one subsidiary for $0.6 million. Other than this
transaction, there were no changes in the Company’s ownership percentage in any of these subsidiaries during fiscal years 2018,
2019, or 2020.

48

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Investments in Unconsolidated Affiliates

The Company’s investments in its unconsolidated affiliates, which include its Zimbabwe operations, are non-marketable
securities.  Universal reviews such investments for impairment whenever events or changes in circumstances indicate that the carrying
amount of an investment may not be recovered.  For example, the Company would review such an investment for impairment if the
investee were to lose a significant customer, suffer a large reduction in sales margins, experience a major change in its business
environment, or undergo any other significant change in its normal business.  In assessing the recoverability of these investments,
the Company follows the applicable accounting guidance in determining the fair value of the investments.  In most cases, this involves
the use of undiscounted and discounted cash flow models (Level 3 of the fair value hierarchy under the accounting guidance).  If
the fair value of an unconsolidated investee is determined to be lower than its carrying value, an impairment loss is recognized.  The
determination of fair value using discounted cash flow models is normally not based on observable market data from independent
sources  and  therefore  requires  significant  management  judgment  with  respect  to  estimates  of  future  operating  earnings  and  the
selection of an appropriate discount rate.  The use of different assumptions could increase or decrease estimated future operating
cash flows, and the discounted value of those cash flows, and therefore could increase or decrease any impairment charge related to
these investments. 

In its consolidated statements of income, the Company reports its proportional share of the earnings of unconsolidated
affiliates accounted for on the equity method based on the pretax earnings of those affiliates, as permitted under the applicable
accounting guidance.  All applicable foreign and U.S. income taxes are provided on these earnings and reported as a component of
consolidated income tax expense.  For unconsolidated affiliates located in foreign jurisdictions, repatriation of the Company’s share
of the earnings through dividends is assumed in determining consolidated income tax expense.  

The following table provides a reconciliation of (1) equity in the pretax earnings of unconsolidated affiliates, as reported
in the consolidated statements of income to (2) equity in the net income of unconsolidated affiliates, net of dividends, as reported in
the consolidated statements of cash flows for the fiscal years ended March 31, 2020, 2019, and 2018

Fiscal Year Ended March 31,

2020

2019

2018

Equity in pretax earnings reported in the consolidated statements of income ..................... $

4,211

$

5,299

$

Less:  Equity in income taxes ...............................................................................................

Equity in net income.............................................................................................................
Less:  Dividends received on investments (1) .......................................................................

(1,390)

2,821

(3,922)

(1,441)

3,858

(7,517)

9,125

(2,063)

7,062

(5,541)

Equity in net income, net of dividends, reported in the consolidated statements of cash

flows ................................................................................................................................. $

(1,101) $

(3,659) $

1,521

(1)

In accordance with the applicable accounting guidance, dividends received from unconsolidated affiliates accounted for on the equity method that represent a
return on capital (i.e., a return of earnings on a cumulative basis) are presented as operating cash flows in the consolidated statements of cash flows.

Earnings Per Share 

 The Company calculates basic earnings per share based on earnings available to common shareholders.  The calculation
uses the weighted average number of common shares outstanding during each period.  Diluted earnings per share is computed in a
similar manner using the weighted average number of common shares and dilutive potential common shares outstanding.  Dilutive
potential common shares include unvested restricted stock units and performance share awards that are assumed to be fully vested
and paid out in shares of common stock.

Calculations of earnings per share for the fiscal years ended March 31, 2020, 2019, and 2018, are provided in Note 5.

Cash and Cash Equivalents

 All highly liquid investments with a maturity of three months or less at the time of purchase are classified as cash equivalents.

49

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Advances to Suppliers

In many sourcing origins where the Company operates, it provides agronomy services and seasonal advances of seed,
fertilizer, and other supplies to tobacco farmers for crop production, or makes seasonal cash advances to farmers for the procurement
of those inputs.  These advances are short term, are repaid upon delivery of tobacco to the Company, and are reported in advances
to suppliers in the consolidated balance sheets.  In several origins, the Company has made long-term advances to tobacco farmers
to finance curing barns and other farm infrastructure.  In some years, due to low crop yields and other factors, individual farmers
may not deliver sufficient volumes of tobacco to fully repay their seasonal advances, and the Company may extend repayment of
those advances into future crop years.  The long-term portion of advances is included in other noncurrent assets in the consolidated
balance sheets.  Both the current and the long-term portions of advances to suppliers are reported net of allowances recorded when
the Company determines that amounts outstanding are not likely to be collected. Short-term and long-term advances to suppliers
totaled approximately $153 million at March 31, 2020 and $129 million at March 31, 2019.  The related valuation allowances totaled
$16 million at March 31, 2020, and $18 million at March 31, 2019, and were estimated based on the Company’s historical loss
information  and  crop  projections.    The  allowances  were  increased  by  net  provisions  for  estimated  uncollectible  amounts  of
approximately $1.0 million in fiscal year 2020 and $3.7 million in fiscal year 2018, and reduced by net recoveries of approximately
$2.3 million in fiscal year 2019.  These net provisions and recoveries are included in selling, general, and administrative expenses
in the consolidated statements of income.  Interest on advances is recognized in earnings upon the farmers’ delivery of tobacco in
payment of principal and interest.  Advances on which interest accrual had been discontinued totaled approximately $5 million at
March 31, 2020 and $6 million at March 31, 2019.

Inventories

Tobacco inventories are valued at the lower of cost or net realizable value.  Raw materials primarily consist of unprocessed
leaf tobacco, which is clearly identified by type and grade at the time of purchase.  The Company tracks the costs associated with
this tobacco in the final product lots, and maintains this identification through the time of sale.  This method of cost accounting is
referred to as the specific cost or specific identification method.  The predominant cost component of the Company’s inventories is
the cost of the unprocessed tobacco.  Direct and indirect processing costs related to these raw materials are capitalized and allocated
to inventory in a systematic manner.  The Company does not capitalize any interest or sales-related costs in inventory.  Freight costs
are recorded in cost of goods sold.  Other inventories consist primarily of seed, fertilizer, packing materials, unprocessed and processed
food and vegetable ingredients, and other supplies, and are valued principally at the lower of average cost or net realizable value.

Recoverable Value-Added Tax Credits

In many foreign countries, the Company’s local operating subsidiaries pay significant amounts of value-added tax (“VAT”)
on purchases of unprocessed and processed tobacco, crop inputs, packing materials, and various other goods and services.  In some
countries, VAT is a national tax, and in other countries it is assessed at the state level.  Items subject to VAT vary from jurisdiction
to jurisdiction, as do the rates at which the tax is assessed.  When tobacco is sold to customers in the country of origin, the operating
subsidiaries generally collect VAT on those sales.  The subsidiaries are normally permitted to offset their VAT payments against the
collections and remit only the incremental VAT collections to the tax authorities.  When tobacco is sold for export, VAT is normally
not assessed.  In countries where tobacco sales are predominately for export markets, VAT collections generated on downstream
sales are often not sufficient to fully offset the subsidiaries’ VAT payments.  In those situations, unused VAT credits can accumulate.
Some jurisdictions have procedures that allow companies to apply for refunds of unused VAT credits from the tax authorities, but
the refund process often takes an extended period of time, and it is not uncommon for refund applications to be challenged or rejected
in part on technical grounds.  Other jurisdictions may permit companies to sell or transfer unused VAT credits to third parties in
private transactions, although approval for such transactions must normally be obtained from the tax authorities, limits on the amounts
that can be transferred may be imposed, and the proceeds realized may be heavily discounted from the face value of the credits.  Due
to these factors, local operating subsidiaries in some countries can accumulate significant balances of VAT credits over time.  The
Company reviews these balances on a regular basis and records valuation allowances on the credits to reflect amounts that are not
expected to be recovered, as well as discounts anticipated on credits that are expected to be sold or transferred.  At March 31, 2020
and 2019, the aggregate balances of recoverable tax credits held by the Company’s subsidiaries totaled approximately $52 million
and $53 million, respectively, and the related valuation allowances totaled approximately $19 million and $17 million, respectively.
The net balances are reported in other current assets and other noncurrent assets in the consolidated balance sheets.

Property, Plant and Equipment 

Depreciation of property, plant and equipment is based upon historical cost and the estimated useful lives of the assets.
Depreciation is calculated primarily using the straight-line method.  Buildings include tobacco processing and blending facilities,
offices, and warehouses. Machinery and equipment consists of processing and packing machinery and transport, office, and computer
equipment.  Estimated useful lives range as follows: buildings - 15 to 40 years; processing and packing machinery - 3 to 11 years;
transport equipment - 3 to 10 years; and office and computer equipment - 3 to 12 years.  Where applicable and material in amount,

50

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

the Company capitalizes related interest costs during periods that property, plant and equipment are being constructed or made ready
for service.  No interest was capitalized in fiscal years 2020, 2019, or 2018.

Leases

As  discussed  below  under  "Accounting  Pronouncements",  the  Company  adopted  updated  comprehensive  accounting
guidance for leases at the beginning of fiscal year 2020 (Accounting Standards Update No. 2016-02, "Leases (Topic 842)" and
supplemental amendments, which superseded the lease accounting requirements in Topic 840).

The Company determines if an arrangement meets the definition of a lease at inception. The Company, as a lessee, enters
into operating leases for land, buildings, equipment, and vehicles. For all operating leases with terms greater than 12 months and
with fixed payment arrangements, a lease liability and corresponding right-of-use asset are recognized in the balance sheet for the
term of the lease by calculating the net present value of future lease payments.  On the date of lease commencement, the present
value of lease liabilities is determined by discounting the future lease payments by the Company’s collateralized incremental borrowing
rate, adjusted for the lease term and currency of the lease payments. If a lease contains a renewal option that the Company is reasonably
certain to exercise, the Company accounts for the original lease term and expected renewal term in the calculation of the lease liability
and right-of-use asset. Certain of the Company’s leases include both lease and non-lease components (e.g., common-area or other
maintenance costs) which are accounted for as a single lease component, as the Company has elected the practical expedient to group
lease and non-lease components for real estate leases. 

Goodwill and Other Intangibles 

Goodwill and other intangibles are disclosed in Note 7.  Goodwill principally consists of the excess of the purchase price
of acquired companies over the fair value of the net assets.   Goodwill is carried at the lower of cost or fair value and is reviewed
for potential impairment on an annual basis as of the end of the fiscal year.  Accounting Standards Codification Topic 350 (“ASC
350”) permits companies to base their initial assessments of potential goodwill impairment on qualitative factors, and the Company
elected to use that approach at March 31, 2020 and 2019.  Those factors did not indicate any potential impairment of the Company's
recorded goodwill at those dates.  

Reporting units are distinct operating subsidiaries or groups of subsidiaries that typically compose the Company’s business
in a specific country or location.  Goodwill is allocated to reporting units based on the country or location to which a specific
acquisition relates, or by allocation based on expected future cash flows if the acquisition relates to more than one country or location.
The majority of the Company’s goodwill relates to its reporting unit in Brazil and recent acquisition of FruitSmart, Inc. See Note 2
for additional information.  Significant adverse changes in the operations or estimated future cash flows for a reporting unit with
recorded goodwill could result in an impairment charge (See Note 4 for additional disclosures regarding goodwill impairment).

Other intangibles principally consists of finite lived intangible assets including customer-related intangibles, trade names,
developed technology, and noncompetition agreements.  Intangible assets acquired in a business combination are recorded at fair
value using a discounted cash flow approach. A discounted cash flow approach to value intangible assets requires assumptions about
the timing, amount, and probability of future net cash flows, as well as the discount rate and market participant considerations.  Other
intangibles are amortized on a straight-line basis over the intangible asset's economic life.

Impairment of Long-Lived Assets 

The Company reviews long-lived assets for impairment, disclosed in Note 4 and Note 12, whenever events, changes in
business conditions, or other circumstances provide an indication that such assets may be impaired.  Potential impairment is initially
assessed by comparing management’s undiscounted estimates of future cash flows from the use or disposition of the assets to their
carrying value.  If the carrying value exceeds the undiscounted cash flows, an impairment charge is recorded to reduce the carrying
value of the asset to its fair value determined in accordance with the accounting guidance.  In many cases, this involves the use of
discounted cash flow models that are not based on observable market data from independent sources (Level 3 of the fair value
hierarchy under the accounting guidance). 

Income Taxes 

The Company provides deferred income taxes on temporary differences between the book and tax basis of its assets and
liabilities. Those differences arise principally from employee benefit accruals, depreciation, deferred compensation, undistributed
earnings of unconsolidated affiliates, undistributed earnings of foreign subsidiaries, goodwill, and valuation allowances on farmer
advances and value-added tax credits.  Income taxes provided on pretax amounts recorded in accumulated other comprehensive
income (loss) are released when the related pretax amounts are reclassified to earnings. Additional disclosures related to the Company's
income taxes are disclosed in Note 6.

51

 
UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Fair Values of Financial Instruments

The fair value of the Company’s long-term debt, disclosed in Note 12, approximates the carrying amount since the variable
interest rates in the underlying credit agreement reflect the market interest rates that were available to the Company at March 31,
2020.  In periods when fixed-rate obligations are outstanding, fair values are estimated using market prices where they are available
or  discounted  cash  flow  models  based  on  current  incremental  borrowing  rates  for  similar  classes  of  borrowers  and  borrowing
arrangements.  The fair values of interest rate swap agreements designated as cash flow hedges and used to fix the variable benchmark
rate on outstanding long-term debt are determined separately and recorded in other long-term liabilities.  Except for interest rate
swaps and forward foreign currency exchange contracts that are discussed below, the fair values of all other assets and liabilities that
qualify as financial instruments approximate their carrying amounts.

Derivative Financial Instruments

The Company recognizes all derivatives on the balance sheet at fair value.  Interest rate swaps and forward foreign currency
exchange contracts are used from time to time to manage interest rate risk and foreign currency risk.  The Company enters into such
contracts only with counterparties of good standing.  The credit exposure related to non-performance by the counterparties and the
Company is considered in determining the fair values of the derivatives, and the effect has not been material to the financial statements
or operations of the Company.  Additional disclosures related to the Company’s derivatives and hedging activities are provided in
Note 11.

Translation and Remeasurement of Foreign Currencies

The financial statements of foreign subsidiaries having the local currency as the functional currency are translated into U.S.
dollars using exchange rates in effect at period end for assets and liabilities and average exchange rates applicable to each reporting
period for results of operations.  Adjustments resulting from translation of financial statements are reflected as a separate component
of other comprehensive income or loss.  The financial statements of foreign subsidiaries having the U.S. dollar as the functional
currency, with certain transactions denominated in a local currency, are remeasured into U.S. dollars.  The remeasurement of local
currency amounts into U.S. dollars creates remeasurement gains and losses that are included in earnings as a component of selling,
general, and administrative expenses.  The Company recognized net remeasurement losses of $16.4 million in fiscal year 2020 and
$1.8 million in fiscal year 2019, and net remeasurement gains of $0.2 million in fiscal year 2018.

Foreign currency transactions and forward foreign currency exchange contracts that are not designated as hedges generate
gains and losses when they are settled or when they are marked to market under the prescribed accounting guidance.  These transaction
gains  and  losses  are  also  included  in  earnings  as  a  component  of  selling,  general,  and  administrative  expenses.   The  Company
recognized net foreign currency transaction losses of $2.9 million in fiscal year 2020, $4.3 million in fiscal year 2019, and $0.1
million in fiscal year 2018.

52

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Revenue Recognition 

As  discussed  below  under  "Accounting  Pronouncements",  the  Company  adopted  updated  comprehensive  accounting
guidance for revenue recognition at the beginning of fiscal year 2019 (Accounting Standards Update No. 2014-09, "Revenue from
Contracts with Customers" and supplemental amendments, now codified as Section 606 of the Financial Accounting Standards Board
("FASB") Accounting Standards Codification).  Under this updated guidance, revenue is recognized when the Company completes
its performance obligation for the transfer of products and services under its contractual arrangements with customers.  For sales of
tobacco, satisfaction of the performance obligation and recognition of the corresponding revenue is based on the transfer of the
ownership and control of the product to the customer, which is substantially unchanged from the previous accounting guidance.  A
large percentage of the Company’s sales are to major multinational manufacturers of consumer tobacco products.  The Company
works closely with those customers to understand and plan for their requirements for volumes, styles, and grades of leaf tobacco
from  its  various  growing  regions,  and  extensive  coordination  is  maintained  on  an  ongoing  basis  to  determine  and  satisfy  their
requirements for transfer of ownership and physical shipment of processed tobacco. The customers typically specify, in sales contracts
and in shipping documents, the precise terms for transfer of title and risk of loss for the tobacco.  Customer returns and rejections
are not significant, and the Company’s sales history indicates that customer-specific acceptance provisions are consistently met upon
transfer of title and risk of loss.

While most of the Company’s revenue is derived from tobacco that is purchased from farmers, processed and packed in its
factories, and then sold to customers, some revenue is earned from processing tobacco owned by customers and from other value-
added services.  The arrangements for processing services usually exist in specific markets where the customers contract directly
with farmers for leaf production, and they have accounted for less than 5% of total revenue on an annual basis through the fiscal
year ended March 31, 2020.  Processing and packing of leaf tobacco is a short-duration process.  Under normal operating conditions,
raw tobacco that is placed into the production line exits as processed and packed tobacco within one hour, and is then later transported
to customer-designated storage facilities.  The revenue for these services is recognized when the performance obligation is met upon
the completion of processing, and the Company’s operating history indicates that customer requirements for processed tobacco are
consistently met upon completion of processing.

Additional disclosures related to the Company's revenue from contracts with customers are provided in Note 3.

Stock-Based Compensation

Share-based payments, such as grants of restricted stock units, performance share awards, restricted stock, stock appreciation
rights, and stock options, are measured at fair value and reported as expense in the financial statements over the requisite service
period.  Additional disclosures related to stock-based compensation are included in Note 15.

Estimates and Assumptions 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States
requires  management  to  make  estimates  and  assumptions  that  affect  the  amounts  reported  in  the  financial  statements  and
accompanying notes.  Actual results could differ from those estimates. 

53

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Accounting Pronouncements 

Pronouncements Adopted in Fiscal Year 2018

In  July  2015,  the  Financial Accounting  Standards  Board  ("FASB")  issued Accounting  Standards  Update  No.  2015-11,
“Simplifying the Measurement of Inventory” (“ASU 2015-11”).  ASU 2015-11 requires that most inventory be measured at the lower
of cost or net realizable value.  ASU 2015-11 defines net realizable value as the "estimated selling price in the ordinary course of
business, less reasonable predictable costs of completion, disposal, and transportation."  ASU 2015-11 was effective for fiscal years
beginning after December 31, 2016, and was adopted by the Company effective April 1, 2017, the beginning of fiscal year 2018.  As
required under the guidance, ASU 2015-11 has been applied prospectively after the date of adoption, and its adoption did not have
a material impact on the Company's consolidated financial statements.

In August 2017, the FASB issued Accounting Standards Update No. 2017-12, "Derivatives and Hedging (Topic 815)" ("ASU
2017-12").  ASU 2017-12 expands derivative strategies that quality for hedge accounting and amends presentation and disclosure
requirements. The guidance was effective for fiscal years beginning after December 15, 2018, with early adoption permitted. The
Company elected to early-adopt ASU 2017-12 in the fourth quarter of fiscal year 2018.  As required under the guidance, ASU 2017-12
was applied using the modified retrospective approach and its adoption did not have a material impact on the Company's consolidated
financial statements.

In  February  2018,  the  FASB  issued  Accounting  Standards  Update  No.  2018-02,  "Income  Statement  -  Reporting
Comprehensive  Income  (Topic  220)  -  Reclassification  of  Certain  Tax  Effects  from  Accumulated  Other  Comprehensive
Income" ("ASU 2018-02") to address the disproportionate income tax effects on pretax amounts recorded in accumulated other
comprehensive income (loss) resulting from the enactment of the Tax Cuts and Jobs Act in December 2017.  Under the existing
accounting guidance, companies were required to record the impact of changes in deferred income tax assets and liabilities from the
enactment of the new law through income from continuing operations, including the impact related to pretax amounts recorded in
accumulated other comprehensive income (loss).  As a result, the income tax effects on amounts recorded in accumulated other
comprehensive income (loss) were not reflective of the rates at which those amounts ultimately would be taxed.  ASU 2018-02
permits companies to reclassify these disproportionate tax effects from accumulated other comprehensive income (loss) to retained
earnings.  It was effective for fiscal years beginning after December 15, 2018, with early adoption permitted.  The Company elected
to early-adopt ASU 2018-02 in the fourth quarter of fiscal year 2018 and reclassify the disproportionate tax effects to retained earnings
as allowed under the guidance.  The reclassification increased accumulated other comprehensive loss and increased retained earnings
by approximately $12.4 million. 

Pronouncements Adopted in Fiscal Year 2019

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (ASU
2014-09), which  superseded substantially all of the current revenue recognition guidance under U.S. generally accepted accounting
principles (“U.S. GAAP”), and was developed under a joint project with the International Accounting Standards Board (“IASB”) to
improve and converge the existing revenue recognition accounting guidance in U.S. GAAP and International Accounting Standards.
Under ASU 2014-09, the central underlying principle is to recognize revenues when promised goods or services are transferred to
customers at an amount determined by the consideration a company expects to receive for those goods or services.  The guidance
outlines a five-step process for determining the amount and timing of revenue to be recognized from those arrangements.  ASU
2014-09 and various supplemental amendments were codified into the U.S. GAAP hierarchy in Section 606 of the FASB Accounting
Standards  Codification  (“ASC  606”).   The  Company's  implementation  process  for  ASU  2014-09  included  a  comprehensive
assessment of its contractual arrangements with customers that involved classifying those arrangements by specific revenue streams,
documenting  the  relevant  terms  and  conditions  of  the  contracts,  and  determining  the  appropriate  revenue  recognition  for  those
contracts under the new guidance.  Through this process, the Company determined in all cases that revenue recognition under the
new guidance based on the transfer of its goods and services to customers was substantially the same as under the prior guidance.
The Company adopted ASU 2014-09 effective April 1, 2018, the beginning of fiscal year 2019.  The adoption of ASU 2014-09 had
no impact on the amount and timing of revenue recognized, and no adjustment for the cumulative effect of implementing the new
guidance  was  required  under  the  modified  retrospective  transition  adoption  method  selected  by  the  Company.   The  disclosures
required for revenue recognition under the new guidance are provided in Note 3.

54

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

In January 2016, the FASB issued Accounting Standards Update No. 2016-01, “Financial Instruments - Recognition and
Measurement of Financial Assets and Financial Liabilities” ("ASU 2016-01").  ASU 2016-01 requires all equity investments to be
measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity
method of accounting or those that result in consolidation of the investee).  The Company adopted ASU 2016-01 effective April 1,
2018, the beginning of fiscal year 2019.  The adoption of ASU 2016-01 did not have a material effect on the Company's financial
statements.

In August 2016, the FASB issued Accounting Standards Update No. 2016-15, "Statement of Cash Flows (Topic 230) -
Classification of Certain Cash Receipts and Cash Payments" ("ASU 2016-15").  ASU 2016-15 provides guidance on the disclosure
and classification of certain items within the statement of cash flows.  The Company adopted ASU 2016-15 using the retrospective
approach effective April 1, 2018, the beginning of fiscal year 2019.  The adoption resulted in the reporting of life insurance proceeds
as a cash flow from investing activities and a corresponding reclassification for the prior year period, but otherwise did not have a
material effect on the Company's consolidated statement of cash flows for the years ended March 31, 2019, 2018, and 2017.

In October 2016, the FASB issued Accounting Standards Update No. 2016-16, "Income Taxes (Topic 740): Intra-Entity
Transfers of Assets Other Than Inventory" ("ASU 2016-16").  ASU 2016-16 requires companies to recognize the income tax effects
of intercompany sales or transfers of assets other than inventory in the income statement as income tax expense in the period the
sale or transfer occurs, rather than deferring those tax effects until the asset has been sold to a third-party or otherwise recognized
in earnings through depreciation, amortization, or impairment.  In prior fiscal reporting periods, various subsidiaries of the Company
sold tobacco processing equipment to other subsidiaries, and the related income effects have been deferred as required under the
previous accounting guidance.  The Company adopted ASU 2016-16 effective April 1, 2018, the beginning of fiscal year 2019. Under
the modified retrospective transition method required by the guidance, the Company recorded a $1.9 million reduction to retained
earnings for the year ended March 31, 2019 for the cumulative effect of recognizing the deferred income tax effects on all prior
intercompany sales of equipment as of the date of adoption.

In March 2017, the FASB issued Accounting Standards Update No. 2017-07, "Compensation - Retirement Benefits (Topic
715)" ("ASU 2017-07").  ASU 2017-07 requires that an employer report the service cost component of  pension or other postretirement
benefits expense in the same line item or items as other compensation costs arising from services rendered by the pertinent employees
during the period.  The other components of net periodic benefit cost are required to be presented in the income statement separately
from the service cost component and outside a subtotal of income from operations.  With the adoption of ASU 2017-07, the service
cost component of net periodic benefit cost continues to be reported in selling, general and administrative expenses in the consolidated
statements of income, or in cost of goods sold for the portion that is recorded as a component of the cost of inventory sold or services
provided to customers.  The other components of net benefit cost, which include interest cost, expected return on plan assets, and
the net amortization and deferral of actuarial gains and losses, are included in other non-operating income (expense) in the consolidated
statements of income.  The Company adopted ASU 2017-07 effective April 1, 2018, the beginning of fiscal year 2019.  The financial
statement presentation for comparative prior periods has been reclassified accordingly using amounts previously disclosed for net
periodic benefit cost as a practical expedient.  The components of net periodic benefit cost and other disclosures related to the
Company's pension and other postretirement benefit plans are provided in Note 13.

Pronouncements Adopted in Fiscal Year 2020

The Company adopted FASB Accounting Standards Update No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”) effective
April 1, 2019, the beginning of the current fiscal year. For leases with fixed payment arrangements, ASU 2016-02 requires a lessee
to recognize lease payment obligations as a lease liability and corresponding right-of-use asset in the balance sheet for the term of
the lease. This guidance superseded Topic 840 “Leases.” The Company elected the practical expedient to not include leases with
terms less than 12 months on the consolidated balance sheet. The Company elected the transition package of practical expedients
that retained the historical lease identification, lease classification, and treatment of initial direct costs for leases prior to the adoption
of ASU  2016-02.   Additionally,  as  permitted  under  the  new  guidance  the  Company  elected  to  not  separate  lease  and  non-lease
components for certain classes of leased assets, including real estate. The Company elected the modified retrospective transition
adoption method. Accordingly, on the date of adoption $36.6 million of operating lease right-of use assets and corresponding operating
lease liabilities of $34.2 million were recognized on the Company's consolidated balance sheet.  The adoption of ASU 2016-02 did
not result in a cumulative-effect adjustment to retained earnings.  The disclosures required for lease accounting under the new guidance
are provided in Note 10.

55

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, "Intangibles - Goodwill and Other (Topic
350)" ("ASU 2017-04").  Under current accounting guidance, the fair value of a reporting unit to which a specific goodwill balance
relates is first compared to its carrying value in the financial statements (Step 1).  If that comparison indicates that the goodwill is
impaired, an implied fair value for the goodwill must then be calculated by deducting the individual fair values of all other assets
and liabilities, including any unrecognized intangible assets, from the total fair value of the reporting unit.  ASU 2017-04 simplifies
the accounting guidance by eliminating Step 2 from the goodwill impairment test and using the fair value of the reporting unit
determined in Step 1 to measure the goodwill impairment loss.  The updated guidance is effective for fiscal years beginning after
December 15, 2019, although early adoption is permitted. The Company early adopted ASU 2017-04 effective July 1, 2019.  There
was no material impact to the consolidated financial statements from the adoption of ASU 2017-04.

Pronouncements to be Adopted in Future Periods

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, "Financial Instruments - Credit Losses (Topic
326) - Measurement of Credit Losses on Financial Instruments" ("ASU 2016-13").  ASU 2016-13 replaces current methods for
evaluating the impairment of financial instruments not measured at fair value with a model that reflects expected credit losses.
Financial instruments to which ASU 2016-13 will apply for the Company primarily include trade accounts receivable.  The guidance
in ASU 2016-13 is effective for fiscal years beginning after December 15, 2019.  The Company will be required to adopt the new
standard effective April 1, 2020, which is the beginning of its fiscal year ending March 31, 2021, and is currently evaluating the
impact that the guidance will have on its consolidated financial statements.

In August 2018, the FASB issued Accounting Standards Update No. 2018-15, “Intangibles - Goodwill and Other - Internal-
Use Software (Subtopic 350-40) - Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement
That  Is  a  Service  Contract  (a  consensus  of  FASB  Emerging  Issues  Task  Force)"  ("ASU  2018-15").  ASU  2018-15  aligns  the
requirements for capitalizing implementation costs in a cloud computing arrangement service contract with the requirements for
capitalizing implementation costs incurred for an internal-use software license. Under that model, implementation costs are capitalized
or expensed depending on the nature of the costs and the project stage during which they are incurred. Capitalized implementation
costs are amortized over the term of the associated hosted cloud computing arrangement service contract on a straight-line basis,
unless another systematic and rational basis is more representative of the pattern in which the entity expects to benefit from its right
to access the hosted software. Capitalized implementation costs would then be assessed for impairment in a manner similar to long-
lived assets. The new guidance is effective for fiscal years beginning after December 15, 2019. Entities can choose to adopt the new
guidance  either  prospectively  to  eligible  costs  incurred  on  or  after  the  date  the  guidance  is  first  applied  or  retrospectively. The
Company will be required to adopt ASU 2018-15 effective April 1, 2020, which is the beginning of its fiscal year ending March 31,
2021,  although  early  adoption  is  permitted.  The  Company  is  currently  evaluating  the  impact  of  adopting  this  standard  on  its
consolidated financial statements.

In December 2019, the FASB issued Accounting Standards Update No. 2019-12, "Income Taxes (Topic 740) - Simplifying
the  Accounting  for  Income  Taxes"  ("ASU  2019-12").  ASU  2019-12  eliminates  certain  exceptions  related  to  the  approach  for
intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax
liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The
updated guidance also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the
accounting for transactions that result in a step-up in the tax basis of goodwill. The guidance in ASU 2019-12 is effective for fiscal
years beginning after December 15, 2020, although early adoption is permitted. The Company will be required to adopt the new
standard effective April 1, 2021, which is the beginning of its fiscal year ending March 31, 2022, and is currently evaluating the
impact that the guidance will have on its consolidated financial statements.

In  March  2020,  the  FASB  issued Accounting  Standards  Update  No.  2020-04,  "Reference  Rate  Reform  (Topic  848)  -
Facilitation of the Effects of Reference Rate Reform on Financial Reporting" ("ASU 2020-04"). ASU 2020-04 provides optional
expedients and exceptions related to contract modifications and hedge accounting to address the transitions from the London Interbank
Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. The guidance permits an entity to consider
contract modification due to reference rate reform to be an event that does not require contract remeasurement at the modification
date or reassessment of a previous accounting determination. ASU 2020-04 also temporarily allows hedge relationships to continue
without de-designation upon changes due to reference rate reform. The standard is effective upon issuance and can be applied as of
March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact that the guidance will have on its
consolidated financial statements.

Reclassifications 

Certain prior year amounts have been reclassified to conform to the current year’s presentation. 

56

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 2.   BUSINESS COMBINATIONS

On January 1, 2020 the Company acquired 100% of the capital stock of FruitSmart, Inc. (“FruitSmart”), an independent
specialty fruit and vegetable ingredient processor serving global markets, for approximately $80 million in cash, up to $25 million
of contingent consideration payments, and $3.8 million of working capital on-hand at the date of acquisition. The contingent
consideration is based on FruitSmart’s achievement of certain adjusted gross profit metrics in calendar years 2020 and 2021. The
fair value of the contingent consideration,  approximately $6.7 million, was recognized on the acquisition date and was measured
using unobservable (Level 3) inputs. The Company estimated the fair value of the contingent consideration liability by applying
a Monte-Carlo  simulation  method using  the  Company’s  projection  of  future  adjusted  gross  profit  results  and  considering  the
estimated probability of achievement of the adjusted gross profit targets. The Monte-Carlo simulation is a statistical technique
used to generate a defined number of valuation paths in order to develop a reasonable estimate of the fair value of the contingent
consideration. Changes in the fair value of the contingent consideration liability in future periods will be recorded in the Company’s
results in the period of the change.

The FruitSmart acquisition was accounted for under the purchase method of accounting and was financed through cash-
on-hand and borrowings under the Company’s revolving credit facility. In a business combination, the purchase price is allocated
to assets acquired and liabilities assumed based on their fair values, with any excess of purchase price over fair value recognized
as goodwill. In addition to recognizing assets and liabilities on the acquired company’s balance sheet, the Company reviews supply
contracts, leases, financial instruments, employment agreements and other significant agreements to identify potential assets or
liabilities  that  require  recognition  in  connection  with  the  application  of  acquisition  accounting  under Accounting  Standards
Codification 805, "Business Combinations." Intangible assets are recognized separate from goodwill when the asset arises from
contractual or other legal rights, or are separable from the acquired entity such that they may be sold, transferred, licensed, rented
or exchanged either on a standalone basis or in combination with a related contract, asset or liability. 

The initial allocation of the purchase price was based on preliminary valuations and assumptions and is subject to change
within  the  12-month  measurement  period  following  the  date  of  acquisition. The  following  table  summarizes  the  preliminary
purchase price allocation of the assets acquired and liabilities assumed on January 1, 2020.

Assets

Cash and cash equivalents............................................................................................................................................................... $

Accounts receivable ........................................................................................................................................................................

Inventory .........................................................................................................................................................................................

Other current assets .........................................................................................................................................................................

Property, plant and equipment.........................................................................................................................................................

Intangibles:

Customer relationships .................................................................................................................................................................

Developed technology ..................................................................................................................................................................

Trade names..................................................................................................................................................................................

Noncompetition agreements .........................................................................................................................................................

Goodwill..........................................................................................................................................................................................

Total assets acquired .....................................................................................................................................................................

Liabilities

Current liabilities.............................................................................................................................................................................

Deferred income taxes.....................................................................................................................................................................

Total liabilities assumed................................................................................................................................................................

1,298

7,707

23,793

310

23,400

9,500

4,800

3,300

1,000

28,863

103,971

8,262

9,004

17,266

Total assets acquired and liabilities assumed.............................................................................................................................. $

86,705

A portion of the goodwill recorded as part of the acquisition was attributable to the assembled workforce of FruitSmart.
The tax basis of the assets acquired and liabilities did not result in a step-up of tax basis and the related goodwill is not deductible
for U.S. income tax purposes. The Company determined the FruitSmart operations are not material to the Company’s consolidated
results. Therefore, pro forma information is not presented.

For the fiscal year ended March 31, 2020, the Company incurred $4.7 million of acquisition-related transaction costs for
the  purchase  of  FruitSmart.  The  acquisition-related  costs  were  expensed  as  incurred  and  recorded  as  selling,  general,  and
administrative expenses on the consolidated statements of income.

57

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 3.   REVENUE FROM CONTRACTS WITH CUSTOMERS

The majority of the Company’s consolidated revenue consists of sales of processed leaf tobacco to customers.  The Company
also earns revenue from processing leaf tobacco owned by customers and from various other services provided to customers.  Payment
terms with customers vary depending on customer creditworthiness, product types, services provided, and other factors.  Contract
durations and payment terms for all revenue categories generally do not exceed one year.  Therefore, the Company has applied a
practical expedient to not adjust the transaction price for the effects of financing components, as the Company expects that the period
from the time the revenue for a transaction is recognized to the time the customer pays for the related good or service transferred
will be one year or less.  Below is a description of the major revenue-generating categories from contracts with customers.

Tobacco Sales

The majority of the Company’s business involves purchasing leaf tobacco from farmers in the origins where it is grown,
processing and packing the tobacco in its factories, and then transferring ownership and control of the tobacco to customers.  On a
much smaller basis, the Company also sources processed tobacco from third-party suppliers for resale to customers.  The contracts
for tobacco sales with customers create a performance obligation to transfer tobacco to the customer.  Transaction prices for the sale
of tobaccos are primarily based on negotiated fixed prices, but the Company does have a small number of cost-plus contracts with
certain customers.  Cost-plus arrangements provide the Company reimbursement of the cost to purchase and process the tobacco,
plus a contractually agreed-upon profit margin.  The Company utilizes the most likely amount methodology under the accounting
guidance to recognize revenue for cost-plus arrangements with customers.  Shipping and handling costs under tobacco sales contracts
with customers are treated as fulfillment costs and included in the transaction price.  Taxes assessed by government authorities on
the sale of leaf tobacco products are excluded from the transaction price.  At the point in time that the customer obtains control over
the tobacco, which is typically aligned with physical shipment under the contractual terms with the customer, the Company completes
its performance obligation and recognizes the revenue for the sale. 

Tobacco Processing Revenue

Processing and packing of customer-owned leaf tobacco is a short-duration process.  Processing charges are primarily based
on negotiated fixed prices per unit of weight processed.  Under normal operating conditions, customer-owned raw tobacco that is
placed into the production line exits as processed and packed tobacco within one hour and is then later transported to customer-
designated storage facilities.  The revenue for these services is recognized when the performance obligation is satisfied, which is
generally when processing is completed.  The Company’s operating history and contract analyses indicate that customer requirements
for processed tobacco are consistently met upon completion of processing.

Other Operating Sales and Revenue

From time to time, the Company enters into various arrangements with customers to provide other value-added services
that may include blending, chemical and physical testing of tobacco, and service cutting for select manufacturers.  The Company
also has fruit and vegetable processing operations that provide customers with a range of food ingredient products.  These other
arrangements  and  operations  are  a  much  smaller  portion  of  the  Company’s  business,  and  are  separate  and  distinct  contractual
agreements from the Company’s tobacco sales or tobacco processing arrangements with customers.  The transaction prices and timing
of revenue recognition of these items are determined by the specifics of each contract.  

Disaggregation of Revenue from Contracts with Customers

The following table disaggregates the Company’s revenue by significant revenue-generating category:

Fiscal Year Ended March 31,

2020

2019

2018

Tobacco sales ............................................................................................................................ $ 1,759,769

$ 2,089,770

$ 1,898,303

Tobacco processing revenue .....................................................................................................

Other sales and revenue from contracts with customers...........................................................

76,123

55,985

85,426

37,930

78,042

42,579

   Total revenue from contracts with customers ........................................................................

1,891,877

2,213,126

2,018,924

Other operating sales and revenues...........................................................................................

18,102

14,027

15,023

   Consolidated sales and other operating revenues .................................................................. $ 1,909,979

$ 2,227,153

$ 2,033,947

Other operating sales and revenues consists principally of interest on advances to suppliers and dividend income from

unconsolidated affiliates.

58

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Major Customers

A material part of the Company’s business is dependent upon a few customers.  The Company's six largest customers are
Altria Group, Inc, British American Tobacco plc, China Tobacco International, Inc., Imperial Brands plc, Japan Tobacco, Inc., and
Philip Morris International, Inc.   In the aggregate, these customers have accounted for approximately 70% of consolidated revenue
for each of the past three fiscal years.  For the fiscal years ended March 31, 2020, 2019, and 2018, revenue from Philip Morris
International, Inc. was approximately $500 million, $650 million, and $520 million, respectively.  For the same periods, Imperial
Brands plc accounted for  revenue of approximately $320 million, $360 million, and $270 million, respectively, and British American
Tobacco plc accounted for revenue of approximately $190 million, $270 million, and $230 million, respectively.  These customers
primarily do business with various affiliates in the Company’s flue-cured and burley leaf tobacco operations.  The loss of, or substantial
reduction in business from, any of these customers could have a material adverse effect on the Company.  

59

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 4.   RESTRUCTURING AND IMPAIRMENT COSTS

During the fiscal years ended March 31, 2020 and 2019, Universal recorded restructuring and impairment costs related to
business changes and various initiatives to adjust certain operations and reduce costs.  For both fiscal years, those costs primarily
related to the Company's flue-cured and burley leaf tobacco operations segment.  There were no restructuring or impairment costs
recorded for the fiscal year ended March 31, 2018.

Fiscal Year Ended March 31, 2020 

In fiscal year 2020, the Company recorded restructuring and impairment costs totaling $7.5 million, primarily related to
$3.4 million of employee termination benefits for a voluntary workforce reduction at the Company's tobacco facilities in North
Carolina, $1.8 million of employee termination benefits for the Company's operations in Africa, and a $1.3 million impairment charge
for machinery used by the Company's operations in Africa. Restructuring and impairment costs were also incurred in connection
with downsizing efforts at several other locations around the Company.

Fiscal Year Ended March 31, 2019 

Due to the decline in customer demand for tobaccos from Tanzania, as well as regulatory, tax, and other business and
operating considerations, the Company undertook a formal review of the Tanzania leaf tobacco market and its operations there in
the third quarter of fiscal year 2019.  Based on that review, the Company’s operating subsidiaries in Tanzania took steps to reduce
operating costs going forward, including discontinuation of a year-round workforce.  As a result of that initiative, the subsidiaries
recorded a $4.0 million restructuring charge for termination benefits paid to employees whose permanent positions were eliminated.
All amounts related to termination benefit costs were paid by the end of fiscal year 2019.

In addition, as a result of the decrease in production volumes of Tanzania tobaccos and the associated reduced profitability,
the Company determined that indicators of impairment in the carrying value of the property, plant and equipment comprising the
Tanzania operations were present at December 31, 2018. Accordingly, based on the applicable accounting guidance, the Company
tested the recoverability of those long-lived assets using undiscounted estimates of the future cash flows from the use of those assets
and their eventual disposition.  The property, plant and equipment were evaluated for recoverability using two distinct asset groups:
(1) the land, building, and equipment comprising the processing facility, and (2) all remaining assets, which are substantially devoted
to buying and receiving delivery of unprocessed leaf from farmers and marketing and shipping the processed tobacco to customers.
The recoverability tests indicated that both asset groups were impaired at December 31, 2018.  As a result, the Company determined
the fair value of each asset group based principally on a probability-weighting of the discounted cash flows expected under multiple
operating and disposition scenarios.  An impairment charge of approximately $14.6 million was recorded to reduce the carrying
value of the assets to their indicated fair values.  The property, plant and equipment assets are used in buying, processing, and shipping
and remains classified as “held and used” at this time as provided for under the accounting guidance. Should the expected cash flows
from the future use and/or disposition of the assets change from the estimates on which their fair values were determined, additional
impairment charges could be required, or gains or losses on any disposition of the assets could be recorded.  The Company also had
goodwill related to the Tanzanian operations of approximately $0.9 million which was separately tested for recoverability and fully
written off based on the results of that test. 

Additional restructuring costs of approximately $0.9 million were incurred in connection with downsizing efforts at other

locations around the Company during fiscal year 2019.

A summary of the restructuring and impairment costs incurred during the fiscal years ended March 31, 2020 and 2019, is

as follows: 

Restructuring Costs:

Fiscal Years Ended March 31,

2020

2019

   Employee termination benefits .........................................................................................................................

$

5,356

$

   Other restructuring costs...................................................................................................................................

Impairment Costs:

   Property, plant, and equipment and other noncurrent assets ............................................................................

   Goodwill ...........................................................................................................................................................

     Total restructuring and impairment costs........................................................................................................

—

5,356

2,187

—

2,187

7,543

$

$

$

$

4,608

223

4,831

14,584

889

15,473

20,304

60

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

A reconciliation of the Company’s liability for employee termination benefits and other restructuring costs for fiscal years

2018 through 2020 is as follows:

Employee 
Termination 
Benefits

Other Costs

Total

Balance at April 1, 2017.........................................................................................................

$

301

$

43

$

344

Fiscal Year 2018 Activity:

Payments ............................................................................................................................

Balance at March 31, 2018 ....................................................................................................

Fiscal Year 2019 Activity:

Costs charged to expense ...................................................................................................

Payments ............................................................................................................................

Balance at March 31, 2019 ....................................................................................................

Fiscal Year 2020 Activity:

Costs charged to expense ...................................................................................................

Payments ............................................................................................................................

(272)

29

4,608

(4,014)

623

5,356

(2,564)

(43)

—

223

—

223

—

(223)

Balance at March 31, 2020 ....................................................................................................

$

3,415

$

— $

(315)

29

4,831

(4,014)

846

5,356

(2,787)

3,415

The restructuring liability at March 31, 2020 is expected to be paid during fiscal year 2021.  Universal continually reviews its
business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes.  The Company
may incur additional restructuring and impairment costs in future periods as business changes occur and additional cost savings initiatives
are implemented.

61

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 5.   EARNINGS PER SHARE 

The following table sets forth the computation of basic and diluted earnings per share:

(in thousands, except share and per share data)

Basic Earnings Per Share

Numerator for basic earnings per share

Fiscal Year Ended March 31,

2020

2019

2018

Net income attributable to Universal Corporation ........................................................................... $

71,680

$

104,121

$

105,662

Denominator for basic earnings per share

Weighted average shares outstanding...............................................................................................

24,982,259

25,129,192

25,274,975

 Basic earnings per share .................................................................................................................. $

2.87

$

4.14

$

4.18

Diluted Earnings Per Share

Numerator for diluted earnings per share

Net income attributable to Universal Corporation ........................................................................... $

71,680

$

104,121

$

105,662

Denominator for diluted earnings per share:

Weighted average shares outstanding...............................................................................................

24,982,259

25,129,192

25,274,975

Effect of dilutive securities

 Employee and outside director share-based awards .....................................................................

124,092

201,245

233,169

Denominator for diluted earnings per share .....................................................................................

25,106,351

25,330,437

25,508,144

Diluted earnings per share................................................................................................................ $

2.86

$

4.11

$

4.14

62

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 6.   INCOME TAXES 

The Company operates in the United States and many foreign countries and is subject to the tax laws of many jurisdictions.
Changes in tax laws or the interpretation of tax laws can affect the Company’s earnings, as can the resolution of pending and contested
tax issues.  The Company's consolidated effective income tax rate is affected by a number of factors, including the mix of domestic
and foreign earnings and the effect of exchange rate changes on local taxable income and deferred taxes in foreign countries.

In December 2017, the Tax Cuts and Jobs Act of 2017 was passed by the United States Congress and signed into law by
the President.  This new law made significant changes to income taxation at the federal level for individuals, pass-through entities,
and corporations.  For corporations, the changes included a reduction in the statutory rate on taxable income from 35% to 21%, and
a move from a worldwide tax system to a system that is more territorial-based for companies with foreign operations.  To accommodate
the move from the previous worldwide tax system, the new law provided for a one-time transition tax on the undistributed post-1986
earnings of foreign subsidiaries as of either November 2, 2017 or December 31, 2017, whichever undistributed earnings amount was
greater.  Other provisions of the new law allow for immediate expensing of investments in property, plant, and equipment, and impose
limitations on the deductibility of interest, executive compensation, and meals and entertainment expense.  For tax years beginning
after the date of enactment, the new law requires that certain income earned by foreign subsidiaries, referred to in the law as global
intangible low-taxed income ("GILTI"), be included in the U.S. taxable income of the parent company.  The Company has made an
accounting policy election to account for any additional tax resulting from the GILTI provisions in the year in which it is incurred
and has not recorded any deferred taxes on temporary book-tax differences related to this income.  For fiscal years ended March 31,
2020 and 2019, the Company's U.S. federal statutory tax rate is the 21.0% rate under the new law.  For the fiscal year ended March
31, 2018, the Company's U.S. federal statutory tax rate was 31.5%, reflecting a portion of the year at the 35% rate under the old law
and a portion at the 21% rate under the new law.  The Company continues to assume repatriation of all undistributed earnings of its
consolidated foreign subsidiaries and has therefore provided for expected foreign withholding taxes on the distribution of those
earnings where applicable, net of any U.S. tax credit attributable to those withholding taxes.  The Company has asserted permanent
reinvestment of the book basis of certain foreign subsidiaries, and accordingly, no deferred income tax liability has been recorded
for any potential taxable gain that may be realized on a future disposition or liquidation of any of those subsidiaries.  It is not
practicable for the Company to quantify any deferred income tax liability that would be attributable to those events.

Under the applicable accounting guidance, the Company accounted for the effects of the changes in the U.S. tax law in the
period  in  which  they  were  enacted,  which  was  the  third  quarter  of  fiscal  year  2018.    Due  to  the  complexities  associated  with
understanding and applying various aspects of the new law and quantifying or estimating amounts upon which calculations required
to account for new law were based, the U.S. Securities and Exchange Commission (“SEC”) issued guidance permitting corporations
to record and report specific items impacted by the new law on a provisional basis using reasonable estimates where final amounts
had not been determined.  The guidance allowed a measurement period of no more than one year from the date of enactment of the
new law to complete all adjustments to amounts recorded on a provisional basis.  The new tax law resulted in a one-time reduction
of income tax expense of $4.5 million for fiscal year 2018, reflecting provisional amounts initially recorded in the third quarter upon
enactment, followed by subsequent adjustments to those provisional amounts in the fourth quarter.  The reduction of income tax
expense from the enactment of the new law was primarily attributable to the adjustment of recorded deferred tax assets and liabilities
to the tax rates at which they are expected to reverse in the future, as well as the reduction of the liability previously recorded for
U.S. income taxes on the undistributed earnings of foreign subsidiaries to the amounts to be paid under the one-time transition tax
provisions of the new law.  Adjustments to the amounts recorded for the enactment of the new law were not material after the fourth
quarter of fiscal year 2018, and all effects that were previously accounted for on a provisional basis were designated as final during
the third quarter of fiscal year 2019.

The effect of the new law in fiscal year 2018 included a $7.8 million net increase in income tax expense from remeasuring
net deferred tax assets to the new lower rates at which they are expected to reverse, generally the 21% U.S. federal statutory tax rate.
That net increase included approximately $12.4 million of net tax expense from remeasuring net deferred tax assets attributable to
pension and other postretirement benefit plans, foreign currency translation adjustments, and other amounts that were recorded
through other comprehensive income to the new lower rates, which initially left disproportionate tax effects recorded on the pretax
amounts  in  accumulated  other  comprehensive  income  (loss). As  discussed  in  Note  1,  the  FASB  issued ASU  2018-02  "Income
Statement  -  Reporting  Comprehensive  Income  (Topic  220)  -  Reclassification  of  Certain  Tax  Effects  from Accumulated  Other
Comprehensive Income" to address this issue by allowing companies to reclassify the disproportionate tax effects from accumulated
other comprehensive income (loss) to retained earnings.  The Company elected to early-adopt ASU 2018-02 in the fourth quarter of
fiscal  year  2018  and  chose  to  reclassify  the  disproportionate  tax  effects.    The  reclassification  increased  accumulated  other
comprehensive loss and increased retained earnings by approximately $12.4 million in fiscal year 2018.

63

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Income Tax Expense

Income taxes for the fiscal years ended March 31, 2020, 2019, and 2018 consisted of the following: 

Fiscal Year Ended March 31,

2020

2019

2018

Current

United States....................................................................................................................... $

2,001

$

(2,639) $

State and local ....................................................................................................................

Foreign................................................................................................................................

Deferred

United States.......................................................................................................................

State and local ....................................................................................................................

Foreign................................................................................................................................

92

41,892

43,985

3,735

(16)

(12,416)

(8,697)

377

39,578

37,316

5,713

(4)

(1,837)

3,872

1,110

175

60,356

61,641

(20,052)

68

8,852

(11,132)

Total ................................................................................................................................. $

35,288

$

41,188

$

50,509

Foreign taxes include any applicable U.S. tax expense on the earnings of foreign subsidiaries. 

Consolidated Effective Income Tax Rate

A reconciliation of the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows:

Fiscal Year Ended March 31,

2020

2019

2018

U.S. federal statutory tax rate................................................................................................

21.0%

21.0%

31.5%

State income taxes, net of federal benefit .............................................................................

Dividends received from deconsolidated operations ............................................................

Foreign earnings taxed at rates other than the U.S. federal statutory tax rate ......................

Foreign dividend withholding taxes......................................................................................

Reversal of dividend withholding tax due to foreign subsidiary tax holiday .......................

Effects of new tax law:

Adjustment of deferred tax assets and liabilities to lower tax rate ...................................

Reduction of U.S. tax liability on undistributed foreign earnings to amounts
payable under one-time transition tax...............................................................................

Changes in uncertain tax positions........................................................................................

Other......................................................................................................................................

0.1

—

(2.0)

5.1

—

—

—

5.6

1.3

Effective income tax rate ......................................................................................................

31.1%

0.2

—

7.1

3.7

(5.1)

—

—

1.4

(1.1)

27.2%

0.1

(1.4)

2.8

(0.2)

—

4.6

(8.3)

0.8

0.4

30.3%

During fiscal year 2020, the Company resolved a transfer pricing matter related to a foreign subsidiary.  The resolution of
the uncertainty with the local country taxing authorities resulted in net additional current income tax expense of $2.8 million.  The
additional income tax expense for fiscal year 2020 increased the effective tax rate for the year by 2.4% 

During fiscal year 2019, the Company reversed amounts previously recorded for dividend withholding taxes on distributed
and undistributed retained earnings of a foreign subsidiary.  The reversal followed the resolution of uncertainties with the local
country taxing authorities with respect to the inclusion of the tax under a tax holiday applicable to the subsidiary and was attributable
to cumulative retained earnings amounts previously distributed or expected to be distributed prior to the expiration of the tax holiday.
The reversal reduced income tax expense for fiscal year 2019 by approximately $7.8 million, which decreased the effective tax rate
for the year by 5.1%, as noted in the above rate reconciliation.

64

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Components of Income Before Income Taxes

The U.S. and foreign components of income before income taxes were as follows:

Fiscal Year Ended March 31,

2020

2019

2018

United States ......................................................................................................................... $

22,916

$

37,478

$

10,442

Foreign ..................................................................................................................................

90,375

113,844

156,235

Total.................................................................................................................................... $

113,291

$

151,322

$

166,677

Deferred Income Tax Liabilities and Assets

Significant components of deferred tax liabilities and assets were as follows:  

March 31,

2020

2019

Liabilities

Foreign withholding taxes.................................................................................................................................. $

19,870

$

20,659

Property, plant and equipment ...........................................................................................................................

Undistributed earnings .......................................................................................................................................

Operating lease right-of-use assets ....................................................................................................................

Goodwill and other intangible assets .................................................................................................................

All other .............................................................................................................................................................

10,078

7,298

9,877

23,435

4,813

Total deferred tax liabilities .......................................................................................................................... $

75,371

$

4,627

6,579

—

19,529

2,461

53,855

Assets

Employee benefit plans...................................................................................................................................... $

22,773

$

20,467

Reserves and accruals ........................................................................................................................................

Deferred income.................................................................................................................................................

Operating lease right-of-use liabilities...............................................................................................................

Currency translation losses of foreign subsidiaries ...........................................................................................

Local currency exchange losses of foreign subsidiaries ....................................................................................

Interest rate swap ...............................................................................................................................................

All other .............................................................................................................................................................

Total deferred tax assets ...............................................................................................................................

Valuation allowance ...........................................................................................................................................

7,708

4,833

9,650

2,173

8,360

7,284

7,464

70,245

(3,394)

Net deferred tax assets.................................................................................................................................. $

66,851

$

7,898

3,829

—

1,993

1,252

248

4,739

40,426

(1,798)

38,628

At March 31, 2020, the Company had no material net operating loss carryforwards in either its domestic or foreign operations.

Combined Income Tax Expense (Benefit)

The combined income tax expense (benefit) allocable to continuing operations and other comprehensive income was as

follows:

65

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Fiscal Year Ended March 31,

2020

2019

2018

Continuing operations ........................................................................................................... $

35,288

$

41,188

$

Other comprehensive income (loss)......................................................................................

(14,392)

(5,390)

Total ................................................................................................................................ $

20,896

$

35,798

$

50,509

23,471

73,980

Uncertain Tax Positions

A reconciliation of the beginning and ending balance of the gross liability for uncertain tax positions is as follows:

Fiscal Year Ended March 31,

2020

2019

2018

Liability for uncertain tax positions, beginning of year........................................................ $

5,625

$

3,673

$

2,426

Additions:

Related to tax positions for the current year.......................................................................

Related to tax positions for prior years ..............................................................................

Reductions:

Due to lapses of statutes of limitations...............................................................................

Due to tax settlements ........................................................................................................

Effect of currency rate changes ..........................................................................................

1,746

4,369

(81)

(8,948)

(334)

85

2,169

(90)

—

(212)

107

1,310

(104)

—

(66)

Liability for uncertain tax positions, end of year .................................................................. $

2,377

$

5,625

$

3,673

 Of the total liability for uncertain tax positions at March 31, 2020, approximately $2.3 million could have an effect on the
consolidated effective tax rate if the tax benefits are recognized.  The liability for uncertain tax positions includes $0.1 million related
to tax positions for which it is reasonably possible that the amounts could change significantly before March 31, 2021.  This amount
reflects a possible decrease in the liability for uncertain tax positions that could result from the completion and resolution of tax
audits and the expiration of open tax years in various tax jurisdictions.  During fiscal year 2020, the Company resolved a transfer
pricing matter related to a foreign subsidiary.  The settlement in fiscal year 2020 represents the resolution of a tax matter with a local
country taxing authority that resulted in a $8.9 million settlement of which $4.5 million was accrued in prior fiscal years.

The Company recognizes accrued interest related to uncertain tax positions as interest expense, and it recognizes penalties
as a component of income tax expense.  Amounts accrued or reversed for interest and penalties were not material for any of the fiscal
years 2018 through 2020, and liabilities recorded for interest and penalties at March 31, 2020 and 2019 also were not material.  

Universal and its subsidiaries file a U.S. federal consolidated income tax return, as well as returns in several U.S. states and
a number of foreign jurisdictions.  As of March 31, 2020, the Company's earliest open tax year for U.S. federal income tax purposes
was its fiscal year ended March 31, 2016.  Open tax years in U.S. federal, state and foreign jurisdictions range from 3 to 6 years.

66

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 7.   GOODWILL AND OTHER INTANGIBLES

The Company's changes in goodwill at March 31, 2020 and 2019 consisted of the following:

(in thousands)

Balance at beginning of year ............................................................................................................................. $
Acquisition of business(1) ..............................................................................................................................

Foreign currency translation adjustment .......................................................................................................
Impairment(2) .................................................................................................................................................

Fiscal Year Ended March 31,

2020

2019

97,907

$

98,807

28,863

56

—

—

(11)

(889)

Balance at end of year ....................................................................................................................................... $

126,826

$

97,907

(1) 

On January 1, 2020 the Company acquired 100% of the capital stock of FruitSmart, an independent specialty fruit and vegetable ingredient processor serving
global markets, for approximately $80 million in cash and up to $25 million of contingent consideration payments. The FruitSmart acquisition resulted in $28.9
million of goodwill and $18.6 million intangibles. See Note 2 for additional information.

(2)  The Company had goodwill related to the Tanzanian operations of approximately $0.9 million, which was impaired as part of the Tanzania operations review

in fiscal year 2019.  See Note 4 for additional information.

The Company's intangible assets primarily consist of capitalized customer-related intangibles, trade names, proprietary
developed technology and noncompetition agreements. The Company's intangible assets subject to amortization consisted of the
following  at March 31, 2020 and 2019:

(in thousands, except useful life)

March 31,

2020

2019

Useful
Life

Gross
Carrying
Value

Accumulated
Amortization

Net
Carrying
Value

Gross
Carrying
Value

Accumulated
Amortization

Net
Carrying
Value

13

$

9,500

$

(183) $

9,317

$

— $

— $

Customer relationships(1)
Trade names(1)
Developed technology(1)
Noncompetition agreements(1)

Other

5

3

5

5

3,300

4,800

1,000

657

(165)

(400)

(50)

(598)

3,135

4,400

950

59

Total intangible assets

$

19,257

$

(1,396) $

17,861

$

—

—

—

761

761

—

—

—

(674)

$

(674) $

—

—

—

—

87

87

Intangible assets are amortized on a straight-line basis over the asset's estimated useful economic life as noted above.

Amortization expense for intangible assets was approximately $0.8 million and $0.1 million for the fiscal years ended
March 31, 2020  and 2019, respectively.  Amortization expense for the developed technology intangible asset is recorded in cost of
goods sold in the consolidated income statements of income. The amortization expense for the other intangible assets is recorded in
selling, general, and administrative expenses in the consolidated income statements of income. 

As of March 31, 2020, the expected future amortization expense for intangible assets is as follows:

Fiscal Year

2021............................................................................................................................................................................................ $

2022............................................................................................................................................................................................

2023............................................................................................................................................................................................

2024............................................................................................................................................................................................

2025 and thereafter ....................................................................................................................................................................

3,221

3,220

2,791

1,590

7,039

Total expected future amortization expense .............................................................................................................................. $

17,861

67

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 8.   CREDIT FACILITIES

Bank Credit Agreement

On December 20, 2018, the Company entered into a senior unsecured bank credit agreement that includes a $430 million
five-year revolving credit facility (expiring December 20, 2023), a $150 million five-year term loan (due December 20, 2023), and
a $220 million seven-year term loan (due December 20, 2025).  Borrowings under the revolving credit facility bear interest at a
variable rate based on either (1) LIBOR plus a margin that is based on the Company's credit measures or (2) the higher of the federal
funds rate plus 0.5%, prime rate, or one-month LIBOR plus 1.0%, each plus a margin.  In addition to interest, the Company pays a
facility fee on the revolving credit facility. No amounts were outstanding under the revolving credit facility at March 31, 2020.  The
credit agreement provides for an expansion of the facility under certain conditions to allow additional borrowings of up to $200
million.  Additional information related to the term loans is provided in Note 9.  The credit agreement includes financial covenants
that require the Company to maintain a minimum level of tangible net worth and observe limits on debt levels.  The Company was
in compliance with those covenants at March 31, 2020.

Short-Term Credit Facilities

The Company maintains short-term uncommitted lines of credit in the United States and in a number of foreign countries.
Foreign borrowings are generally in the form of overdraft facilities at rates competitive in the countries in which the Company
operates.  Generally, each foreign line is available only for borrowings related to operations of a specific country.  As of March 31,
2020 and 2019, approximately $78 million and $54 million, respectively, were outstanding under these uncommitted lines of credit.
The weighted-average interest rates on short-term borrowings outstanding as of March 31, 2020 and 2019, were approximately 4.2%
and 4.6%, respectively.  At March 31, 2020, the Company and its consolidated affiliates had unused uncommitted lines of credit
totaling approximately $238 million. 

NOTE 9.   LONG-TERM DEBT

The Company's long-term debt at March 31, 2020 and 2019 consisted of the following:

March 31,

2020

2019

Senior bank term loans ....................................................................................................................................... $

370,000

$

370,000

Less: current portion...........................................................................................................................................

Less: unamortized debt issuance costs ...............................................................................................................

—

(1,236)

—

(1,497)

Long-term debt ............................................................................................................................................... $

368,764

$

368,503

As discussed in Note 8, on December 20, 2018, the Company entered into a bank credit agreement.  The credit agreement
includes  a  $150  million  five-year  term  loan  maturing  in  December  2023  and  a  $220  million  seven-year  term  loan  maturing  in
December 2025. Both term loans were fully funded at closing, require no amortization, and are prepayable without penalty prior to
maturity.  Under the credit agreement, both term loans bear interest at variable rates plus a margin based on the Company's credit
measures.

As discussed in Note 11, the Company had receive-floating/pay-fixed interest rate swap agreements in place with respect
to prior loans that were initially designated and carried over to hedge the variable interest payments on the new loans. Those swap
agreements were subsequently terminated in February 2019 and concurrently replaced with new interest rate swap agreements that
will continue to convert the variable benchmark rate to a fixed rate through December 20, 2023 for the five-year term loan and
through December 20, 2025 for the seven-year term loan. The proceeds received for the fair value of the terminated interest rate
swap agreements, approximately $5.4 million, is being amortized from accumulated other comprehensive income into earnings as
a reduction of interest expense through their original maturity dates. With the new swap agreements in place, the effective interest
rates on the $150 million five-year loan and the $220 million seven-year loan were 3.94% and 4.26%, respectively, at March 31,
2020.  The effective rates will change only if a change in the Company's credit measures results in adjustments to the applicable
credit spreads specified in the underlying loan agreement. 

In November 2017, the Company filed an undenominated automatic universal shelf registration statement with the U.S.
Securities and Exchange Commission to provide for the future issuance of an undefined amount of additional debt or equity securities
as determined by the Company and offered in one or more prospectus supplements prior to issuance.

Disclosures about the fair value of long-term debt are provided in Note 12.

68

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 10.   LEASES

The Company, as a lessee, enters into operating leases for land, buildings, equipment, and vehicles. For all operating leases
with terms greater than 12 months and with fixed payment arrangements, a lease liability and corresponding right-of-use asset are
recognized in the balance sheet for the term of the lease by calculating the net present value of future lease payments.  On the date
of lease commencement, the present value of lease liabilities is determined by discounting the future lease payments by the Company’s
collateralized incremental borrowing rate, adjusted for the lease term and currency of the lease payments. If a lease contains a renewal
option that the Company is reasonably certain to exercise, the Company accounts for the original lease term and expected renewal
term in the calculation of the lease liability and right-of-use asset. 

The following table sets forth the right-of-use assets and lease liabilities for operating leases included in the Company’s

consolidated balance sheet:

(in thousands)

Assets

March 31, 2020

   Operating lease right-of-use assets.....................................................................................................................................

$

39,256

Liabilities

    Current portion of operating lease liabilities ..................................................................................................................

    Long-term operating lease liabilities ..............................................................................................................................

          Total operating lease liabilities ....................................................................................................................................

$

$

9,823

25,893

35,716

The following table sets forth the location and amount of operating lease costs included in the Company's consolidated

statement of income:

(in thousands)

Income Statement Location

Fiscal Year Ended
March 31,

2020

   Cost of goods sold ..............................................................................................................................................................

   Selling, general, and administrative expenses....................................................................................................................
          Total operating lease costs(1)........................................................................................................................................

$

$

10,954

8,574

19,528

(1)

Includes variable operating lease costs.  

For the fiscal years ended March 31, 2019 and 2018, the Company recorded $17.3 million and $16.0 million of total expense

for operating leases, respectively.  

The following table reconciles the undiscounted cash flows to the operating lease liabilities in the Company’s consolidated

balance sheet:

(in thousands)

Maturity of Operating Lease Liabilities

March 31, 2020

2021 .......................................................................................................................................................................................

$

11,317

2022 .......................................................................................................................................................................................

2023 .......................................................................................................................................................................................

2024 .......................................................................................................................................................................................

2025 .......................................................................................................................................................................................

2026 and thereafter ................................................................................................................................................................

          Total undiscounted cash flows for operating leases ....................................................................................................

$

          Less: Imputed interest..................................................................................................................................................

Total operating lease liabilities ..............................................................................................................................................

$

7,440

6,166

4,776

3,928

6,778

40,405

(4,689)

35,716

As of March 31, 2020, the Company had no leases that have not yet commenced.

69

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following table sets forth supplemental information related to operating leases:

(in thousands, except lease term and incremental borrowing rate)

Supplemental Cash Flow Information

Cash paid for amounts included in the measurement of operating lease liabilities...............................................................

Right-of-use assets obtained in exchange for new operating leases......................................................................................

$

$

Weighted Average Remaining Lease Term (years)

Weighted Average Collateralized Incremental Borrowing Rate

NOTE 11.   DERIVATIVES AND HEDGING ACTIVITIES

Fiscal Year Ended
March 31,

2020

11,983

14,957

5.61

4.10%

Universal is exposed to various risks in its worldwide operations and uses derivative financial instruments to manage two
specific types of risks – interest rate risk and foreign currency exchange rate risk. Interest rate risk has been managed by entering
into interest rate swap agreements, and foreign currency exchange rate risk has been managed by entering into forward foreign
currency exchange and option contracts. However, the Company’s policy also permits other types of derivative instruments. In
addition, foreign currency exchange rate risk is also managed through strategies that do not involve derivative instruments, such as
using local borrowings and other approaches to minimize net monetary positions in non-functional currencies. The disclosures below
provide additional information about the Company’s hedging strategies, the derivative instruments used, and the effects of these
activities on the consolidated statements of income and comprehensive income and the consolidated balance sheets. In the consolidated
statements of cash flows, the cash flows associated with all of these activities are reported in net cash provided by operating activities.

 Cash Flow Hedging Strategy for Interest Rate Risk

In February 2019, the Company entered into receive-floating/pay-fixed interest rate swap agreements that were designated
and qualify as hedges of the exposure to changes in interest payment cash flows created by fluctuations in variable interest rates on
two outstanding non-amortizing bank term loans that were funded as part of a new bank credit facility in December 2018.  Although
no significant ineffectiveness is expected with this hedging strategy, the effectiveness of the interest rate swaps is evaluated on a
quarterly basis.  At March 31, 2020, the total notional amount of the interest rate swaps was $370 million, which corresponded with
the aggregate outstanding balance of the term loans.

Previously, the Company had receive-floating/pay-fixed interest rate swap agreements that were designated and qualified
as cash flow hedges for two outstanding non-amortizing bank loans that were repaid concurrent with closing on the new bank credit
facility. Those swap agreements were subsequently terminated in February 2019 concurrent with the inception of the new swap
agreements. The fair value of the previous swap agreements, approximately $5.4 million, was received from the counterparties upon
termination and is being amortized from accumulated other comprehensive loss into earnings as a reduction of interest expense
through the original maturity dates of those agreements.

Cash Flow Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Forecast Purchases of Tobacco and Related
Processing Costs

The majority of the tobacco production in most countries outside the United States where Universal operates is sold in
export markets at prices denominated in U.S. dollars. However, sales of crop inputs (such as seeds and fertilizers) to farmers, purchases
of tobacco from farmers and most processing costs (such as labor and energy) in those countries are usually denominated in the local
currency. Changes in exchange rates between the U.S. dollar and the local currencies where tobacco is grown and processed affect
the ultimate U.S. dollar sales of crop inputs and cost of processed tobacco. From time to time, the Company enters into forward and
option contracts to buy U.S. dollars and sell the local currency at future dates that coincide with the sale of crop inputs to farmers.
In the case of forecast purchases of tobacco and the related processing costs, the Company enters into forward and option contracts
to sell U.S. dollars and buy the local currency at future dates that coincide with the expected timing of a portion of the tobacco
purchases and processing costs. These strategies offset the variability of future U.S. dollar cash flows for sales of crop inputs, tobacco
purchases, and processing costs for the foreign currency notional amount hedged. These hedging strategies have been used mainly
for tobacco purchases, processing costs, and sales of crop inputs in Brazil, although the Company has also entered into hedges for
a portion of the tobacco purchases in Africa. The aggregate U.S. dollar notional amount of forward and option contracts entered for
these purposes during fiscal years 2020, 2019, and 2018 was as follows:

70

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(in millions)

Fiscal Year Ended March 31,

2020

2019

2018

Tobacco purchases .................................................................................................................

$

123.2

$

76.9

$

Processing costs .....................................................................................................................

Crop input sales......................................................................................................................

35.1

21.7

19.8

—

Total ...................................................................................................................................

$

180.0

$

96.7

$

43.3

17.1

—

60.4

Variations in exchange rates and in the amount and timing of fixed-price orders from customers for their purchases from
individual crop years routinely cause variations in the U.S. dollar notional amount of forward contracts entered into from one year
to the next. The increased U.S. dollar notional amounts for tobacco purchases and processing costs hedged during fiscal year 2020
primarily reflect purchase and processing hedges entered into for the 2020 crop year in Brazil, which historically were entered into
during the fourth quarter of the fiscal year and into the first quarter of the subsequent year, as well as the additional hedging of
forecast tobacco purchases in Africa.  All contracts related to tobacco purchases were designated and qualified as hedges of the future
cash flows associated with the forecast purchases of tobacco.  As a result, changes in fair values of the forward contracts have been
recognized in comprehensive income as they occurred, but only recognized in earnings upon sale of the related tobacco to third-
party customers.  Forward and option contracts related to processing costs and sales of crop inputs have not been designated as
hedges, and gains and losses on those contracts have been recognized in earnings on a mark-to-market basis. 

For substantially all hedge gains and losses related to 2020 crops recorded in accumulated other comprehensive loss at
March 31, 2020, the Company expects to complete the sale of the tobacco and recognize the amounts in earnings during fiscal year
2021.  At March 31, 2020, all hedged forecast purchases of tobacco not yet completed remained probable of occurring within the
originally designated time period and, as a result, no hedges had been discontinued. Purchases of the 2020 crops in Brazil and Africa
are expected to be completed by June 2020, and all forward contracts to hedge those purchases will mature and be settled by that
time. Purchases of the 2021 crops in Africa are expected to be completed by May 2021 and all forward contracts to hedge those
purchases will mature and be settled by that time.

Hedging Strategy for Foreign Currency Exchange Rate Risk Related to Net Local Currency Monetary Assets and Liabilities of
Foreign Subsidiaries

Most of the Company’s foreign subsidiaries transact the majority of their sales in U.S. dollars and finance the majority of
their  operating  requirements  with  U.S.  dollar  borrowings,  and  therefore  use  the  U.S.  dollar  as  their  functional  currency. These
subsidiaries normally have certain monetary assets and liabilities on their balance sheets that are denominated in the local currency.
Those assets and liabilities can include cash and cash equivalents, accounts receivable and accounts payable, advances to farmers
and suppliers, deferred income tax assets and liabilities, recoverable value-added taxes, operating lease liabilities, and other items.
Net monetary assets and liabilities denominated in the local currency are remeasured into U.S. dollars each reporting period, generating
gains and losses that the Company records in earnings as a component of selling, general, and administrative expenses. The level of
net monetary assets or liabilities denominated in the local currency normally fluctuates throughout the year based on the operating
cycle, but it is most common for monetary assets to exceed monetary liabilities, sometimes by a significant amount. When this
situation  exists  and  the  local  currency  weakens  against  the  U.S.  dollar,  remeasurement  losses  are  generated.    Conversely,
remeasurement gains are generated on a net monetary asset position when the local currency strengthens against the U.S. dollar. To
manage a portion of its exposure to currency remeasurement gains and losses, the Company enters into forward contracts to buy or
sell the local currency at future dates coinciding with expected changes in the overall net local currency monetary asset position of
the subsidiary. Gains and losses on the forward contracts are recorded in earnings as a component of selling, general, and administrative
expenses for each reporting period as they occur, and thus directly offset the related remeasurement losses or gains in the consolidated
statements of income for the notional amount hedged. The Company does not designate these contracts as hedges for accounting
purposes. The contracts are generally arranged to hedge the subsidiary's projected exposure to currency remeasurement risk for
specified periods of time, and new contracts are entered as necessary throughout the year to replace previous contracts as they mature.
The Company is currently using forward currency contracts to manage its exposure to currency remeasurement risk in Brazil.  The
total notional amounts of contracts outstanding at March 31, 2020 and 2019, were approximately $8.9 million and $24.8 million,
respectively. To further mitigate currency remeasurement exposure, the Company’s foreign subsidiaries may utilize short-term local
currency financing during certain periods.  This strategy, while not involving the use of derivative instruments, is intended to minimize
the subsidiary’s net monetary position by financing a portion of the local currency monetary assets with local currency monetary
liabilities, thus hedging a portion of the overall position. 

Several of the Company’s foreign subsidiaries transact the majority of their sales and finance the majority of their operating
requirements  in  their  local  currency,  and  therefore  use  their  respective  local  currencies  as  the  functional  currency  for  reporting
purposes.  From time to time, these subsidiaries sell tobacco to customers in transactions that are not denominated in the functional

71

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

currency.  In those situations, the subsidiaries routinely enter into forward exchange contracts to offset currency risk for the period
of time that a fixed-price order and the related trade account receivable are outstanding with the customer. The contracts are not
designated as hedges for accounting purposes.

Effect of Derivative Financial Instruments on the Consolidated Statements of Income

The table below outlines the effects of the Company’s use of derivative financial instruments on the consolidated statements

of income for the fiscal years ended March 31, 2020, 2019, and 2018.

Fiscal Year Ended March 31,
2019

2018

2020

Cash Flow Hedges - Interest Rate Swap Agreements

Derivative

Effective Portion of Hedge

Gain (loss) recorded in accumulated other comprehensive loss............................................

Gain (loss) reclassified from accumulated other comprehensive loss into earnings .............

Gain on terminated interest rate swaps amortized from accumulated other comprehensive
loss into earnings................................................................................................................

Location of gain (loss) reclassified from accumulated other comprehensive loss into

earnings ..............................................................................................................................

$

$

$

(32,389) $

(7,496) $

(1,577) $

1,689

2,691

$

260

Interest expense

$

$

4,869

(1,244)

—

Ineffective Portion of Hedge

Gain (loss) recognized in earnings.........................................................................................

$

— $

— $

—

Location of gain (loss) recognized in earnings ......................................................................

Selling, general and administrative expenses

Hedged Item

Description of hedged item.......................................................................................................

Floating rate interest payments on term loans

Cash Flow Hedges - Forward Foreign Currency Exchange Contracts

Derivative

Effective Portion of Hedge

Gain (loss) recorded in accumulated other comprehensive loss............................................

Gain (loss) reclassified from accumulated other comprehensive loss into earnings .............

$

$

(13,646) $

(2,623) $

1,108

$

(3,034) $

(1,204)

(1,099)

Location of gain (loss) reclassified from accumulated other comprehensive loss into
earnings ................................................................................................................................

Cost of goods sold

Ineffective Portion and Early De-designation of Hedges

Gain (loss) recognized in earnings.........................................................................................

$

— $

— $

(5)

Location of gain (loss) recognized in earnings ......................................................................

Selling, general and administrative expenses

Hedged Item

Description of hedged item......................................................................................................

 Forecast purchases of tobacco in 
Brazil and Africa

Derivatives Not Designated as Hedges -
Forward Foreign Currency Exchange Contracts

Gain (loss) recognized in earnings.........................................................................................

$

(4,013) $

(4,671) $

(234)

Location of gain (loss) recognized in earnings ......................................................................

Selling, general and administrative expenses

For the outstanding interest rate swap agreements, the effective portion of the gain or loss on the derivative is recorded in
accumulated other comprehensive loss and any ineffective portion is recorded in selling, general and administrative expenses.  For
the terminated interest rates swaps previously designated as cash flow hedges, a $2.5 million net realized hedge gain remained in
accumulated  other  comprehensive  loss  at  March 31,  2020.  The  Company  expects  to  amortize  $1.4  million  of  this  remaining
unamortized gain into earnings as a reduction of interest expense in fiscal year 2021.

For the forward foreign currency exchange contracts designated as cash flow hedges of tobacco purchases in Brazil and
Africa, a $14.4 million net hedge loss remained in accumulated other comprehensive loss at March 31, 2020.  That balance reflects
losses on contracts related to the 2020 Brazil crops and the 2020 and 2021 Africa crops. No hedge gain or loss had been reclassified
to earnings at March 31, 2020 since shipments of those tobaccos had not yet started. The majority of the balance in accumulated
other comprehensive loss will be recognized in earnings as a component of cost of goods sold in fiscal year 2021 as the 2020 crops

72

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

in Brazil and Africa are sold to customers.  The balance in accumulated other comprehensive loss associated with the 2021 Africa
crop is expected to be recognized in earnings in fiscal year 2022.  Based on the hedging strategy, as the gain or loss is recognized in
earnings, it is expected to be offset by a change in the direct cost for the tobacco or by a change in sales prices if the strategy has
been mandated by the customer.  Generally, margins on the sale of the tobacco will not be significantly affected.

Effect of Derivative Financial Instruments on the Consolidated Balance Sheets

The table below outlines the effects of the Company’s derivative financial instruments on the consolidated balance sheets

at March 31, 2020 and 2019:

Derivatives Designated as Hedging
Instruments

Interest rate swap agreements

Forward foreign currency exchange contracts

Total

Derivatives Not Designated as Hedging
Instruments

Forward foreign currency exchange contracts

Total

Derivatives in a Fair Value
Asset Position

Derivatives in a Fair Value
Liability Position

Balance 
Sheet 
Location

Fair Value as of March 31,

2020

2019

Balance 
Sheet 
Location

Fair Value as of March 31,

2020

2019

Other
non-current
assets

Other
current
assets

Other
current
assets

$

$

$

$

Other
long-term
liabilities

Accounts
payable and
accrued
expenses

Accounts
payable and
accrued
expenses

— $

—

—

— $

307

307

314

314

$

$

233

233

$

37,163

$

6,351

11,467

—

$

48,630

$

6,351

$

$

4,375

4,375

$

$

386

386

Substantially all of the Company's forward foreign currency exchange contracts are subject to master netting arrangements,
whereby the right to offset occurs in the event of default by a participating party. The Company has elected to present these contracts
on a gross basis in the consolidated balance sheets.

NOTE 12.   FAIR VALUE MEASUREMENTS

Universal measures certain financial and nonfinancial assets and liabilities at fair value based on applicable accounting
guidance.  The financial assets and liabilities measured at fair value include money market funds, trading securities associated with
deferred compensation plans, interest rate swap agreements, forward foreign currency exchange contracts, and guarantees of bank
loans to tobacco growers.  The application of the fair value guidance to nonfinancial assets and liabilities primarily includes the
determination of fair values for goodwill and long-lived assets when indicators of potential impairment are present.  

Under the accounting guidance, fair value is defined as the price that would be received to sell an asset or paid to transfer
a liability in an orderly transaction between market participants at the measurement date.  The framework for measuring fair value
is based on a fair value hierarchy that distinguishes between observable inputs and unobservable inputs.  Observable inputs are based
on market data obtained from independent sources.  Unobservable inputs require the Company to make its own assumptions about
the value placed on an asset or liability by market participants because little or no market data exists.  There are three levels within
the fair value hierarchy. 

Level

1

2

3

Description

quoted prices in active markets for identical assets or liabilities that the Company has the ability to access as of the
reporting date;

quoted prices in active markets for similar assets or liabilities, or quoted prices for identical or similar assets or liabilities
in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and

unobservable inputs for the asset or liability.

73

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

As permitted under the accounting guidance, the Company uses net asset value per share ("NAV") as a practical expedient
to measure the fair value of its money market funds.  The fair values for those funds are presented under the heading "NAV" in the
tables that follow in this disclosure.  In measuring the fair value of liabilities, the Company considers the risk of non-performance
in determining fair value.  Universal has not elected to report at fair value any financial instruments or any other assets or liabilities
that are not required to be reported at fair value under current accounting guidance.

Recurring Fair Value Measurements

At March 31, 2020 and 2019, the Company had certain financial assets and financial liabilities that were required to be
measured and reported at fair value on a recurring basis.  These assets and liabilities are listed in the tables below and are classified
based on how their values were determined under the fair value hierarchy or the NAV practical expedient:

March 31, 2020

Fair Value Hierarchy

NAV

Level 1

Level 2

Level 3

Total

Assets

Money market funds.............................................................................................

$

4,011

$

— $

— $

— $

4,011

Trading securities associated with deferred compensation plans .........................

Forward foreign currency exchange contracts......................................................

—

—

12,635

—

—

314

—

—

12,635

314

Total financial assets measured and reported at fair value ................................

$

4,011

$ 12,635

$

314

$

— $ 16,960

Liabilities

Guarantees of bank loans to tobacco growers ......................................................

$

— $

— $

— $

103

$

103

Acquisition-related contingent consideration obligations - short-term ................

Acquisition-related contingent consideration obligations - long-term .................

Interest rate swap agreements...............................................................................

Forward foreign currency exchange contracts......................................................

—

—

—

—

—

—

—

—

—

—

37,163

15,842

4,173

2,532

—

—

4,173

2,532

37,163

15,842

Total financial liabilities measured and reported at fair value ...........................

$

— $

— $ 53,005

$

6,808

$ 59,813

March 31, 2019

Fair Value Hierarchy

NAV

Level 1

Level 2

Level 3

Total

Assets

Money market funds ..............................................................................................

$ 156,864

$

— $

— $

— $ 156,864

Trading securities associated with deferred compensation plans ..........................

Forward foreign currency exchange contracts.......................................................

—

—

16,315

—

—

540

—

—

16,315

540

 Total financial assets measured and reported at fair value................................

$ 156,864

$ 16,315

$

540

$

— $ 173,719

Liabilities

Guarantees of bank loans to tobacco growers........................................................

$

— $

— $

— $

803

$

803

Interest rate swap agreements ................................................................................

Forward foreign currency exchange contracts.......................................................

—

—

—

—

6,351

386

—

—

6,351

386

 Total financial liabilities measured and reported at fair value ..........................

$

— $

— $

6,737

$

803

$

7,540

74

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Money market funds

The fair value of money market funds, which are reported in cash and cash equivalents in the consolidated balance sheets,
is based on NAV, which is the amount at which the funds are redeemable and is used as a practical expedient for fair value.  These
funds are not classified in the fair value hierarchy, but are disclosed as part of the fair value table above.

Trading securities associated with deferred compensation plans

Trading securities represent mutual fund investments that are matched to employee deferred compensation obligations.
These  investments  are  bought  and  sold  as  employees  defer  compensation,  receive  distributions,  or  make  changes  in  the  funds
underlying their accounts.  Quoted market prices (Level 1) are used to determine the fair values of the mutual funds.

Interest rate swap agreements

The fair values of interest rate swap agreements are determined based on dealer quotes using a discounted cash flow model
matched to the contractual terms of each instrument.  Since inputs to the model are observable and significant judgment is not required
in determining the fair values, interest rate swaps are classified within Level 2 of the fair value hierarchy.

Forward foreign currency exchange contracts

The fair values of forward foreign currency exchange contracts are also determined based on dealer quotes using a discounted
cash flow model matched to the contractual terms of each instrument.  Since inputs to the model are observable and significant
judgment is not required in determining the fair values, forward foreign currency exchange contracts are classified within Level 2
of the fair value hierarchy.

Acquisition-related contingent consideration obligations

The Company estimates the fair value of acquisition-related contingent consideration obligations by applying an income
approach model that utilizes probability-weighted discounted cash flows.  As a result of the acquisition of FruitSmart, Inc., the
Company  recognized  a  contingent  consideration  liability  of $6.7  million  on  the  date  of  acquisition.  See  Note  2  for  additional
information.    Each  period  the  Company  evaluates  the  fair  value  of  the  acquisition-related  contingent  consideration  obligations.
Significant judgment is applied to this model and therefore the acquisition-related contingent consideration obligation is classified
within Level 3 of the fair value hierarchy.

A reconciliation of the change in the balance of the acquisition-related contingent consideration obligation (Level 3) for the

fiscal years ended March 31, 2020 and 2019 is provided below.

Fiscal Year Ended March 31,

2020

2019

Balance beginning of year ................................................................................................................................... $

— $

Additions .............................................................................................................................................................

Payments..............................................................................................................................................................

6,705

—

Balance at end of year.......................................................................................................................................... $

6,705

$

—

—

—

—

Guarantees of bank loans to tobacco growers

The Company guarantees bank loans to tobacco growers in Brazil for crop financing.  In the event that the farmers default
on their payments to the banks, the Company would be required to perform under the guarantees.  The Company regularly evaluates
the likelihood of farmer defaults based on an expected loss analysis and records the fair value of its guarantees as an obligation in
its  consolidated  financial  statements.   The  fair  value  of  the  guarantees  is  determined  using  the  expected  loss  data  for  all  loans
outstanding at each measurement date.  The present value of the cash flows associated with the estimated losses is then calculated
at a risk-adjusted interest rate that is aligned with the expected duration of the liability and includes an adjustment for nonperformance
risk.   This  approach  is  sometimes  referred  to  as  the  “contingent  claims  valuation  method.”   Although  historical  loss  data  is  an
observable input, significant judgment is required in applying this information to the portfolio of guaranteed loans outstanding at
each measurement date and in selecting a risk-adjusted interest rate.  Significant increases or decreases in the risk-adjusted interest
rate may result in a significantly higher or lower fair value measurement.  The guarantees of bank loans to tobacco growers are
therefore classified within Level 3 of the fair value hierarchy.

75

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

A reconciliation of the change in the balance of the financial liability for guarantees of bank loans to tobacco growers (Level

3) for the fiscal years ended March 31, 2020 and 2019 is provided below. 

Fiscal Year Ended March 31,

2020

2019

$

803

$

974

(659)

(5)

(7)

(29)

(765)

749

53

(208)

803

Balance at beginning of year ...............................................................................................................................
Payments under the guarantees and transfers to allowance for loss on direct loans to farmers (removal of

prior crop year loans from the portfolio) .........................................................................................................

Provision for loss or transfers from allowance for loss on direct loans to farmers (addition of current crop

year loans)........................................................................................................................................................

Change in discount rate and estimated collection period ....................................................................................

Currency remeasurement .....................................................................................................................................

Balance at end of year..........................................................................................................................................

$

103

$

Long-term Debt

The fair value of the Company’s long-term debt was approximately $370 million at each of the balance sheet dates March 31,
2020 and 2019.  The Company estimates the fair value of its long-term debt using Level 2 inputs which are based upon quoted market
prices for the same or similar obligations or on calculations that are based on the current interest rates available to the Company for
debt of similar terms and maturities.

Nonrecurring Fair Value Measurements

Assets and liabilities that are measured at fair value on a nonrecurring basis primarily relate to long-lived assets, right-of-
use operating lease assets and liabilities, goodwill and intangibles, and other noncurrent assets. These assets and liabilities fair values
are evaluated for impairment when potential indicators of impairment exist.  Accordingly, the nonrecurring measurement of the fair
value of these assets and liabilities are classified within Level 3 of the fair value hierarchy.

Long-Lived Assets

As discussed in Note 4, due to business changes that have affected the leaf tobacco market in Tanzania and the Company's
operations there, the long-lived assets of those operations were tested for impairment at December 31, 2018, and an impairment
charge was recorded to reduce their carrying value to fair value in fiscal year 2019.  The long-lived assets consist principally of the
Company's  processing  facility  and  equipment,  storage  facilities,  tobacco  buying  and  receiving  stations,  employee  housing,  and
vehicles  and  transportation  equipment.    The  aggregate  fair  value  and  carrying  value  of  those  assets  following  the  impairment
adjustments was approximately $17 million.  The fair values of the property, plant and equipment were determined based principally
on a probability-weighting of the discounted cash flows expected under multiple operating and disposition scenarios.  Significant
judgment was required in estimating the amount and timing of the future cash flows associated with the use and disposition of the
assets, as well as the probabilities associated with the respective operating and disposition scenarios. 

76

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 13.   PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS 

Defined Benefit Plans

Description of Plans 

 The Company sponsors several defined benefit pension plans covering salaried and certain hourly employees in the U.S.,
as  well  as  certain  foreign  and  other  employee  groups.    These  plans  provide  retirement  benefits  based  primarily  on  employee
compensation and years of service.  Plan assets consist primarily of equity and fixed income investments.  The Company also sponsors
defined benefit plans that provide postretirement health and life insurance benefits for eligible U.S. employees and retirees who have
attained specific age and service levels, although postretirement life insurance benefits were discontinued several years ago for all
employees who were not already retired.  The health benefits are funded by the Company as the costs of those benefits are incurred.
The plan design includes cost-sharing features such as deductibles and coinsurance.  The life insurance benefits are funded with
deposits to a reserve account held by an insurance company.  The Company has the right to amend or discontinue its pension and
other postretirement benefit plans at any time.

In the following disclosures, the term “accumulated benefit obligation” (“ABO”) represents the actuarial present value of
estimated future benefit payments earned by participants in the Company's defined benefit pension plans as of the balance sheet date
without  regard  to  the  estimated  effect  of  future  compensation  increases  on  those  benefits.    The  term  does  not  apply  to  other
postretirement benefits.  “Projected benefit obligation” refers to the projected benefit obligation (“PBO”) for pension benefits and
the accumulated postretirement benefit obligation (“APBO”) for other postretirement benefits.  These amounts represent the actuarial
present value of estimated future benefit payments earned by participants in the benefit plans as of the balance sheet date.  For pension
benefits, the projected benefit obligation includes the estimated effect of future compensation increases on those benefits.

Actuarial Assumptions

Assumptions used for financial reporting purposes to compute net periodic benefit cost and benefit obligations for the

Company's primary defined benefit plans were as follows:

Pension Benefits

Other Postretirement Benefits

2020

2019

2018

2020

2019

2018

Discount rates:

Benefit cost for plan year ...........................

Benefit obligation at end of plan year ........

4.00%

3.60%

4.10%

4.00%

4.10%

4.10%

3.80%

3.40%

3.90%

3.80%

3.90%

3.90%

Expected long-term return on plan assets:

Benefit cost for plan year ...........................

6.75%

6.75%

7.00%

3.00%

3.00%

3.00%

Salary scale:

Benefit cost for plan year ...........................

Benefit obligation at end of plan year ........

Healthcare cost trend rate..............................

4.00%

4.00%

N/A

4.00%

4.00%

N/A

4.00%

4.00%

N/A

4.00%

4.00%

7.34%

4.00%

4.00%

7.60%

4.00%

4.00%

8.10%

Changes in the discount rates in the above table reflect prevailing market interest rates at the end of each fiscal year when
the benefit obligations are actuarially measured.  The expected long-term return on plan assets is developed from financial models
used to project future returns on the underlying assets of the funded plans and is reviewed on an annual basis. The healthcare cost
trend rate used by the Company is based on a study of medical cost inflation rates that is reviewed and updated annually for continued
applicability.  The revised trend assumption of 7.34% in 2020 declines gradually to 4.44% in 2028.  The Company has caps in place
on postretirement medical benefits that limit its cost for a large segment of the retiree population.  As a result, changes to the healthcare
cost trend rate have a limited impact on the postretirement medical plan liability and expense. 

77

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Benefit Obligations, Plan Assets, and Funded Status

The following table reflects the changes in benefit obligations and plan assets in fiscal years 2020 and 2019, as well as the

funded status of the plans at March 31, 2020 and 2019:

Pension
Benefits

March 31,

Other Postretirement
Benefits

March 31,

2020

2019

2020

2019

Actuarial present value of benefit obligation:

Accumulated benefit obligation ...................................................................... $

281,242

$

273,370

Projected benefit obligation ............................................................................

287,082

278,189

$

30,282

$

31,635

Change in projected benefit obligation:

Projected benefit obligation, beginning of year .............................................. $

278,189

$

273,658

$

31,635

$

32,945

Service cost .....................................................................................................

Interest cost .....................................................................................................

Effect of discount rate change .........................................................................

Foreign currency exchange rate changes ........................................................

Settlements ......................................................................................................

Other................................................................................................................

5,990

10,747

14,479

(1,477)

(6,038)

1,029

6,008

10,810

5,177

199

1,306

1,326

(2,526)

(1,012)

—

7,268

—

(744)

222

1,371

563

(447)

—

(126)

Benefit payments.............................................................................................

(15,837)

(22,206)

(2,428)

(2,893)

Projected benefit obligation, end of year ........................................................ $

287,082

$

278,189

$

30,282

$

31,635

3,467

150

2,993

—

—

Change in plan assets:

Plan assets at fair value, beginning of year ..................................................... $

244,969

$

229,568

$

3,717

$

Actual return on plan assets ............................................................................

Employer contributions ...................................................................................

Settlements ......................................................................................................

Foreign currency exchange rate changes ........................................................

10,551

6,037

(6,038)

(1,232)

Benefit payments.............................................................................................

(15,837)

9,772

29,489

—

(1,654)

(22,206)

152

1,928

—

—

(2,428)

(2,893)

Plan assets at fair value, end of year ............................................................... $

238,450

$

244,969

$

3,369

$

3,717

Funded status:

Funded status of the plans, end of year ........................................................... $

(48,632) $

(33,220) $

(26,913) $

(27,918)

In fiscal year 2020, some employees covered by a foreign pension plan elected to convert their lifetime annuity benefit into
limited fixed payments based on the actuarially determined liability at the time of the election. The election to change the defined
benefit resulted in a partial plan settlement and recognition of a $0.7 million settlement charge for the fiscal year ended March 31,
2020.  

The Company funds its non-regulated U.S. pension plan, one of its foreign pension plans, and its postretirement medical
plans on a pay-as-you-go basis as the benefit payments are incurred.  Those plans account for approximately 71% of the $48.6 million
unfunded pension obligation and approximately 94% of the $26.9 million unfunded postretirement benefit obligation shown on the
funded status line in the above table at March 31, 2020.  The increase in employer pension contributions in fiscal year 2019 reflects
higher contributions to the Company's U.S. ERISA-regulated pension plan to realize incremental income tax benefits, as well as
higher contributions to the non-regulated U.S. plan to fund lump-sum benefit payments to retiring participants.

78

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The funded status of the Company’s plans at the end of fiscal years 2020 and 2019 was reported in the consolidated balance

sheets as follows:

Pension
Benefits

March 31,

Other Postretirement
Benefits

March 31,

2020

2019

2020

2019

Non-current asset (included in other noncurrent assets).................................... $

346

$

1,837

$

— $

—

Current liability (included in accounts payable and accrued expenses) ............

Non-current liability (reported as pensions and other postretirement benefits)

(2,978)

(46,000)

(1,490)

(33,567)

(2,233)

(24,680)

(2,228)

(25,690)

Amounts recognized in the consolidated balance sheets ................................... $

(48,632) $

(33,220) $

(26,913) $

(27,918)

Additional information on the funded status of the Company’s plans as of the respective measurement dates for the fiscal

years ended March 31, 2020 and 2019, is as follows:

Pension
Benefits

March 31,

Other Postretirement
Benefits

March 31,

2020

2019

2020

2019

For plans with a projected benefit obligation in excess of plan assets:

Aggregate projected benefit obligation (PBO)................................................ $

284,327

$

269,622

$

30,282

$

31,635

Aggregate fair value of plan assets .................................................................

235,349

234,565

3,369

3,717

For plans with an accumulated benefit obligation in excess of plan
assets:

Aggregate accumulated benefit obligation (ABO)..........................................

Aggregate fair value of plan assets .................................................................

278,515

235,349

35,070

4,023

N/A

N/A

N/A

N/A

With the additional employer contributions noted above and the return on plan assets during fiscal year 2019, the assets of

the Company's U.S. ERISA-regulated pension plan exceeded the accumulated benefit obligation (ABO) at March 31, 2019.

Net Periodic Benefit Cost

The components of the Company’s net periodic benefit cost were as follows:

Pension Benefits

Other Postretirement Benefits

Fiscal Year Ended March 31,

Fiscal Year Ended March 31,

2020

2019

2018

2020

2019

2018

Components of net periodic benefit cost:

Service cost ................................................ $

5,990

$

6,008

$

5,177

$

199

$

222

$

Interest cost ................................................

10,747

10,810

10,801

Expected return on plan assets...................

(16,671)

(15,695)

(15,962)

Settlement cost ...........................................

Net amortization and deferral ....................

676

3,709

—

3,491

—

3,735

1,306

(106)

—

(647)

1,371

(99)

—

(710)

Net periodic benefit cost ............................ $

4,451

$

4,614

$

3,751

$

752

$

784

$

229

1,471

(87)

—

(620)

993

A one-percentage-point increase or decrease in the assumed healthcare cost trend rate would not result in a significant
change to the March 31, 2020 accumulated postretirement benefit obligation or the aggregate service and interest cost components
of the net periodic postretirement benefit expense for fiscal year 2021.   

79

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Amounts Included in Accumulated Other Comprehensive Loss

Amounts included in accumulated other comprehensive loss at the beginning of the year are amortized as a component of
net periodic benefit cost during the year.  The amounts recognized in other comprehensive income or loss for fiscal years 2020 and
2019 and the amounts included in accumulated other comprehensive loss at the end of those fiscal years are shown below.  All
amounts shown are before allocated income taxes.

Pension
Benefits

March 31,

Other Postretirement
Benefits

March 31,

2020

2019

2020

2019

Change in net actuarial loss (gain):

Net actuarial loss (gain), beginning of year..................................................... $

81,502

$

69,333

$

(6,201) $

(7,247)

Losses (gains) arising during the year .............................................................

Settlement ........................................................................................................

Amortization included in net periodic benefit cost during the year ................

Net actuarial loss (gain), end of year ...............................................................

Change in prior service cost (benefit):

Prior service cost (benefit), beginning of year.................................................

Amortization included in net periodic benefit cost during the year ................

Prior service cost (benefit), end of year...........................................................

21,838

(529)

(5,786)

97,025

(7,479)

2,077

(5,402)

17,884

—

(5,715)

81,502

(9,703)

2,224

(7,479)

302

—

534

513

—

533

(5,365)

(6,201)

(766)

202

(564)

(965)

199

(766)

Total amounts in accumulated other comprehensive loss 

at end of year, before income taxes ............................................................. $

91,623

$

74,023

$

(5,929) $

(6,967)

Amounts in the above table reflect the Company and its consolidated subsidiaries.  The accumulated other comprehensive
loss reported in the consolidated balance sheets also includes pension and other postretirement benefit amounts related to ownership
interests in unconsolidated affiliates. 

The Company expects to recognize approximately $6.1 million of the March 31, 2020 net actuarial loss and $2.2 million

of the March 31, 2020 prior service benefit in net periodic benefit cost during fiscal year 2021.

Allocation of Pension Plan Assets

The  Company  has  established,  and  periodically  adjusts,  target  asset  allocations  for  its  investments  in  its  U.S.  ERISA-
regulated defined benefit pension plan, which represents 97% of consolidated plan assets and 85% of consolidated PBO at March 31,
2020, to balance the needs of liquidity, total return, and risk control.  The assets are required to be diversified across asset classes
and investment styles to achieve that balance.  During the year, the asset allocation is reviewed for adherence to the target policy
and rebalanced to the targeted weights.  The Company reviews the expected long-term returns of the asset allocation each year to
help determine whether changes are needed.  The return is evaluated on a weighted-average basis in relation to inflation.  The assumed
long-term rate of return used to calculate annual benefit expense is based on the asset allocation and expected market returns for the
respective asset classes.

80

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The weighted–average target pension asset allocation and target ranges at the March 31, 2020 measurement date and the

actual asset allocations at the March 31, 2020 and 2019 measurement dates by major asset category were as follows:

Major Asset Category

Target
Allocation

Actual Allocation

March 31,

Range

2020

2019

Equity securities......................................................................................
(1) .....................................................................

Fixed income securities 

Alternative investments ..........................................................................

29.0% 19% - 39%

66.0% 56% - 76%

5.0% 0% - 10%

25.4%

70.3%

4.3%

31.2%

64.8%

4.0%

Total...................................................................................................

100.0%

100.0%

100.0%

(1)

Actual amounts include high yield securities and cash balances held for the payment of benefits.

Universal  makes  regular  contributions  to  its  pension  and  other  postretirement  benefit  plans.   As  previously  noted,  for
postretirement health benefits, contributions reflect funding of those benefits as they are incurred.  The Company expects to make
contributions of approximately $6.0 million to its ERISA regulated defined benefit pension plan and $4.0 million to its non-ERISA
regulated pension plans in fiscal year 2021.

Estimated future benefit payments to be made from the Company’s plans are as follows:

Fiscal Year

Pension
Benefits

Other
Postretirement
Benefits

2021.................................................................................................................................................................... $

17,561

$

2022....................................................................................................................................................................

2023....................................................................................................................................................................

2024....................................................................................................................................................................

2025....................................................................................................................................................................

2026 - 2030 ........................................................................................................................................................

19,620

17,326

17,992

17,774

89,919

2,668

2,545

2,445

2,346

2,246

9,672

81

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Fair Values of Pension Plan Assets

Assets held by the Company's defined benefit pension plans primarily consist of equity securities, fixed income securities,
and alternative investments.  Equity securities are primarily invested in actively-traded mutual funds with underlying common stock
investments in U.S. and foreign companies ranging in size from small to large corporations.  Fixed income securities are also held
primarily through actively-traded mutual funds with the underlying investments in both U.S. and foreign securities.  The methodologies
for determining the fair values of the plan assets are outlined below.  Where the values are based on quoted prices for the securities
in an active market, they are classified as Level 1 of the fair value hierarchy.  Where secondary pricing sources are used, they are
classified as Level 2 of the hierarchy.  Pricing models that use significant unobservable inputs are classified as Level 3.

•

•

•

Equity securities:  Investments in equity securities through actively-traded mutual funds are valued based on the net
asset values of the units held in the respective funds, which are determined by obtaining quoted prices on nationally
recognized securities exchanges.  These securities are classified as Level 1.

Fixed income securities:  Fixed income investments that are held through mutual funds are valued based on the net
asset values of the units held in the respective funds, which are determined by obtaining quoted prices on nationally
recognized securities exchanges.  These securities are classified as Level 1.  Other fixed income investments are valued
at an estimated price that a dealer would pay for a similar security on the valuation date using observable market inputs
and are classified as Level 2.  These market inputs may include yield curves for similarly rated securities.  Small amounts
of cash are held in common collective trusts.  Fixed income securities also include insurance assets, which are valued
based on an actuarial calculation. Those securities are classified as Level 3.

Alternative investments:  Real estate assets are valued using valuation models that incorporate income and market
approaches, including external appraisals, to derive fair values.  The hedge fund allocation is a fund of hedge funds
and is valued by the manager based on the net asset value of each fund.  These models use significant unobservable
inputs and are classified as Level 3 within the fair value hierarchy.

Fair values of the assets of the Company’s pension plans as of March 31, 2020 and 2019, classified based on how their

values were determined under the fair value hierarchy are as follows:

March 31, 2020

Level 1

Level 2

Level 3

Total

Equity securities.......................................................................................... $
Fixed income securities (1) ..........................................................................

Alternative investments ..............................................................................

58,204

$

— $

— $

58,204

162,667

—

3,101

—

4,668

9,810

170,436

9,810

Total investments................................................................................... $

220,871

$

3,101

$

14,478

$

238,450

March 31, 2019

Level 1

Level 2

Level 3

Total

Equity securities.......................................................................................... $
Fixed income securities (1) ..........................................................................

Alternative investments ..............................................................................

71,561

$

— $

— $

71,561

149,798

—

10,399

—

4,025

9,186

164,222

9,186

Total investments................................................................................... $

221,359

$

10,399

$

13,211

$

244,969

(1)

Includes high yield securities and cash and cash equivalent balances.

Other Benefit Plans

Universal and several subsidiaries offer employer defined contribution savings plans.  Amounts charged to expense for
these plans were approximately $2.7 million for fiscal year 2020, $2.6 million for fiscal year 2019, and $2.3 million for fiscal year
2018.

82

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 14.   COMMON AND PREFERRED STOCK 

Common Stock

At March 31, 2020, the Company’s shareholders had authorized 100,000,000 shares of its common stock, and 24,421,835
shares were issued and outstanding.  Holders of the common stock are entitled to one vote for each share held on all matters requiring
a vote.  Holders of the common stock are also entitled to receive dividends when, as, and if declared by the Company’s Board of
Directors.  The Board of Directors customarily declares and pays regular quarterly dividends on the outstanding common shares;
however, such dividends are at the Board’s full discretion, and there is no obligation to continue them. 

Preferred Stock

The Company is also authorized to issue up to 5,000,000 shares of preferred stock.  No preferred stock was outstanding at

March 31, 2020. 

Share Repurchase Programs

Universal’s Board of Directors has authorized programs to repurchase outstanding shares of the Company’s capital stock
(common and preferred stock). Under these programs, the Company has made and may continue to make share repurchases from
time to time in the open market or in privately negotiated transactions at prices not exceeding prevailing market rates.  Programs
have been in place continuously throughout fiscal years 2018 through 2020.  The current program, which replaced an expiring
program, was authorized and became effective on November 7, 2017 and further extended on May 29, 2019.  It authorizes the
purchase of up to $100 million of the Company's outstanding common stock and expires on the earlier of November 15, 2020, or
when the funds authorized for the program have been exhausted.  At March 31, 2020, $56 million of the authorization remained
available for share repurchases under the current program.

Repurchases of common stock under the programs for fiscal years 2020, 2019, and  2018 were as follows:

Number of shares repurchased.....................................................................................................

656,820

Cost of shares repurchased (in thousands of dollars) .................................................................. $

Weighted-average cost per share ................................................................................................. $

33,457

50.94

$

$

30,777

1,443

46.87

$

$

403,624

21,610

53.54

Fiscal Year Ended March 31,

2020

2019

2018

83

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 15.   EXECUTIVE STOCK PLANS AND STOCK-BASED COMPENSATION 

Executive Stock Plans

The Company’s shareholders have approved executive stock plans under which officers, directors, and employees of the
Company may receive grants and awards of common stock, restricted stock, restricted stock units (“RSUs”), performance share
awards (“PSAs”), stock appreciation rights (“SARs”), incentive stock options, and non-qualified stock options.  Currently, grants
are outstanding under the 1997 Executive Stock Plan, the 2002 Executive Stock Plan, the 2007 Stock Incentive Plan, and the 2017
Stock Incentive Plan.  Together, these plans are referred to in this disclosure as the “Plans.”  Up to 1,000,000 shares may be issued
under the 2017 Stock Incentive Plan, with no specific share limit for any of the award types.  New awards may no longer be issued
under the 1997, 2002, and 2007 Plans.

The Company’s practice is to award grants of stock-based compensation to officers at the first regularly-scheduled meeting
of the Compensation Committee of the Board of Directors (the “Compensation Committee”) in the fiscal year following the public
release of the Company’s financial results for the prior year.  In recent years, the Compensation Committee has awarded only grants
of RSUs and PSAs.  Outside directors automatically receive restricted stock units following each annual meeting of shareholders.

RSUs awarded under the Plans vest 5 years from the grant date and are then paid out in shares of common stock.  Under
the terms of the RSU awards, grantees receive dividend equivalents in the form of additional RSUs that vest and are paid out on the
same date as the original RSU grant.  The PSAs vest 3 years from the grant date, are paid out in shares of common stock at the vesting
date, and do not carry rights to dividends or dividend equivalents prior to vesting.  Shares ultimately paid out under PSA grants are
dependent on the achievement of predetermined performance measures established by the Compensation Committee and can range
from zero to 150% of the stated award.  RSUs awarded to outside directors prior to fiscal 2020 vest 3 years after the grant date and
those granted in fiscal 2020 vest in 1 year, and restricted stock vests upon the individual’s retirement from service as a director.

84

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

RSUs, Restricted Stock, and PSAs

The following table summarizes the Company’s RSU, restricted stock, and PSA activity for fiscal years 2018 through 2020:

RSUs

Restricted Stock

PSAs

Weighted-
Average
Grant Date
Fair Value

Shares

Weighted-
Average
Grant Date
Fair Value

Shares

Weighted-
Average
Grant Date
Fair Value

Shares

Fiscal Year Ended March 31, 2018:

Unvested at beginning of year ...................

325,638

$

Granted.......................................................

Vested.........................................................

Forfeited.....................................................

72,032

(60,751)

—

Unvested at end of year..............................

336,919

Fiscal Year Ended March 31, 2019:

Granted.......................................................

Vested.........................................................

Forfeited.....................................................

87,621

(99,549)

—

Unvested at end of year..............................

324,991

Fiscal Year Ended March 31, 2020:

Granted.......................................................

Vested.........................................................

Forfeited.....................................................

85,463

(74,518)

—

Unvested at end of year..............................

335,936

$

52.01

64.13

45.51

—

55.77

64.53

59.09

—

57.12

56.39

54.20

—

57.89

30,200

$

42.37

160,350

$

—

—

—

—

—

—

30,200

42.37

—

(8,950)

—

21,250

—

—

—

—

44.25

—

41.58

—

—

—

39,100

(41,667)

(6,783)

151,000

54,800

(49,092)

(9,834)

146,874

60,728

(67,402)

—

21,250

$

41.58

140,200

$

46.86

60.37

46.41

46.41

50.50

57.12

45.06

45.55

55.12

50.16

49.17

—

55.73

Shares granted and vested in the above table include dividend equivalents on RSUs and any shares awarded above the base
grant under the performance provisions of PSAs.  Shares forfeited or canceled include any reductions from the base PSA grant under
those same performance provisions.  The fair values of RSUs, restricted stock, and PSAs are based on the market price of the common
stock on the grant date.

Stock-Based Compensation Expense

Fair value expense for stock-based compensation is recognized ratably over the period from grant date to the earlier of (1)
the vesting date of the award, or (2) the date the grantee is eligible to retire without forfeiting the award.  For employees who are
already eligible to retire at the date an award is granted, the total fair value of the award is recognized as expense at the date of grant.
For the fiscal years ended March 31, 2020, 2019, and 2018, total stock-based compensation expense and the related income tax
benefit recognized were as follows:

Total stock-based compensation expense ................................................................................ $

Income tax benefit recorded on stock-based compensation expense ...................................... $

5,631

1,182

$

$

8,152

1,712

$

$

7,610

2,397

At March 31, 2020, the Company had $4.6 million of unrecognized compensation expense related to stock-based awards,

which will be recognized over a weighted-average period of approximately 1.2 years.

Fiscal Year Ended March 31,

2020

2019

2018

85

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 16.   COMMITMENTS, CONTINGENCIES, AND OTHER MATTERS 

Commitments

The Company enters into contracts to purchase tobacco from farmers in a number of the countries where it operates.  Contracts
in  most  countries  cover  one  annual  growing  season.    Primarily  with  the  farmer  contracts  in  Brazil,  Malawi,  Mozambique,  the
Philippines, Guatemala, and Mexico, the Company provides seasonal financing to support the farmers’ production of their crops or
guarantees their financing from third-party banks.  At March 31, 2020, the Company had contracts to purchase approximately $378
million of tobacco to be delivered during the coming fiscal year and $88 million of tobacco to be delivered in subsequent years.
These amounts are estimates since actual quantities purchased will depend on crop yields, and prices will depend on the quality of
the tobacco delivered and other market factors.  Tobacco purchase obligations have been partially funded by short-term advances to
farmers and other suppliers, which totaled approximately $134 million, net of allowances, at March 31, 2020.  The Company withholds
payments due to farmers on delivery of the tobacco to satisfy repayment of the financing it provided to the farmers.  As noted above
and discussed in more detail below, the Company also has arrangements to guarantee bank loans to farmers in Brazil, and payments
are also withheld on delivery of tobacco to satisfy repayment of those loans.  In addition to its contractual obligations to purchase
tobacco,  the  Company  had  commitments  related  to  agricultural  materials,  approved  capital  expenditures,  and  various  other
requirements that approximated $52 million at March 31, 2020.

Guarantees and Other Contingent Liabilities

Guarantees of Bank Loans and Other Contingent Liabilities

Guarantees of bank loans to growers for crop financing have long been industry practice in Brazil and support the farmers’
production of tobacco there.  The Company's operating subsidiary in Brazil had guarantees outstanding at March 31, 2020, all of
which expire within one year.  As noted above, the subsidiary withholds payments due to the farmers on delivery of tobacco and
forwards those payments to the third-party banks.  Failure of farmers to deliver sufficient quantities of tobacco to the subsidiary to
cover their obligations to the third-party banks could result in a liability for the subsidiary under the related guarantees; however, in
that case, the subsidiary would have recourse against the farmers.  The maximum potential amount of future payments that the
Company’s subsidiary could be required to make at March 31, 2020, was the face amount, $3 million including unpaid accrued
interest ($17 million as of March 31, 2019).  The fair value of the guarantees was a liability of approximately $0.1 million at March 31,
2020  ($1.0  million  at  March 31,  2019).    In  addition  to  these  guarantees,  the  Company  has  other  contingent  liabilities  totaling
approximately $1 million at March 31, 2020, primarily under outstanding letters of credit. 

Value-Added Tax Assessments in Brazil

As discussed in Note 1, the Company's local operating subsidiaries pay significant amounts of value-added tax ("VAT") in
connection with their normal operations.  In Brazil, VAT is assessed at the state level when green tobacco is transferred between
states.  The Company's operating subsidiary there pays VAT when tobaccos grown in the states of Santa Catarina and Parana are
transferred to its factory in the state of Rio Grande do Sul for processing.  The subsidiary has received assessments for additional
VAT plus interest and penalties from the tax authorities for the states of Santa Catarina and Parana based on audits of the subsidiary's
VAT filings for specified periods.  In June 2011, tax authorities for the state of Santa Catarina issued assessments for tax, interest,
and penalties for periods from 2006 through 2009 totaling approximately $8 million.  In September 2014, tax authorities for the state
of Parana issued an assessment for tax, interest, and penalties for periods from 2009 through 2014 totaling approximately $11 million.
These amounts are based on the exchange rate for the Brazilian currency at March 31, 2020.  Management of the operating subsidiary
and outside counsel believe that errors were made by the tax authorities for both states in determining all or significant portions of
these assessments and that various defenses support the subsidiary's positions.

With respect to the Santa Catarina assessments, the subsidiary took appropriate steps to contest the full amount of the claims.
As of March 31, 2020, a portion of the subsidiary's arguments had been accepted, and the outstanding assessment had been reduced,
although interest on the remaining assessment has continued to accumulate.  The reduced assessment, together with the related
accumulated interest through the end of the current reporting period, totaled approximately $9 million at the March 31, 2020 exchange
rate.  The subsidiary is continuing to contest the full remaining amount of the assessment.  While the range of reasonably possible
loss is zero up to the full $9 million remaining assessment, based on the strength of the subsidiary's defenses, no loss within that
range is considered probable at this time and no liability has been recorded at March 31, 2020.

86

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

With respect to the Parana assessment, management of the subsidiary and outside counsel challenged the full amount of
the claim.  A significant portion of the Parana assessment was based on positions taken by the tax authorities that management and
outside counsel believe deviate significantly from the underlying statutes and relevant case law.  In addition, under the law, the
subsidiary's tax filings for certain periods covered in the assessment were no longer open to any challenge by the tax authorities.    In
December 2015, the Parana tax authorities withdrew the initial claim and subsequently issued a new assessment covering the same
tax periods.  The new assessment totaled approximately $3 million at the March 31, 2020 exchange rate, reflecting a substantial
reduction from the original $11 million assessment. Notwithstanding the reduction, management and outside counsel continue to
believe that the new assessment is not supported by the underlying statutes and relevant case law and have challenged the full amount
of the claim.  The range of reasonably possible loss is considered to be zero up to the full $3 million assessment.  However, based
on the strength of the subsidiary's defenses, no loss within that range is considered probable at this time and no liability has been
recorded at March 31, 2020.

In both states, the process for reaching a final resolution to the assessments is expected to be lengthy, and management is
not currently able to predict when either case will be concluded.  Should the subsidiary ultimately be required to pay any tax, interest,
or penalties in either case, the portion paid for tax would generate value-added tax credits that the subsidiary may be able to recover.

Tanzania Fair Competition Commission Proceeding

In June 2012, the Company’s Tanzanian subsidiary, Tanzania Leaf Tobacco Company Ltd. (“TLTC”), entered into a two
crop-year supply agreement for unprocessed “green” tobacco with a newly-formed Tanzanian subsidiary of one of the Company’s
major customers.  The agreement involved green tobacco purchases from four of the approximately 400 grower cooperatives in
Tanzania, which allowed the customer and its Tanzanian subsidiary on a small test basis to evaluate whether it would be a viable
alternative for the customer to establish its own vertically integrated supply operations in that market.  Prior to that time, the customer’s
subsidiary did not exist, and it only purchased processed Tanzanian tobacco from tobacco dealers in specified amounts and only for
certain grades and stalk positions.  In contrast, the agreement with TLTC required the customer’s subsidiary to purchase green tobacco
on a “run of crop” basis.  “Run of crop” requires the purchase of all green tobacco produced on the tobacco plant, regardless of grade
or stalk position.  The agreement, therefore, enabled the customer’s subsidiary on a small test basis to evaluate the quality of green
tobacco purchased on a “run of crop” basis and to assess how such tobacco would be suited to the customer's tobacco requirements.
The customer unilaterally elected to establish its own vertically integrated supply operations in Tanzania after the expiration of the
agreement, and its subsidiary began purchasing green tobacco directly from Tanzanian grower cooperatives during the second crop
year thereafter.

Despite the pro-competitive object and effect of the agreement between TLTC and the customer’s subsidiary, in October
2016, the Tanzania Fair Competition Commission (“FCC”) notified TLTC and the customer’s subsidiary that it reviewed the agreement
and provisionally concluded that it infringed Tanzania antitrust law by having the object and effect of preventing competition in the
purchase of unprocessed green tobacco in the area in which the four grower cooperatives were located.  The FCC also provisionally
concluded that the Company’s U.S. subsidiary, Universal Leaf Tobacco Company, Inc. (“ULT”), and additional subsidiaries of the
customer, were jointly and severally liable for the actions of TLTC and the customer’s Tanzanian subsidiary, respectively.  TLTC
and ULT submitted a written response contesting the FCC’s allegations, and on February 27, 2018, the FCC issued its decision to
TLTC and ULT which ignored TLTC's and ULT's submissions and confirmed its initial conclusion that the agreement infringed
Tanzanian antitrust law.  In its decision, the FCC concluded incorrectly that the parties to the agreement unfairly benefited in the
amount of $105 thousand.  The FCC arbitrarily assessed a fine jointly against TLTC and ULT of approximately $197 million and a
fine jointly against the customer’s Tanzanian subsidiary and another subsidiary of the customer exceeding $1 billion.

TLTC and ULT worked closely with expert legal advisors and economists on this matter.  Based on these engagements and
consultations, the Company firmly believed the FCC’s allegations were frivolous and clearly without merit or support from the facts,
law or economic analysis.  The Company further believed the FCC’s proceedings were rife with irregularities and did not comply
with applicable legal and regulatory procedures with respect to this matter, including failing to establish jurisdiction over ULT or to
offer a legal justification for including ULT in the proceeding.  To the contrary, the Company believed the facts, law and economic
analysis clearly supported the legality and pro-competitive nature of the agreement and supported a proper conclusion that there was
no infringement of Tanzania antitrust law, and the agreement had no negative impact on the Tanzania tobacco market.  The Company
further believed the FCC’s proposed fine is ludicrous, unwarranted and contrary to Tanzania law.  TLTC and ULT immediately
appealed the FCC findings to the Tanzania Fair Competition Tribunal, which immediately stayed the execution of any FCC fines. 

87

UNIVERSAL CORPORATION 
CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

On January 22, 2019, the FCC delivered provisional findings regarding two new allegations of antitrust violations.  In those
two new provisional findings, the FCC manufactured claims against ULT and ULT's subsidiaries in Tanzania, in addition to other
parties in Tanzania.  ULT and its Tanzania subsidiaries had already begun working closely with expert legal advisors on these matters
to prepare and submit to the FCC proper and comprehensive responses.  The Company also believed the most recent FCC provisional
findings and allegations were frivolous and clearly without merit and lack facts, law or economic analysis to support them. In one
of the two new matters, based on the Company's review of the provisional findings and consultation with counsel, the Company
believed the FCC was seeking an equally large, ludicrous, unwarranted, and unlawful fine as the one sought in the original matter.
The FCC's motivations for initiating these additional, spurious allegations against the Company's subsidiaries were unclear.  

The FCC contacted TLTC during the pendency of the three matters to initiate settlement discussions in order to resolve and
dismiss all outstanding matters.  After protracted negotiations with the FCC regarding mutually-agreeable and reasonable procedural
aspects of settlement, on March 27, 2020, ULT, its Tanzania subsidiaries and the FCC executed a binding no-fault settlement of the
three matters (the “Settlement Agreement”).  The terms of the Settlement Agreement included mutual confidentiality obligations and
mutual releases which discharged all actions, claims, rights and demands of the FCC, ULT and its Tanzania subsidiaries in all these
matters, as well as a settlement amount to be paid to the FCC.  Although the confidentiality obligations in the Settlement Agreement
do not permit the Company publicly to disclose the settlement amount, such amount was not material to the fourth fiscal quarter or
the fiscal year ended March 31, 2020.  We are pleased to avoid the cost of further litigating these frivolous matters, and we believe
no further related costs will be incurred.

Other Legal and Tax Matters

Various  subsidiaries  of  the  Company  are  involved  in  other  litigation  and  tax  examinations  incidental  to  their  business
activities.  While the outcome of these matters cannot be predicted with certainty, management is vigorously defending the matters
and does not currently expect that any of them will have a material adverse effect on the Company’s business or financial position.
However, should one or more of these matters be resolved in a manner adverse to management’s current expectation, the effect on
the Company’s results of operations for a particular fiscal reporting period could be material.

88

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 17.   OPERATING SEGMENTS

Universal’s  primary  operations  involve  selecting,  procuring,  processing,  packing,  storing,  shipping,  and  financing  leaf
tobacco for sale to, or for the account of, manufacturers of consumer tobacco products throughout the world.  Through various
operating subsidiaries located in tobacco-growing countries around the world and significant ownership interests in unconsolidated
affiliates, the Company processes and/or sells flue-cured and burley tobaccos, dark air-cured tobaccos, and oriental tobaccos.  Flue-
cured, burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly
in the manufacture of cigars, pipe tobacco, and smokeless tobacco products. Some of these tobacco types are also increasingly used
in the manufacture of non-combustible tobacco products that are intended to provide consumers with an alternative to traditional
combustible  products.  A  substantial  portion  of  the  Company’s  revenues  are  derived  from  sales  to  a  limited  number  of  large,
multinational cigarette manufacturers.

The principal approach used by management to evaluate the Company’s performance is by geographic region, although the
dark air-cured and oriental tobacco businesses are each evaluated on the basis of their worldwide operations.  Oriental tobacco
operations consist principally of a 49% interest in an affiliate, and the performance of those operations is evaluated based on the
Company’s equity in the pretax earnings of that affiliate.  Under this structure, the Company has the following primary operating
segments:  North America, South America, Africa, Europe, Asia, Dark Air-Cured, Oriental, and Special Services.  North America,
South America, Africa, Europe, and Asia are primarily involved in flue-cured and/or burley leaf tobacco operations for supply to
cigarette manufacturers.  The Dark Air-Cured group supplies dark air-cured tobacco principally to manufacturers of cigars, pipe
tobacco, and smokeless tobacco products, and the Oriental business supplies oriental tobacco to cigarette manufacturers.  From time
to time, the segments may trade in tobaccos that differ from their main varieties, but those activities are not significant to their overall
results.  Special Services includes the Company's laboratory services business, which provides physical and chemical product testing
and smoke testing for customers, its food ingredients business (including FruitSmart), and its liquid nicotine business.

The  five  regional  operating  segments  serving  the  Company’s  cigarette  manufacturer  customer  base  share  similar
characteristics in the nature of their products and services, production processes, class of customer, product distribution methods,
and regulatory environment.  Based on the applicable accounting guidance, four of the regions – South America, Africa, Europe,
and Asia – are aggregated into a single reporting segment, “Other Regions”, because they also have similar economic characteristics.
North America is reported as an individual operating segment because its economic characteristics differ from the other regions,
generally because its operations require lower working capital investments for crop financing and inventory.  The Dark Air-Cured,
Oriental and Special Services segments, which have dissimilar characteristics in some of the categories mentioned above, are reported
together as “Other Tobacco Operations” because each is below the measurement threshold for separate reporting.

Universal  incurs  overhead  expenses  related  to  senior  management,  sales,  finance,  legal,  and  other  functions  that  are
centralized at its corporate headquarters, as well as functions performed at several sales and administrative offices around the world.
These overhead expenses are allocated to the various operating segments, generally on the basis of tobacco volumes planned to be
purchased and/or processed.  Management believes this method of allocation is representative of the value of the related services
provided to the operating segments.  The Company evaluates the performance of its segments based on operating income after
allocated overhead expenses, plus equity in the pretax earnings of unconsolidated affiliates.

89

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Reportable segment data as of, or for, the fiscal years ended March 31, 2020, 2019, and 2018, is as follows:

Sales and Other Operating Revenues

Operating Income

Fiscal Year Ended March 31,

Fiscal Year Ended March 31,

2020

2019

2018

2020

2019

2018

Flue-Cured and Burley Leaf Tobacco Operations:

North America ......................................................... $

236,262

$

382,631

$

308,691

$

8,353

$

23,069

$

23,091

Other Regions 

(1) ....................................................

1,372,424

1,569,738

1,482,188

Subtotal ...............................................................

1,608,686

1,952,369

1,790,879

Other Tobacco Operations 

(2)

 ......................................

301,293

274,784

243,068

Segment total ...............................................................

1,909,979

2,227,153

2,033,947

110,766

119,119

19,002

138,121

151,527

174,596

12,176

186,772

146,761

169,852

10,098

179,950

Deduct: Equity in pretax earnings of unconsolidated

affiliates (3)

Restructuring and impairment costs 

 ................................................
(4)  .........

(4,211)

(7,543)

(5,299)

(20,304)

(9,125)

—

Consolidated total ........................................................ $

1,909,979

$

2,227,153

$

2,033,947

$

126,367

$

161,169

$

170,825

Segment Assets

March 31,

Accounts Receivable, net (5)

March 31,

2020

2019

2018

2020

2019

2018

Flue-Cured and Burley Leaf Tobacco Operations:

   North America ...................................................... $

290,720

$

294,064

$

368,672

$

33,232

$

31,939

$

44,726

   Other Regions 

(1)

  .................................................

1,335,814

1,473,100

1,460,961

      Subtotal .........................................................
(2) ......................................

Other Tobacco Operations 

1,626,534

1,767,164

1,829,633

494,387

366,020

338,999

250,698

283,930

56,781

295,442

327,381

40,729

296,213

340,939

36,180

Segment and consolidated totals.................................. $

2,120,921

$

2,133,184

$

2,168,632

$

340,711

$

368,110

$

377,119

Goodwill and Intangibles, net

Depreciation and Amortization

March 31,

Fiscal Year Ended March 31,

2020

2019

2018

2020

2019

2018

Flue-Cured and Burley Leaf Tobacco Operations:

   North America ...................................................... $
   Other Regions (1) ................................

      Subtotal .........................................................
(2) .........................

Other Tobacco Operations 

— $

— $

— $

4,413

$

4,756

$

4,772

96,308

96,308

48,379

96,281

96,281

1,713

97,214

97,214

1,713

24,211

28,624

9,755

24,088

28,844

8,306

24,547

29,319

5,574

Segment and consolidated totals.................................. $

144,687

$

97,994

$

98,927

$

38,379

$

37,150

$

34,893

Capital Expenditures

Fiscal Year Ended March 31,

2020

2019

2018

Flue-Cured and Burley Leaf Tobacco Operations:

   North America ...................................................... $

1,997

$

3,137

$

3,316

   Other Regions 

(1) .................................................

      Subtotal .........................................................

Other Tobacco Operations 

(2)

  ......................................

28,229

30,226

5,001

22,569

25,706

13,054

21,820

25,136

8,901

Segment and consolidated totals.................................. $

35,227

$

38,760

$

34,037

90

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(1)

Includes South America, Africa, Europe, and Asia regions, as well as inter-region eliminations.

(2)

(3)

(4)

Includes Dark Air-Cured, Oriental, and Special Services, as well as intercompany eliminations.  Sales and other operating revenues, accounts receivable, goodwill
and intangibles, depreciation and amortization, and capital expenditures include limited amounts or no amounts for Oriental because the business is accounted
for on the equity method and its financial results consist principally of equity in the pretax earnings of the unconsolidated affiliate.  The investment in the
unconsolidated affiliate is included in segment assets and was approximately $76.4 million, $79.2 million, and $89.3 million, at March 31, 2020, 2019, and
2018, respectively.

Equity in pretax earnings of unconsolidated affiliates is included in segment operating income (Other Tobacco Operations segment), but is reported below
consolidated operating income and excluded from that total in the consolidated statements of income.

Restructuring  and  impairment  costs  are  excluded  from  segment  operating  income,  but  are  included  in  consolidated  operating  income  in  the  consolidated
statements of income (see Note 4).

(5) Accounts receivable, net includes allowances for doubtful accounts of approximately $2.0 million, $3.0 million and $2.0 million at March 31, 2020, 2019, and

2018 respectively.  Accounts receivable are generally unsecured and due within 30 days.

Geographic data as of, or for, the fiscal years ended March 31, 2020, 2019, and 2018, is presented below. Sales and other
operating revenues are attributed to individual countries based on the final destination of the shipment. Long-lived assets generally
consist of net property, plant, and equipment, goodwill, and other intangibles.

Geographic Data

Sales and Other Operating Revenues

Fiscal Year Ended March 31,

2020

2019

2018

Belgium ..................................................................................................................................................... $

361,889

$

390,433

$

339,391

United States..............................................................................................................................................

China .........................................................................................................................................................

Germany ....................................................................................................................................................

Poland........................................................................................................................................................

Indonesia ...................................................................................................................................................

Philippines .................................................................................................................................................

221,428

105,683

104,525

84,011

80,891

68,143

227,771

115,174

166,397

145,478

104,268

69,820

All other countries .....................................................................................................................................

883,409

1,007,812

249,281

120,859

114,386

110,445

73,544

52,902

973,139

Consolidated total...................................................................................................................................... $

1,909,979

$

2,227,153

$

2,033,947

Long-Lived Assets

March 31,

2020

2019

2018

United States.............................................................................................................................................. $

145,764

$

81,270

$

88,196

Brazil .........................................................................................................................................................

Mozambique..............................................................................................................................................

All other countries .....................................................................................................................................

138,157

42,964

132,955

139,624

45,051

134,543

141,087

47,800

145,638

Consolidated total...................................................................................................................................... $

459,840

$

400,488

$

422,721

91

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 18. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table summarizes the changes in the balances for each component of accumulated other comprehensive

income (loss) attributable to the Company for the fiscal years ended March 31, 2020, 2019, and 2018:

(in thousands of dollars)

Foreign currency translation:

Fiscal Year Ended March 31,

2020

2019

2018

Balance at beginning of year........................................................................................................................

$ (40,101) $ (23,942) $ (33,138)

Other comprehensive income (loss) attributable to Universal Corporation:

Net gain (loss) on foreign currency translation (net of tax (expense) benefit of $180 in 2020 and

$(5,806) in 2018) ...................................................................................................................................

(3,066)

(16,316)

14,162

Less: Net loss on foreign currency translation attributable to noncontrolling interests ............................

244

157

372

Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes.............

(2,822)

(16,159)

14,534

Other changes:

Reclassification to retained earnings

(5) .................................................................................................
Balance at end of year ..................................................................................................................................

—

—

(5,338)

$ (42,923) $ (40,101) $ (23,942)

Foreign currency hedge:

Balance at beginning of year........................................................................................................................

$

(376) $

(35) $

(258)

Other comprehensive income (loss) attributable to Universal Corporation:

Net gain (loss) on derivative instruments (net of tax (expense) benefit of $2,880, $602, and $(944)).....
Reclassification of net (gain) loss to earnings (net of tax expense (benefit) of $136, $(640), and

(12,391)

(6,490)

1,416

$827)

(1) .............................................................................................................
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes.............

Balance at end of year ..................................................................................................................................

$ (12,226) $

(376) $

541

6,149

(1,193)

(11,850)

(341)

223

(35)

Interest rate hedge:

Balance at beginning of year........................................................................................................................

$

(934) $

6,528

$

1,398

Other comprehensive income (loss) attributable to Universal Corporation:

Net gain (loss) on derivative instruments (net of tax (expense) benefit of $6,801, $1,574, and $(1,182)
Reclassification of net (gain) loss to earnings (net of tax expense (benefit) of $234, $409, and

(25,588)

(5,922)

3,687

(2) .....................................................................................................................................................................
$(433))
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes.............

(880)

(26,468)

(1,540)

(7,462)

811

4,498

Other changes:

Reclassification to retained earnings

(5) .................................................................................................
Balance at end of year ..................................................................................................................................

—

—

632

$ (27,402) $

(934) $

6,528

Pension and other postretirement benefit plans:

Balance at beginning of year........................................................................................................................

$ (54,280) $ (42,615) $ (37,561)

Other comprehensive income (loss) attributable to Universal Corporation:

Net gain (loss) arising during the year (net of tax (expense) benefit of $4,715, $4,073, and $(527))

(3) ..
(4) ............................
Other comprehensive income (loss) attributable to Universal Corporation, net of income taxes.............

Amortization included in earnings (net of tax benefit of $(554), $(628), and $(933))

(16,810)

(13,927)

2,044

2,262

(14,766)

(11,665)

295

2,318

2,613

Other changes:

Reclassification to retained earnings

(5) .................................................................................................
Balance at end of year ..................................................................................................................................

—

—

(7,667)

$ (69,046) $ (54,280) $ (42,615)

Total accumulated other comprehensive income (loss) at end of year ...........................................................

$(151,597) $ (95,691) $ (60,064)

92

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
(1)   

Gain (loss) on foreign currency cash flow hedges related to forecast purchases of tobacco is reclassified from accumulated other comprehensive
income (loss) to cost of goods sold when the tobacco is sold to customers. See Note 11 for additional information.

(2)  

(3)   

(4)  

Gain (loss) on interest rate cash flow hedges is reclassified from accumulated other comprehensive income (loss) to interest expense when
the related interest payments are made on the debt for open interest rate swap agreements, or as amortized to interest expense over the period
to original maturity for terminated swap agreements. See Note 11 for additional information.

These items arise from the remeasurement of the assets and liabilities of the Company's defined benefit pension and other postretirement
benefit plans.  Those remeasurements are made on an annual basis at the end of the fiscal year.  See Note 13 for additional information.

This accumulated other comprehensive income (loss) component is included in the computation of net periodic benefit cost. See Note 13 for
additional information.

(5)     

In  the  fourth  quarter  of  fiscal  year  2018,  the  Company  adopted  FASB  Accounting  Standards  Update  2018-02,  which  addressed  the
disproportionate income tax effects on pretax amounts recorded in accumulated other comprehensive income (loss) arising from the enactment
of the Tax Cuts and Jobs Act of 2017.  With the adoption of ASU 2018-02, the disproportionate tax effects were reclassified to retained earnings,
and the resulting tax effects remaining in accumulated other comprehensive income (loss) are reflective of the rates which those amounts will
ultimately be taxed.

93

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 19.   UNAUDITED QUARTERLY FINANCIAL DATA 

Unaudited quarterly financial data for the fiscal years ended March 31, 2020 and 2019 is provided in the table below.  Due
to the seasonal nature of the Company's business, management believes it is generally more meaningful to focus on cumulative rather
than quarterly results.

First 
Quarter

Second 
Quarter

Third 
Quarter

Fourth 
Quarter

Fiscal Year Ended March 31, 2020

Operating Results:

Sales and other operating revenues ...................................................................... $

296,915

$

475,921

$

505,049

$

632,094

Gross profit...........................................................................................................

Net income ...........................................................................................................

Net income attributable to Universal Corporation ...............................................

Earnings per common share:

Basic.................................................................................................................

Diluted..............................................................................................................

58,650

895

2,072

0.08

0.08

96,029

29,747

28,077

1.12

1.11

92,973

29,318

25,966

1.04

1.04

109,160

18,043

15,565

0.63

0.63

Cash Dividends Declared:

Per share of common stock ..................................................................................

0.76

0.76

0.76

0.76

Market Price Range of Common Stock:

High ......................................................................................................................

Low.......................................................................................................................

60.94

51.02

62.70

49.39

57.06

50.27

58.14

38.58

Fiscal Year Ended March 31, 2019

Operating Results:

Sales and other operating revenues ...................................................................... $

379,719

$

539,604

$

636,107

$

671,723

Gross profit...........................................................................................................

Net income ...........................................................................................................

Net income attributable to Universal Corporation ...............................................

Earnings per common share:

Basic.................................................................................................................

Diluted..............................................................................................................

72,221

11,060

13,179

0.53

0.52

99,460

34,293

31,446

1.25

1.24

115,430

31,089

28,135

1.12

1.11

119,480

33,692

31,361

1.25

1.24

Cash Dividends Declared:

Per share of common stock ..................................................................................

0.75

0.75

0.75

0.75

Market Price Range of Common Stock:

High ......................................................................................................................

Low.......................................................................................................................

68.25

46.40

71.60

55.66

76.98

53.03

60.67

52.60

Note:

Earnings per share amounts for each fiscal year may not equal the total of the four quarterly amounts due to differences in
weighted-average outstanding shares for the respective periods.

94

UNIVERSAL CORPORATION 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Significant items included in the quarterly results were as follows:

Fiscal Year Ended March 31, 2020 

•

•

•

•

First Quarter – Net income attributable to Universal Corporation included $2.8 million of additional income tax expense
for the settlement of an income tax matter at a foreign subsidiary. The increase in income tax expense reduced diluted
earnings per share for the quarter by $0.11. 

Second  Quarter  –  Net  income  attributable  to  Universal  Corporation  included  $0.9  million  in  non-tax  deductible
transaction costs associated with the acquisition of FruitSmart, which was completed during the fourth quarter of fiscal
year 2020. These costs were primarily related to due diligence fees. These costs reduced diluted earnings per share for
the quarter by $0.04. 

Third Quarter – Net income attributable to Universal Corporation included additional non-tax deductible transaction
costs of $1 million associated with the acquisition of FruitSmart. These costs reduced diluted earnings per share for
the quarter by $0.04. 

Fourth Quarter – Results included $7.5 million in restructuring and impairment costs, primarily related to voluntary
workforce reductions at operations in North America (see Note 4). The restructuring and impairment costs included
employee termination benefits, as well as impairment charges related to certain property, plant, and equipment, and
other  noncurrent  assets.  The  restructuring  and  impairment  costs  reduced  net  income  attributable  to  Universal
Corporation by $6.3 million and diluted earnings per share by $0.25.  Net income attributable to Universal Corporation
was reduced by $2.1 million of costs relating to the expensing of a fair value adjustment to inventory associated with
the initial acquisition accounting for FruitSmart. These costs reduced diluted earnings per share by $0.08. Additionally,
net  income  attributable  to  Universal  Corporation  was  reduced  by  $2.8  million  of  additional  non-tax  deductible
transaction costs associated with the acquisition of FruitSmart. These costs reduced diluted earnings per share for the
quarter $0.11. 

Fiscal Year Ended March 31, 2019 

•

•

•

•

First  Quarter  –  Net  income  attributable  to  Universal  Corporation  included  a  $6.9  million  reduction  of  income  tax
expense for the reversal of amounts previously recorded for dividend withholding taxes on distributed and undistributed
retained earnings of a foreign subsidiary following the resolution of uncertainties with the local country taxing authorities
with respect to the inclusion of the tax under a tax holiday applicable to the subsidiary. The reduction of income tax
expense increased diluted earnings per share for the quarter by $0.27.

Second Quarter – Net income attributable to Universal Corporation included a $0.9 million additional reduction of
income tax expense for amounts previously recorded for dividend withholding taxes on distributed and undistributed
retained earnings of a foreign subsidiary due to the above-mentioned tax holiday.  The reduction of income tax expense
increased diluted earnings per share for the quarter by $0.03.

Third Quarter – Results included restructuring and impairment costs totaling $19.4 million, related to the Company's
operations in Tanzania (see Note 4).  The restructuring and impairment costs included employee termination benefits,
as well as impairment charges related to certain property, plant, equipment, and goodwill.  Those costs reduced net
income attributable to Universal Corporation by $15.8 million and diluted earnings per share by $0.62.

Fourth Quarter – Results included restructuring costs of approximately $0.9 million related to smaller operations, which
reduced net income attributable to Universal Corporation by approximately $0.6 million and diluted earnings per share
by $0.02. 

95

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm

To the Shareholders and the Board of Directors of Universal Corporation

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Universal Corporation (the Company) as of March 31, 2020 and
2019, the related consolidated statements of income, comprehensive income, shareholders’ equity and cash flows for each of the
three years in the period ended March 31, 2020, and the related notes and financial statement schedule listed in the Index at Item 15
(a)2 (collectively referred to as the “consolidated financial statements”).  In our opinion, the consolidated financial statements present
fairly, in all material respects, the financial position of the Company at March 31, 2020 and 2019, and the results of its operations
and  its  cash  flows  for  each  of  the  three  years  in  the  period  ended March 31,  2020,  in  conformity  with  U.S.  generally  accepted
accounting principles. 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB),
the Company’s internal control over financial reporting as of March 31, 2020, based on criteria established in Internal Control-
Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and
our report dated May 28, 2020 expressed an unqualified opinion thereon.

Adoption of New ASU No. 2016-02

As discussed in Note 10 to the consolidated financial statements, the Company changed its method of accounting for leases in 2020
due to the adoption of ASU No. 2016-02, Leases (Topic 842), as amended, effective April 1, 2019, using the modified retrospective
approach.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the
Company’s financial statements based on our audits.  We are a public accounting firm registered with the PCAOB and are required
to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether
due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial statements.  Our audits also included evaluating the accounting
principles  used  and  significant  estimates  made  by  management,  as  well  as  evaluating  the  overall  presentation  of  the  financial
statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were
communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material
to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of
critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are
not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts
or disclosures to which they relate.

96

Description of
the Matter

Allowance for Advances to Suppliers
The Company’s short-term and long-term advances to suppliers totaled approximately $153
million as of March 31, 2020, and the allowances totaled $16 million. As discussed in Note 1
of the financial statements, the Company provides agronomy services and seasonal advances
of seed, fertilizer, and other supplies to tobacco farmers for crop production. These advances
are  repaid  through  the  delivery  of  tobacco  to  the  Company.  Management  determined  the
allowance based on assumptions including the assessment of historical loss information and
crop projections. 

Auditing management’s estimate for the allowance on advances to suppliers was complex and
involved subjective auditor judgment as the estimate relies on a number of factors that are
affected  by  market  and  economic  conditions  outside  the  Company’s  control.  There  is
uncertainty associated with the assumptions used which could have a significant effect on the
allowance estimate.

How We
Addressed the
Matter in Our
Audit

We obtained an understanding, evaluated the design, and tested the operating effectiveness of
the Company’s internal controls over the allowance on the advances to suppliers. For example,
we tested controls over the supplier advance approval and management’s review and approval
of the models used to calculate the allowance. We also tested controls used by management
to evaluate the data used in making the estimates for completeness and accuracy.  

Description of
the Matter

To test the allowance for advances to suppliers, our audit procedures included, among others,
evaluating the significant assumptions used in the allowance calculation. For example, we
compared historical loss information to management’s estimate of projected crop yield and
analyzed the sensitivity of significant assumptions to evaluate the changes in the allowance
that would result from changes in the assumptions. We analyzed subsequent events to identify
potential sources of contrary information to management’s assumptions.

Allowance for Recoverable Value-Added Tax (“VAT”) Credits
The  Company’s  gross  balance  of  recoverable  value-added  tax  (“VAT”)  credits  totaled
approximately  $52  million  as  of  March  31,  2020,  and  the  related  allowance  totaled
approximately $19 million. As discussed in Note 1 of the financial statements, in many foreign
countries, the Company pays and receives a significant amount of VAT on purchases and sales
of  tobacco  and  tobacco  related  material.  Items  subject  to  a VAT  vary  from  jurisdiction  to
jurisdiction as do the rates at which the tax is assessed. Some jurisdictions allow companies
to apply for refunds of unused VAT credits from the tax authorities, but the refund process may
take an extended period of time and it is not uncommon for refund applications to be challenged
or rejected. Some jurisdictions also permit companies to sell or transfer unused VAT credits
to third parties in private transactions although the proceeds realized may be heavily discounted
from the face value of the credits. Management applied judgment in calculating the valuation
allowance to estimate the credits that are not expected to be recovered. 

Auditing  management’s  estimate  of  the VAT  allowance  was  complex  and  involved  a  high
degree of subjectivity as the estimate relies on a number of factors including interpretations
of applicable tax laws and regulations as well as economic and political conditions outside the
Company’s control. There is uncertainty associated with the assumptions used which could
have a significant effect on the estimate.

How We
Addressed the
Matter in Our
Audit

We obtained an understanding, evaluated the design, and tested the operating effectiveness of
the Company’s internal controls over the allowance on the VAT. For example, we tested controls
over  management’s  review  and  approval  of  the  models  used  in  the  allowance  and  the
completeness and accuracy of the data inputs and outputs used in the calculation.  

 To test the VAT allowance estimate, our audit procedures included, among others, evaluating
the significant assumptions used to estimate the VAT allowance and assessing the historical
accuracy of management’s estimates. For example, we evaluated whether the historical loss
of credits used in management’s calculation was representative of the current collectability of
the credits. We analyzed the sensitivity of significant assumptions to evaluate the changes in
the  allowance  that  that  would  result  from  changes  in  the  assumptions  and  we  considered
subsequent  events  to  identify  potential  sources  of  contrary  information  to  management’s
assumptions.

97

Description of
the Matter

Accounting for Acquisition of Fruitsmart
As described in Note 1 and 2 to the consolidated financial statements, on January 1, 2020 the
Company  acquired  100%  of  the  capital  stock  of  FruitSmart,  Inc.  (“FruitSmart”)  for
approximately $80 million in cash, up to $25 million of contingent consideration payments,
and  $3.8  million  of  working  capital  on-hand  at  the  date  of  acquisition. The  acquisition  of
FruitSmart was accounted for as a business combination. 

Auditing  the  Company's  accounting  for  its  business  combination  was  complex  due  to  the
significant estimation required by management to determine the fair value of the contingent
consideration ($6.7 million) and identifiable intangible assets including customer relationships
($9.5  million).  Significant  estimation  was  required  due  to  the  application  of  the  valuation
models  and  assumptions  used  by  management  to  measure  the  fair  value  of  the  contingent
consideration liability and the customer-related intangible asset.  The significant assumptions
used in determining the fair value included volatility, discount rate and forecasted results (e.g.,
revenue growth rates and operating profit margins).

How We
Addressed the
Matter in Our
Audit

We tested the Company's controls over its accounting for business combinations. For example,
we  tested  controls  over  the  recognition  and  measurement  of  consideration  transferred
(including  contingent  consideration)  and  the  customer-related  intangible  asset  acquired,
including management’s review over the valuation models and significant assumptions.

To test the estimated fair value of the contingent consideration and customer related intangible
asset, we performed audit procedures that included, among others, assessing the conditions
that  must  be  met  for  the  contingent  consideration  to  become  payable  and  the  significant
assumptions  used  in  the  estimated  fair  value  of  the  customer-related  intangible  asset  and
contingent  consideration.  For  example,  we  tested  the  completeness  and  accuracy  of  the
underlying  data  and  compared  the  significant  assumptions  to  current  industry,  market  and
economic  trends,  historical  results  of  the  acquired  business,  and  other  guidelines  used  by
companies  within  the  same  industry.  We  involved  our  valuation  specialists  to  assist  in
evaluating the Company's use of its valuation models. We performed a sensitivity analysis of
the significant assumptions to evaluate the change in the fair values that would result from
changes in assumptions.  

/s/ Ernst & Young LLP

We have served as the Company’s auditor since 1971.
Richmond, Virginia
May 28, 2020

98

 Report of Ernst & Young LLP, Independent Registered Public Accounting Firm, 
on Internal Control Over Financial Reporting

To the Shareholders and the Board of Directors of Universal Corporation

Opinion on Internal Control over Financial Reporting

We have audited Universal Corporation’s internal control over financial reporting as of March 31, 2020, based on criteria established
in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013
framework) (the COSO criteria).  In our opinion, Universal Corporation, (the Company) maintained, in all material respects, effective
internal control over financial reporting as of March 31, 2020, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB),
the consolidated balance sheets of the Company as of March 31, 2020 and 2019, and the related consolidated statements of income,
comprehensive income, shareholders’ equity and cash flows for each of the three years in the period ended March 31, 2020, and the
related notes and financial statement schedule listed in the Index at Item 15(a)2 report dated May 28, 2020 expressed an unqualified
opinion thereon.

As indicated in the accompanying Management’s Report on Internal Control over Financial Reporting, management’s assessment
of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Fruitsmart,
Inc., which is included in the 2020 consolidated financial statements of the Company and constituted 5% and 8% of total and net
assets, respectively, as of March 31, 2020 and 1% and (3)% of net sales and net income, respectively, for the year then ended. Our
audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over
financial reporting of Fruitsmart, Inc. 

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment
of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal
Control over Financial Reporting.  Our responsibility is to express an opinion on the Company’s internal control over financial
reporting based on our audit.  We are a public accounting firm registered with the PCAOB and are required to be independent with
respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness
exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing
such other procedures as we considered necessary in the circumstances.  We believe that our audit provides a reasonable basis for
our opinion.

Definitions and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability
of  financial  reporting  and  the  preparation  of  financial  statements  for  external  purposes  in  accordance  with  generally  accepted
accounting principles.  A company’s internal control over financial reporting includes those policies and procedures that (1) pertain
to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets
of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being
made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance
regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a
material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes
in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Ernst & Young LLP

Richmond, Virginia

May 28, 2020

99

Item 9.   Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 

For the three years ended March 31, 2020, there were no changes in independent auditors, nor were there any disagreements

between the Company and its independent auditors on any matter of accounting principles, practices, or financial disclosures.

Item 9A.  Controls and Procedures

Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be
disclosed in reports filed by the Company under the Exchange Act is recorded, processed, summarized and reported within the time
periods  specified  in  the  SEC  rules  and  forms  and  that  such  information  is  accumulated  and  communicated  to  the  Company’s
management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding
required disclosure.  The Company’s Chief Executive Officer and Chief Financial Officer evaluated, with the participation of the
Company’s management, the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rule
13a-15(e)), as of the end of the period covered by this Annual Report. Based on this evaluation, the Company’s management, including
its Chief Executive Officer and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were
effective.  

Management’s Report on Internal Control Over Financial Reporting

The  Company’s  management  is  responsible  for  establishing  and  maintaining  effective  internal  control  over  financial
reporting as defined in Rule 13a-15(f) under the Exchange Act.  The Company’s internal control over financial reporting is designed
to provide reasonable assurance to management and the Board of Directors regarding the preparation and fair presentation of the
consolidated financial statements.  Due to inherent limitations, internal control over financial reporting may not prevent or detect all
errors or misstatements in the financial statements, and even control procedures that are determined to be effective can provide only
reasonable  assurance  with  respect  to  financial  statement  preparation  and  presentation.   Also,  projections  of  any  evaluation  of
effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions.

As required by Exchange Act Rule 13a-15(c), the Company’s Chief Executive Officer and Chief Financial Officer, with
the participation of other members of management, assessed the effectiveness of the Company’s internal control over financial
reporting as of March 31, 2020.  The evaluation was based on the criteria set forth in “Internal Control – Integrated Framework”
issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (“the COSO criteria”).  We
have  excluded  FruitSmart,  Inc.  (FruitSmart),  our  wholly-owned  subsidiary  which  is  included  in  our  Consolidated  Financial
Statements, from our assessment of internal control over financial reporting as of March 31, 2020. FruitSmart represented $104.3
million (5%) of consolidated total assets as of March 31, 2020 and $18.1 million (1%) of consolidated sales and other operating
revenues for the fiscal year then ended.  Based on this assessment, the Company’s management concluded that the Company’s internal
control over financial reporting was effective at the reasonable assurance level as of March 31, 2020.

The Company’s independent registered public accounting firm, Ernst & Young LLP, has audited the Company’s internal

control over financial reporting as of March 31, 2020.  Their report on this audit appears on page 90 of this Annual Report.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s last
fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial
reporting.

Item 9B.   Other Information

None.

100

Item 10.   Directors, Executive Officers, and Corporate Governance 

PART III

Except as to the matters set forth below, information required by this Item is incorporated herein by reference to the Company’s

2020 Proxy Statement.     

The following are executive officers of the Company as of May 28, 2020:

Name and Age
G. C. Freeman, III (57) Chairman, President, and

Position

Chief Executive Officer

A. L. Hentschke (50)

Senior Vice President and
Chief Operating Officer

J. C. Kroner (52)

Senior Vice President and
Chief Financial Officer

T. G. Broome (66)

Executive Vice President and
Sales Director, Universal
Leaf Tobacco Company, Inc.

P. D. Wigner (51)

Vice President, General
Counsel and Secretary

C. H. Claiborne (59)

Vice President and Assistant
Secretary

Business Experience During Past The Five Years
Mr. Freeman was elected Chairman of the Board in August 2008, Chief
Executive Officer effective April 2008, President in December 2006,
and Vice President in November 2005. Mr. Freeman served as General
Counsel and Secretary from February 2001 until November 2005 and
has been employed with the Company since 1997.

Mr. Hentschke was elected Senior Vice President and Chief Operating
Officer in April 2015.  From January 2013 to April 2015, he served as
Executive  Vice  President  of  Universal  Leaf  Tobacco  Company,
Incorporated  ("Universal  Leaf").    From  November  2009  to  January
2013, Mr. Hentschke served as President and Chief Executive Officer
of  Universal  Leaf  Tabacos,  Limitada,  the  Company's  operating
subsidiary in Brazil.  He has been employed with the Company and its
affiliates since 1991.

Mr.  Kroner  was  elected  Senior  Vice  President  and  Chief  Financial
Officer effective September 2018.  Mr. Kroner was elected Senior Vice
President  in  February  2018.  He  served  as  Senior  Vice  President  of
Universal Leaf from September 2014 to September 2018.  He served
as Vice President from October 2011 to September 2014.  He has been
employed with the Company since July 1993.

Mr. Broome was elected Executive Vice President and Sales Director,
Universal Leaf, in October 2012.  From April 2011 through October
2012, Mr. Broome served as Executive Vice President.  From September
1998 through March 2011, Mr. Broome served as Senior Vice President-
Sales.  He has been employed with the Company since 1994.

Mr. Wigner was elected Vice President in August 2007, and General
Counsel  and  Secretary  in  November  2005  and  also  served  as  Chief
Compliance Officer from November 2007 until September 2012. Mr.
Wigner served as Senior Counsel of Universal Leaf from November
2004 until November 2005.  He has been employed with the Company
since 2003.
Mrs.  Claiborne  was  elected  Vice  President  and  Assistant  Secretary
effective February 2018. She served as Assistant Secretary from  2001
to February 2018.  From October 2004 to February 2018, Mrs. Claiborne
served as Vice President, Associate General Counsel, and Secretary of
Universal  Leaf.  She  has  been  employed  with  the  Company  since
December 1999.

C. C. Formacek (59)

Vice President and Treasurer Ms. Formacek was elected Vice President and Treasurer effective April
2012.  Ms. Formacek served as Treasurer of Universal Leaf from April
2011 through March 2012.  She joined the Company in September 2009
and  served  as Assistant  Treasurer  of  Universal  Leaf  from  that  time
through March 2011.

S.J. Bleicher (43)

Vice President and Controller Mr. Bleicher was elected Vice President and Controller in June 2019.
Mr. Bleicher joined the Company in August 2014 and served as Assistant
Controller through May 2019.

There are no family relationships between any of the above officers.

101

The Company has a Code of Conduct that includes the NYSE requirements for a “Code of Business Conduct and Ethics”
and the SEC requirements for a “Code of Ethics for Senior Financial Officers.”  The Code of Conduct is applicable to all officers,
employees, and outside directors of the Company, including the principal executive officer, principal financial officer, and principal
accounting  officer.   A  copy  of  the  Code  of  Conduct  is  available  through  the  “Corporate  Governance-Overview”  section  of  the
Company’s website at www.universalcorp.com.  If the Company amends a provision of the Code of Conduct, or grants a waiver
from any such provision to a director or executive officer, the Company will disclose such amendments and the details of such
waivers on the Company’s website www.universalcorp.com to the extent required by the SEC or the NYSE. 

The information required by Items 407(c)(3), (d)(4) and (d)(5) of Regulation S-K is contained under the captions “Corporate
Governance and Committees—Committees of the Board—Compensation Committee,” “Corporate Governance and Committees—
Committees of the Board—Audit Committee” of the Company’s 2020 Proxy Statement and such information is incorporated by
reference herein.

Item 11.   Executive Compensation 

Refer to the captions “Executive Compensation” and “Directors’ Compensation” in the Company’s 2020 Proxy Statement,

which information is incorporated herein by reference. 

Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 

Refer to the caption “Stock Ownership” in the Company’s 2020 Proxy Statement, which information is incorporated herein

by reference. 

Item 13.   Certain Relationships and Related Transactions, and Director Independence    

Refer to the caption “Certain Transactions” in the Company’s 2020 Proxy Statement, which information is incorporated
herein by reference. The information required by Item 407(a) of Regulation S-K is contained under the caption “Corporate Governance
and Committees—Director Independence” of the Company’s 2020 Proxy Statement and such information is incorporated by reference
herein.

Item 14.   Principal Accounting Fees and Services 

Refer to the captions “Audit Information – Fees of Independent Auditors” and “Audit Information – Pre-Approval Policies

and Procedures” in the Company’s 2020 Proxy Statement, which information is incorporated herein by reference.

102

Item 15.   Exhibits, Financial Statement Schedules 

(a)

The following are filed as part of this Annual Report:

1. Financial Statements. 

PART IV 

Consolidated Statements of Income for the Fiscal Years Ended March 31, 2020, 2019, and 2018 
Consolidated Statements of Comprehensive Income for the Fiscal Years Ended March 31, 2020, 2019, and 2018
Consolidated Balance Sheets at March 31, 2020 and 2019 
Consolidated Statements of Cash Flows for the Fiscal Years Ended March 31, 2020, 2019, and 2018 
Consolidated Statements of Changes in Shareholders’ Equity for the Fiscal Years Ended March 31, 2020, 2019,
and 2018 
Notes to Consolidated Financial Statements for the Fiscal Years Ended March 31, 2020, 2019, and 2018 
Report of Ernst & Young LLP, Independent Registered Public Accounting Firm
Report of Ernst & Young LLP, Independent Registered Public Accounting Firm, on Internal Control Over Financial
Reporting

2. Financial Statement Schedules. 

Schedule II – Valuation and Qualifying Accounts

3. Exhibits.  The exhibits are listed in the Exhibit Index immediately prior to the signature pages to this Annual Report.

(b)

Exhibits

The response to this portion of Item 15 is submitted as a separate section to this Annual Report.

(c)

Financial Statement Schedules

Schedule II – Valuation and Qualifying Accounts appears on the following page of this Annual Report.  All other
schedules are not required under the related instructions or are not applicable and therefore have been omitted. 

Item 16.   Form 10-K Summary

None.

103

Schedule II - Valuation and Qualifying Accounts
Universal Corporation
Fiscal Years Ended March 31, 2020, 2019, and 2018 

Description

(in thousands of dollars)

Fiscal Year Ended March 31, 2018:

Allowance for doubtful accounts (deducted from accounts

receivable) ...........................................................................

$

Balance at
Beginning
of Year

Net
Additions
(Reversals)
Charged
to Expense

Additions
Charged
to Other
Accounts

Deductions (1)

Balance
at End
of Year

3,947

$

(2,006) $

— $

(158) $

1,783

Allowance for supplier accounts (deducted from advances

to suppliers and other noncurrent assets).............................

27,074

3,730

Allowance for recoverable taxes (deducted from other

current assets and other noncurrent assets)..........................

12,552

1,732

—

—

(9,084)

21,720

395

14,679

Fiscal Year Ended March 31, 2019:

Allowance for doubtful accounts (deducted from accounts

receivable) ...........................................................................

$

1,783

$

1,358

$

— $

(156) $

2,985

Allowance for supplier accounts (deducted from advances

to suppliers and other noncurrent assets).............................

21,720

(2,339)

Allowance for recoverable taxes (deducted from other

current assets and other noncurrent assets)..........................

14,679

3,535

—

—

(1,276)

18,105

(1,033)

17,181

Fiscal Year Ended March 31, 2020:

Allowance for doubtful accounts (deducted from accounts

receivable) ...........................................................................

$

2,985

$

(128) $

— $

(463) $

2,394

Allowance for supplier accounts (deducted from advances

to suppliers and other noncurrent assets).............................

18,105

937

Allowance for recoverable taxes (deducted from other

current assets and other noncurrent assets)..........................

17,181

(2,586)

—

—

(2,614)

16,428

4,183

18,778

(1)

  Includes direct write-offs of assets and currency remeasurement.

104

EXHIBIT INDEX

3.1 Amended and Restated Articles of Incorporation, effective August 9, 2011 (incorporated herein by reference to the

Registrant’s Current Report on Form 8-K Registration Statement filed August 9, 2011, File No. 001-00652).

3.2 Amended and Restated Bylaws (as of April 9, 2019) (incorporated herein by reference to the Registrant’s Current Report

on Form 8-K dated April 12, 2019, File No. 001-00652).

4.1 Description of Registrant's Securities Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended.*

4.2

Indenture between the Registrant and Chemical Bank, as trustee (incorporated herein by reference to the Registrant’s
Current Report on Form 8-K dated February 25, 1991, File No. 001-00652).

4.3 Specimen  Common  Stock  Certificate  (incorporated  herein  by  reference  to  the  Registrant’s Amendment  No.  1  to

Registrant’s Form 8-A Registration Statement, dated May 7, 1999, File No. 001-00652).

10.1 Form of Universal Leaf Tobacco Company, Incorporated Executive Life Insurance Agreement (incorporated herein by
reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994, File No. 001-00652).

10.2 Universal  Leaf  Tobacco  Company,  Incorporated  Deferred  Income  Plan  (incorporated  herein  by  reference  to  the

Registrant’s Report on Form 8-K, dated February 8, 1991, File No. 001-00652).

10.3 Universal Leaf Tobacco Company, Incorporated Benefit Replacement Plan (incorporated herein by reference to the

Registrant’s Report on Form 8-K, dated February 8, 1991, File No. 001-00652).

10.4 Universal Leaf Tobacco Company, Incorporated 1994 Benefit Replacement Plan (incorporated herein by reference to
the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1994, File No. 001-00652).

10.5 Universal Leaf Tobacco Company, Incorporated 1996 Benefit Restoration Plan (incorporated herein by reference to
the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1996, File No. 001-00652).

10.6 Universal Leaf Tobacco Company, Incorporated 1994 Deferred Income Plan, amended and restated as of July 1, 1998
(incorporated herein by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September
30, 1998, File No. 001-00652).

10.7 Universal Corporation Outside Directors’ Deferred Income Plan, restated as of October 1, 1998 (incorporated herein
by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1998, File No.
001-00652).

10.8 Revised Form of Universal Corporation Non-Employee Director Restricted Stock Agreement (incorporated herein by

reference to the Registrant’s Current Report on Form 8-K dated June 9, 2010, File No. 001-00652).

10.9 Form Change of Control Agreement (incorporated herein by reference to the Registrant’s Current Report on Form 8-

K filed November 10, 2008, File No. 001-00652).

10.10 Universal  Corporation  Director’s  Charitable Award  Program  (incorporated  herein  by  reference  to  the  Registrant’s

Annual Report on Form 10-K for the fiscal year ended June 30, 1998, File No. 001-00652).

10.11 Universal Corporation 1997 Executive Stock Plan, as amended on August 7, 2003 (incorporated herein by reference
to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, File No. 001-00652).

10.12 Universal Corporation 2002 Executive Stock Plan, as amended on August 7, 2003 (incorporated herein by reference
to the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, File No. 001-00652).

10.13 Form of Restricted Stock Units Award Agreement (incorporated herein by reference to the Registrant’s Current Report

on Form 8-K filed November 10, 2008, File No. 001-00652).

10.14 Universal Corporation 2007 Amended and Restated Stock Incentive Plan effective August 7, 2012 (incorporated herein

by reference to Exhibit A to the Registrant’s definitive proxy statement filed June 28, 2012, File No. 001-00652).

105

10.15 Amended  and  Restated  Universal  Corporation  Executive  Officer  Annual  Incentive  Plan  (incorporated  herein  by

reference to the Registrant's definitive proxy statement filed July 24, 2019, File No. 001-00652).

10.16 Universal Corporation 2017 Stock Incentive Plan (incorporated herein by reference to the Registrant's definitive proxy

statement filed June 26, 2017 (File No. 001-00652).

10.17 Form of Universal Corporation 2010 Restricted Stock Units Agreement with Schedule of Awards to named executive
officers (incorporated herein by reference to the Registrant’s Annual Report on Form 10-K for the fiscal year ended
March 31, 2010, File No. 001-00652).

10.18 Universal Leaf Tobacco Company, Incorporated Deferred Income Plan III, amended and restated as of December 31,
2008 (incorporated herein by reference to the Registrant's Annual Report on Form 10-K for the fiscal year ended March
31, 2010, File No. 001-00652).

10.19 Universal Corporation Outside Directors' Deferred Income Plan III, amended and restated as of December 31, 2008,
and amended as of February 1, 2010 (incorporated herein by reference to the Registrant's Annual Report on Form 10-
K for the fiscal year ended March 31, 2010, File No. 001-00652).

10.20 Form of Universal Corporation 2011 Restricted Stock Units Award Agreement (incorporated herein by reference to the

Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).

10.21 Form  of  Universal  Corporation  Performance  Share  Award  Agreement  (incorporated  herein  by  reference  to  the

Registrant's Annual Report on Form 10-K for the fiscal year ended March 31, 2011, File No. 001-00652).

10.22 Credit Agreement dated December 20, 2018 among the Company, JPMorgan Chase Bank, N.A., as Administrative
Agent, SunTrust Bank and AgFirst Farm Credit Bank, as Co-Syndication Agents and Keybank National Association
and  Capital  One,  National  Association,  as  Co-Documentation  Agents  (incorporated  herein  by  reference  to  the
Registrant’s Current Report on Form 8-K dated December 21, 2018 (December 20, 2018), File No. 001-00652).

10.23 Stock Purchase Agreement, dated as of November 20, 2019, by and among Universal Corporation, FruitSmart, Inc.,
the Sellers named therein and James P. Early, as the Sellers’ Representative (incorporated herein by reference to the
Registrant’s Current Report on Form 8-K, filed November 20, 2019, File No. 001-00652)

21 Subsidiaries of the Registrant.*

23 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.*

31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1 Statement of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350.*

32.2 Statement of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350.*

101

Interactive Data Files (submitted electronically herewith)*

101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its
XBRL tags are embedded within the Inline XBRL document.  101.SCH XBRL Taxonomy Extension Schema Document
101.CAL  XBRL  Taxonomy  Extension  Calculation  Linkbase  Document  101.DEF  XBRL  Taxonomy  Extension
Definition  Linkbase  Document  101.LAB  XBRL Taxonomy  Extension  Label  Linkbase  Document  101.PRE  XBRL
Taxonomy Extension Presentation Linkbase Document  In accordance with Rule 406T of Regulation S-T, the XBRL
related information in Exhibit 101 to this Annual Report on Form 10-K shall not be deemed to be “filed” for purposes
of Section 18 of the Exchange Act, or otherwise subject to the liability of that section and shall not be part of any
registration or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth
by specific reference in such filing.

_________

* Filed herewith.

106

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has

duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

SIGNATURES 

May 28, 2020

UNIVERSAL CORPORATION

By:

/s/  GEORGE C. FREEMAN, III
George C. Freeman, III
Chairman, President, and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the

following persons on behalf of the Registrant and in the capacities and on the dates indicated. 

Signature
/s/  GEORGE C. FREEMAN, III
George C. Freeman, III

Title

Chairman, President, Chief Executive Officer, and Director
(Principal Executive Officer)

/s/  JOHAN C. KRONER
Johan C. Kroner

Senior Vice President and Chief Financial Officer
(Principal Financial Officer)

/s/  SCOTT J. BLEICHER
Scott J. Bleicher

Vice President and Controller
(Principal Accounting Officer)

/s/  DIANA F. CANTOR
Diana F. Cantor

/s/  LENNART R. FREEMAN
Lennart R. Freeman

/s/  THOMAS H. JOHNSON
Thomas H. Johnson

/s/  MICHAEL T. LAWTON
Michael T. Lawton

/s/  EDDIE N. MOORE, JR.
Eddie N. Moore, Jr.

/s/  ROBERT C. SLEDD
Robert C. Sledd

/s/  THOMAS H. TULLIDGE, JR.
Thomas H. Tullidge, Jr.

/s/  JACQUELINE T. WILLIAMS
Jacqueline T. Williams

Director

Director

Director

Director

Director

Director

Director

Director

107

Date
May 28, 2020

May 28, 2020

May 28, 2020

May 28, 2020

May 28, 2020

May 28, 2020

May 28, 2020

May 28, 2020

May 28, 2020

May 28, 2020

May 28, 2020

SHAREHOLDER INFORMATION

Annual Meeting

SEC Form 10-K

The  Annual  Meeting  of  Shareholders  will  be  held 

Shareholders  may  obtain  additional  copies  of  the 

on Tuesday, August 4, 2020. We intend to hold the 

Company’s Annual Report on Form 10-K filed with the 

meeting at the offices of the Company, 9201 Forest 

Securities and Exchange Commission on its website 

Hill  Avenue,  Richmond,  Virginia.  We  are  actively 

or by writing to the Treasurer of the Company. 

monitoring  the  ongoing  COVID-19  pandemic,  and 

we  reserve  the  right  to  instead  hold  the  meeting 

Stock Listed

soley by means of remote communication.

New York Stock Exchange

Independent Registered Public Accounting Firm

Stock Symbol

Ernst & Young LLP 

The Edgeworth Building 

2100 East Cary Street, Suite 201 

Richmond, Virginia 23223

Investor Relations

Contact: 

     Candace C. Formacek 

        Vice President and Treasurer

UVV

Dividend Reinvestment Plan

The Company offers to its common shareholders an 

automatic dividend reinvestment and cash payment 

plan  to  purchase  additional  shares.  The  Company 

bears  all  brokerage  and  service  fees.  Booklets 

describing  the  plan  in  detail  are  available  upon 

request.

     Jennifer S. Rowe 

        Assistant Vice President, Capital Markets  

     (804) 254-3789

Transfer Agent & Registrar &  
Dividend Reinvestment Plan Agent

Broadridge Corporate Issuer Solutions 

Information Requests: 

     (804) 254-3789  

     or  

P.O. Box 1342 

Brentwood, New York 11717 

Toll-Free: (866) 804-4445 

Outside U.S.: (702) 414-6868 

     Email: investor@universalleaf.com

Email: shareholder@broadridge.com 

Dividend Payments

or 

Universal Corporation 

Dividend  declarations  are  subject  to  approval  by 

Investor Relations 

the  Company’s  Board  of  Directors.  Dividends  on 

(804) 254-3789

the  Company’s  common  stock  have  traditionally 

been  paid  quarterly  in  February,  May,  August,  and 

November to shareholders of record on the second 

Monday of the previous month.

P.O. Box 25099  •  Richmond, VA 23260
www.universalcorp.com